
<html lang="en"     class="pb-page"  data-request-id="631a108f-745a-4a18-abd6-4d2c9ea5460a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2011.54.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm2007084;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Rational Design of Phosphoinositide 3-Kinase α Inhibitors That Exhibit Selectivity over the Phosphoinositide 3-Kinase β Isoform" /></meta><meta name="dc.Creator" content="Timothy P.  Heffron" /></meta><meta name="dc.Creator" content="BinQing  Wei" /></meta><meta name="dc.Creator" content="Alan  Olivero" /></meta><meta name="dc.Creator" content="Steven T.  Staben" /></meta><meta name="dc.Creator" content="Vickie  Tsui" /></meta><meta name="dc.Creator" content="Steven  Do" /></meta><meta name="dc.Creator" content="Jennafer  Dotson" /></meta><meta name="dc.Creator" content="Adrian J.  Folkes" /></meta><meta name="dc.Creator" content="Paul  Goldsmith" /></meta><meta name="dc.Creator" content="Richard  Goldsmith" /></meta><meta name="dc.Creator" content="Janet  Gunzner" /></meta><meta name="dc.Creator" content="John  Lesnick" /></meta><meta name="dc.Creator" content="Cristina  Lewis" /></meta><meta name="dc.Creator" content="Simon  Mathieu" /></meta><meta name="dc.Creator" content="Jim  Nonomiya" /></meta><meta name="dc.Creator" content="Stephen  Shuttleworth" /></meta><meta name="dc.Creator" content="Daniel P.  Sutherlin" /></meta><meta name="dc.Creator" content="Nan Chi  Wan" /></meta><meta name="dc.Creator" content="Shumei  Wang" /></meta><meta name="dc.Creator" content="Christian  Wiesmann" /></meta><meta name="dc.Creator" content="Bing-Yan  Zhu" /></meta><meta name="dc.Description" content="Of the four class I phosphoinositide 3-kinase (PI3K) isoforms, PI3Kα has justly received the most attention for its potential in cancer therapy. Herein we report our successful approaches to achiev..." /></meta><meta name="Description" content="Of the four class I phosphoinositide 3-kinase (PI3K) isoforms, PI3Kα has justly received the most attention for its potential in cancer therapy. Herein we report our successful approaches to achiev..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 21, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm2007084" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm2007084" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm2007084" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm2007084" /></link>
        
    
    

<title>Rational Design of Phosphoinositide 3-Kinase α Inhibitors That Exhibit Selectivity over the Phosphoinositide 3-Kinase β Isoform | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm2007084" /></meta><meta property="og:title" content="Rational Design of Phosphoinositide 3-Kinase α Inhibitors That Exhibit Selectivity over the Phosphoinositide 3-Kinase β Isoform" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0017.jpeg" /></meta><meta property="og:description" content="Of the four class I phosphoinositide 3-kinase (PI3K) isoforms, PI3Kα has justly received the most attention for its potential in cancer therapy. Herein we report our successful approaches to achieve PI3Kα vs PI3Kβ selectivity for two chemical series. In the thienopyrimidine series of inhibitors, we propose that select ligands achieve selectivity derived from a hydrogen bonding interaction with Arg770 of PI3Kα that is not attained with the corresponding Lys777 of PI3Kβ. In the benzoxepin series of inhibitors, the selectivity observed can be rationalized by the difference in electrostatic potential between the two isoforms in a given region rather than any specific interaction." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm2007084"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm2007084">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm2007084&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm2007084&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm2007084&amp;href=/doi/10.1021/jm2007084" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 7815-7833</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200677b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2008826" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Rational Design of Phosphoinositide 3-Kinase α Inhibitors That Exhibit Selectivity over the Phosphoinositide 3-Kinase β Isoform<a class="ref internalNav" href="#pdb" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+P.++Heffron">Timothy P. Heffron</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=BinQing++Wei">BinQing Wei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan++Olivero">Alan Olivero</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+T.++Staben">Steven T. Staben</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vickie++Tsui">Vickie Tsui</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Do">Steven Do</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennafer++Dotson">Jennafer Dotson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adrian+J.++Folkes">Adrian J. Folkes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Goldsmith">Paul Goldsmith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Goldsmith">Richard Goldsmith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janet++Gunzner">Janet Gunzner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Lesnick">John Lesnick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Lewis">Cristina Lewis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon++Mathieu">Simon Mathieu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jim++Nonomiya">Jim Nonomiya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Shuttleworth">Stephen Shuttleworth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+P.++Sutherlin">Daniel P. Sutherlin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nan+Chi++Wan">Nan Chi Wan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shumei++Wang">Shumei Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Wiesmann">Christian Wiesmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bing-Yan++Zhu">Bing-Yan Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text">Piramed Pharma, 957 Buckingham Avenue, Slough, Berks SL1 4NL, United Kingdom</span></div><div class="corresp-info">Phone: (650) 467-3214. Fax: (650) 225-2061. E-mail: <a href="/cdn-cgi/l/email-protection#0b7f636e6d6d7964654b6c6e656e25686466"><span class="__cf_email__" data-cfemail="99edf1fcffffebf6f7d9fefcf7fcb7faf6f4">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm2007084&amp;href=/doi/10.1021%2Fjm2007084" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 7815–7833</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 10, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 June 2011</li><li><span class="item_label"><b>Published</b> online</span>21 October 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 November 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm2007084" title="DOI URL">https://doi.org/10.1021/jm2007084</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7815%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTimothy%2BP.%2BHeffron%252C%2BBinQing%2BWei%252C%2BAlan%2BOlivero%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D22%26contentID%3Djm2007084%26title%3DRational%2BDesign%2Bof%2BPhosphoinositide%2B3-Kinase%2B%25CE%25B1%2BInhibitors%2BThat%2BExhibit%2BSelectivity%2Bover%2Bthe%2BPhosphoinositide%2B3-Kinase%2B%25CE%25B2%2BIsoform%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7833%26publicationDate%3DNovember%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm2007084"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4351</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">47</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm2007084" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Rational Design of Phosphoinositide 3-Kinase α Inhibitors That Exhibit Selectivity over the Phosphoinositide 3-Kinase β Isoform&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;P. Heffron&quot;},{&quot;first_name&quot;:&quot;BinQing&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Olivero&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;T. Staben&quot;},{&quot;first_name&quot;:&quot;Vickie&quot;,&quot;last_name&quot;:&quot;Tsui&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Do&quot;},{&quot;first_name&quot;:&quot;Jennafer&quot;,&quot;last_name&quot;:&quot;Dotson&quot;},{&quot;first_name&quot;:&quot;Adrian&quot;,&quot;last_name&quot;:&quot;J. Folkes&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Goldsmith&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Goldsmith&quot;},{&quot;first_name&quot;:&quot;Janet&quot;,&quot;last_name&quot;:&quot;Gunzner&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Lesnick&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Lewis&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Mathieu&quot;},{&quot;first_name&quot;:&quot;Jim&quot;,&quot;last_name&quot;:&quot;Nonomiya&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Shuttleworth&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;P. Sutherlin&quot;},{&quot;first_name&quot;:&quot;Nan&quot;,&quot;last_name&quot;:&quot;Chi Wan&quot;},{&quot;first_name&quot;:&quot;Shumei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Wiesmann&quot;},{&quot;first_name&quot;:&quot;Bing-Yan&quot;,&quot;last_name&quot;:&quot;Zhu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;7815-7833&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm2007084&quot;},&quot;abstract&quot;:&quot;Of the four class I phosphoinositide 3-kinase (PI3K) isoforms, PI3Kα has justly received the most attention for its potential in cancer therapy. Herein we report our successful approaches to achieve PI3Kα vs PI3Kβ selectivity for two chemical series. In the thienopyrimidine series of inhibitors, we propose that select ligands achieve selectivity derived from a hydrogen bonding interaction with Arg770 of PI3Kα that is not attained with the corresponding Lys777 of PI3Kβ. In the benzoxepin series of inhibitors, the selectivity observed can be rationalized by the difference in electrostatic potential between the two isoforms in a given region rather than any specific interaction.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2007084&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007084" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2007084&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007084" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2007084&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007084" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm2007084&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007084&amp;href=/doi/10.1021/jm2007084" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm2007084" /></input><a href="/doi/pdf/10.1021/jm2007084" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm2007084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm2007084%26sid%3Dliteratum%253Aachs%26pmid%3D21985639%26genre%3Darticle%26aulast%3DHeffron%26date%3D2011%26atitle%3DRational%2BDesign%2Bof%2BPhosphoinositide%2B3-Kinase%2B%25CE%25B1%2BInhibitors%2BThat%2BExhibit%2BSelectivity%2Bover%2Bthe%2BPhosphoinositide%2B3-Kinase%2B%25CE%25B2%2BIsoform%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D22%26spage%3D7815%26epage%3D7833%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291654" title="Homology">Homology</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jmcmar.2011.54.issue-22/production/jmcmar.2011.54.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0017.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Of the four class I phosphoinositide 3-kinase (PI3K) isoforms, PI3Kα has justly received the most attention for its potential in cancer therapy. Herein we report our successful approaches to achieve PI3Kα vs PI3Kβ selectivity for two chemical series. In the thienopyrimidine series of inhibitors, we propose that select ligands achieve selectivity derived from a hydrogen bonding interaction with Arg770 of PI3Kα that is not attained with the corresponding Lys777 of PI3Kβ. In the benzoxepin series of inhibitors, the selectivity observed can be rationalized by the difference in electrostatic potential between the two isoforms in a given region rather than any specific interaction.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span>†</span> Accession Codes</h4><p class="last">The coordinates of <b>33</b> in PI3Kγ have been deposited with PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T8M">3T8M</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55478" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55478" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The phosphoinositide 3-kinases (PI3Ks) are attractive targets for the design of small molecule inhibitors because of the frequent occurrence of aberrant signaling of this pathway in several different disease states. Within the PI3 kinase family, there are four class I PI3 kinase isoforms (α, β, δ, and γ).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> PI3Kβ has been targeted for thrombosis prevention or treatment, and small molecules that display selectivity for this isoform have been reported.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> PI3Kδ and PI3Kγ have been identified as targets for inflammatory, autoimmune, and respiratory indications.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Accordingly, compounds that display modest to high levels of isoform selectivity have been reported for the inhibition of PI3Kδ, PI3Kγ, or both.<a onclick="showRef(event, 'ref1 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref5">(1, 5)</a> For its promise in the treatment of cancer, inhibition of PI3Kα has received considerable attention.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> However, despite the significant effort to identify inhibitors of PI3Kα, there are only few reports of PI3Kα inhibitors that either specifically inhibit this isoform or achieve selectivity relative to any of the other isoforms.<a onclick="showRef(event, 'ref1 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref7">(1, 7)</a></div><div class="NLM_p">We previously reported our efforts to identify PI3Kα inhibitors including clinical candidate <b>1</b> (GDC-0941).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Each of our previous disclosures culminated with molecules that are highly selective relative to other kinases but inhibit each of the four class I PI3K isoforms with minimal selectivity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Class I PI3K IC<sub>50</sub>s of Key Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0001.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kβ</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kδ</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kγ</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr></tbody></table></div></div><div class="NLM_p">As a continuation of this work, we became interested in studying the biological effects of inhibitors of PI3Kα that had differential selectivity profiles relative to one or more of the other isoforms. Among the selectivity profiles we were interested in evaluating was inhibition of PI3Kα with selectivity over PI3Kβ. This particular selectivity profile was of interest because of the potential role of PI3Kβ in insulin signaling.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Because of this potential critical role, it is reasonable to speculate whether or not the tolerability of PI3Kα inhibitors for the treatment of cancer might be improved if they have selectivity over PI3Kβ. However, at the onset of our studies it was unclear whether reduced PI3Kβ inhibition would compromise efficacy. Taken together, compounds with high PI3Kβ/PI3Kα selectivity were of interest to us as tools for studying the implication on efficacy and safety. At the onset of this effort, designing PI3K inhibitors that displayed selectivity over PI3Kβ presented a challenge because no crystal structure of PI3Kβ had been reported.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> On the other hand, cocrystal structures containing PI3K inhibitors have been available for PI3Kγ for several years.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> More recently, crystal structures of PI3Kδ<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (cocrystallized with inhibitors) and PI3Kα<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> have been reported.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">To guide our attempts at achieving PI3Kα vs PI3Kβ selectivity, we utilized a public crystal structure of PI3Kα<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> along with a homology model of PI3Kβ developed from a PI3Kδ crystal structure.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> While each of the class I PI3Ks exhibits a high degree of homology within the active site of the enzyme, there are differences in primary sequence among residues that are predicted to reside on the periphery of the active site in a solvent exposed region (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). These differences presented an opportunity using our thienopyrimidine scaffold to achieve the desired selectivity. In addition, there is the potential for disparate conformational dynamics within the P-loop (Met804-Pro810, PI3Kγ numbering).</div><div class="NLM_p">We discuss below our results in gaining selectivity for PI3Kα relative to PI3Kβ on two distinct scaffolds. With each of the two scaffolds studied, the selectivity observed can be explained using our homology model of PI3Kβ.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> These studies lend support to the use of our homology model of PI3Kβ for compound design as well as provide opportunity to evaluate the desirability of this selectivity profile.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cocrystal structure of <b>1</b> in PI3Kγ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS">3DBS</a>). Residues nearest the active site that are different between PI3Kα and at least one other isoform are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We first prepared compounds that achieve PI3Kβ/PI3Kα selectivity fortuitously when evaluating analogues of <b>1</b>. <b>1</b> is just modestly selective for PI3Kα relative to PI3Kβ (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). However, modification of the central core of the thienopyrimidine to the isomeric thiophene (<b>6</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) resulted in significantly improved PI3Kβ/PI3Kα selectivity as a result of notable reduction in PI3Kβ inhibition.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of PI3Kα and PI3Kβ Potency for <b>1</b> and Related Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0002.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kβ</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub>(PI3Kβ)/IC<sub>50</sub>(PI3Kα)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">332</td><td class="colsep0 rowsep0" align="char" char=".">111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">194</td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr></tbody></table></div></div><div class="NLM_p">A cocrystal structure of <b>1</b> in PI3Kγ shows that a sulfonamide oxygen achieves a hydrogen bond with the backbone NH of Ala805 (PI3Kγ).<a onclick="showRef(event, 'cit8a'); return false;" href="javascript:void(0);" class="ref cit8a">(8a)</a> Our models suggest that this interaction is likely maintained in the other PI3K isoforms with <b>1</b> hydrogen bonding with Ser773 backbone NH in PI3Kα (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a) and Asp780 backbone NH in PI3Kβ (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b). In addition, our model of <b>1</b> in PI3Kα suggests the other sulfonamide oxygen is capable of hydrogen bonding with Arg770 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a). However, according to our model, this is unlikely in PI3Kβ in which Arg770 is now Lys777 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b). This suggested loss of a hydrogen bond is a possible explanation for the 10-fold reduced potency against that isoform. Upon modification of the central core to the isomeric thiophene <b>6</b>, the sulfonamide oxygens are positioned further away from the key backbone NH (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c,d). Still, our model suggests that <b>6</b> is able to achieve the two hydrogen bonds in PI3Kα (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c), while in PI3Kβ <b>6</b> is no longer able to achieve either of these hydrogen bonds. It is possible that this explanation accounts for why <b>6</b> is 100-fold less potent toward PI3Kβ relative to PI3Kα (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d). Additionally, compound <b>7</b>, in which the thiophene has been replaced by a furan, should display the piperazine sulfonylamide with a vector much closer to compound <b>6</b> than to <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>e). In the end, furanopyrimidine <b>7</b> achieves potency and selectivity similar to those of compound <b>6</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Model of <b>1</b> in PI3Kα. Hydrogen bonds with Ser773 backbone NH and Arg770 are illustrated. (b) Model of <b>1</b> in PI3Kβ, illustrating hydrogen bond with Asp780 backbone NH but suboptimal distance to Lys777. (c) Model of <b>6</b> in PI3Kα. Hydrogen bonds with Ser773 backbone NH and Arg770 are illustrated. (d) Model of <b>6</b> in PI3Kβ, illustrating suboptimal hydrogen bonding distances to Asp780 backbone NH and Lys777. (e) Overlay of <b>1</b> (green), <b>6</b> (magenta), and <b>7</b> (lavender), with morpholine and indazole rigidly superimposed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Encouraged by the selectivity achieved with compounds <b>6</b> and <b>7</b>, we extended our studies to further evaluate contributions to isoform selectivity using the isomeric thiophene core of <b>6</b>. Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> highlights the SAR describing PI3Kβ/PI3Kα selectivity. A comparison of compounds <b>6</b> and <b>8</b> demonstrates that the indazole moiety contributes minimally to PI3Kβ selectivity and that the aminopyrimidine group improves potency against both PI3Kα and PI3Kβ isoforms. Entries <b>9</b> and <b>10</b> illustrate that the portion of the molecule that is directed toward the residue differences (R<sup>1</sup>) is essential to the selectivity observed, as compounds without substitution of the thiophene have minimal selectivity. Having identified that the indazole does not contribute to PI3Kβ selectivity, we limited additional studies to the aminopyrimidine motif (R<sup>2</sup>) that had previously been identified to have superior potency and pharmacokinetic properties.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> That the sulfonamide oxygens are essential to achieving high PI3Kβ/PI3Kα selectivity is demonstrated with piperazine <b>11</b> and piperidine <b>12</b>. A comparison of <b>11</b> and <b>12</b> illustrates that a more basic center at the distal end of the ring erodes selectivity. Piperidinesulfonylamide <b>13</b> has potency and selectivity comparable to those of <b>8</b>, indicating that the remaining basic center does not impact either. The sulfone analogue <b>14</b> exhibits reduced selectivity when compared to compound <b>8</b> because of a modest drop in PI3Kβ potency. The position of the sulfonamide oxygens is critical, as demonstrated with compound <b>15</b> which had the lowest selectivity of any sulfone or sulfonamide containing analogue. Nevertheless, the 20-fold selectivity of compound <b>15</b> is still significant relative to the unsubstituted entry <b>10</b>. Entry <b>16</b> illustrates that a carbonyl functionality can also achieve good levels of selectivity. Finally, an aromatic ring could replace the heterocyclic ring present in the other examples. Arylsulfone <b>17</b> proved to be potent and had reasonable selectivity; however, it had poor solubility that prevented it from advancing further, as even at the higher concentrations required in cellular assays the compound precipitated over time. In general, the selectivity achieved is unique to the PI3Kβ isoform, as consistently low levels of selectivity (<10-fold) for PI3Kα were observed relative to PI3Kδ and PI3Kγ.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Class I PI3K Isoform Selectivity for Isomeric Thienopyrimidines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0003.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0004.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">Having identified an approach to selectivity for PI3Kα over PI3Kβ, we were interested in whether we could apply the hypothesis to achieve the same type of selectivity on a distinct scaffold. Recently we disclosed initial efforts on a class of benzoxepins that are potent PI3Kα inhibitors.<a onclick="showRef(event, 'cit8e'); return false;" href="javascript:void(0);" class="ref cit8e">(8e)</a> A cocrystal structure of a representative benzoxepin, <b>21</b>, with PI3Kγ is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a. For the sake of comparison, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b shows an overlay of benzoxepin <b>21</b> and thienopyrimidine <b>1</b>. From this overlay it is apparent that substitution of the benzene ring of the benzoxepin offers a different vector compared with substitution of the thienopyrimidine class of compounds.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Cocrystal structure of benzoxepin <b>21</b> in PI3Kγ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R7R">3R7R</a>). (b) Overlay of <b>1</b> in the cocrystal structure of <b>21</b> in PI3Kγ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An initial SAR scan compared R<sup>1</sup> and R<sup>2</sup> substitution of thienobenzoxepins. An analysis of the specific substitution revealed that R<sup>1</sup> functionality generally led to increased likelihood of PI3Kβ/PI3Kα selectivity when compared to R<sup>2</sup> substitution (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). This result was unanticipated because it seemed that R<sup>2</sup> substitution would be able to grant access to Arg770 and Ser773 that we exploited for selectivity in the thienopyrimidine series (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The apparent predisposal for the desired selectivity led us to prioritize our efforts to R<sup>1</sup> substitution to improve selectivity over PI3Kβ.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Correlation of the position of substitution on the benzoxepin core and level of PI3Kβ/PI3Kα selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Revisiting the PI3Kα and PI3Kβ homology models we employed earlier, we recognized that in the vicinity of the R<sup>1</sup> position of the benzoxepin core there were a number of residues that differed between PI3Kα and PI3Kβ (see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Importantly, there are several acidic residues in the area of PI3Kβ where R<sup>1</sup> substitution is positioned. This is in contrast to the same region of PI3Kα, in which there are no acidic residues. Anticipating that many of the solvent exposed residues would likely be flexible, making specific hydrogen bonding interactions difficult to achieve, we viewed the relevant region of the enzyme as an electrostatic potential map.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This model suggested that simply incorporating highly electron rich or even lipophilic functionality should result in improved selectivity for PI3Kα relative to PI3Kβ. On the other hand, incorporation of a positively charged functionality should lead to reduced selectivity. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a depicts a model of benzoxepin <b>21</b> bound to PI3Kα, highlighting the electrostatic potential in the region accessible through substitution of the core at R<sup>1</sup>. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b depicts the electrostatic potential map of PI3Kβ in the same area with the same compound included for reference.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Poisson–Boltzmann electrostatic potentials plotted on the solvent accessible surfaces of PI3Kα crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HIZ">3HIZ</a>) (a) and PI3Kβ homology model (b). Compound <b>21</b> is depicted for reference.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> highlights that the electrostatic potential maps of PI3Kα and PI3Kβ derived from a PI3Kα crystal structure and our PI3Kβ homology model are indeed predictive of selectivity. Entry <b>18</b> established that the benzoxepin core without substitution of the benzene ring has good PI3Kα potency and <20-fold selectivity relative to PI3Kβ. Compound <b>19</b> shows the impact of an uncharged R<sup>1</sup> substituent on PI3Kβ/PI3Kα selectivity. In this case, the level of selectivity is increased to 82-fold. We found that many uncharged groups at R<sup>1</sup> resulted in similarly enhanced PI3Kβ/PI3Kα selectivity. As further examples, nitrile <b>20</b>, acetamide <b>21</b>, and amides <b>22</b> and <b>23</b> all achieve greater than 50-fold selectivity for PI3Kα relative to PI3Kβ. However, incorporating a basic center diminishes selectivity as a result of increased affinity for PI3Kβ (<b>24</b>). Moreover, as the electrostatic potential map predicts, exact positioning of a positive charge is not essential to diminish PI3Kβ/PI3Kα selectivity as examples <b>24</b> and <b>25</b> demonstrate. When a negatively charged functionality was incorporated (<b>26</b>), the selectivity increased to nearly 100-fold. However, because the negative charge in <b>26</b> prevented the molecule from effectively permeating a cell membrane, this compound was not studied further. In contrast to the carboxylic acid in <b>26</b>, the related analogue <b>27</b> incorporated a basic amine that essentially negated the impact of R<sup>1</sup> substitution, as the potency and selectivity are comparable to those of the unsubstituted <b>18</b>. Substitution of R<sup>2</sup> also resulted in improvement in PI3Kβ/PI3Kα selectivity (compounds <b>28</b>–<b>30</b>), similar to how the same functionality improved selectivity at R<sup>1</sup> (compare compounds <b>20</b> and <b>30</b> and compare <b>23</b> and <b>29</b>).</div><div class="NLM_table-wrap" id="tbl4">Table 4<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0005.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0006.gif" alt="" id="fx6" /></img><div></div></div><div class="NLM_p">It was interesting to note that substitution of R<sup>3</sup> with an amide resulted in diminished PI3Kβ/PI3Kα selectivity. For example, compound <b>31</b> has just 10-fold selectivity whereas the analogue without the amide at R<sup>3</sup> (compound <b>22</b>) has 87-fold selectivity. Moving the position of the <i>N</i>,<i>N</i>-dimethylamide from R<sup>3</sup> to R<sup>4</sup> resulted in a notable gain in selectivity (<b>32</b>). A similar trend was observed with <i>N</i>-methylpiperazineamides <b>33</b> and <b>34</b>. In this case, moving the amide to R<sup>4</sup> restores the selectivity found in the simpler analogue <b>22</b>. A cocrystal structure of compound <b>33</b> with PI3Kγ (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) shows that the piperazineamide carbonyl achieves a hydrogen bond with Ser806. A potential explanation for this reduction in selectivity is that, despite being conserved among the four isoforms, the conformation of Ser806 as part of the flexible G-loop is such that a hydrogen bond to it is more beneficial for PI3Kβ potency than for PI3Kα and so results in reduced selectivity. Similar to the thienopyrimidine series, benzoxepins <b>18</b>–<b>34</b> also generally display low levels of selectivity for PI3Kα relative to PI3Kδ and PI3Kγ.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0015.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. A cocrystal structure of PI3Kγ and <b>33</b> (PDB code <a href="https://3T8M" class="ext-link">3T8M</a>) shows a hydrogen bond between the piperazineamide carbonyl and Ser806.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A study including <b>6</b> was consistent with the apparent importance of PI3Kβ inhibition to inhibit proliferation of a cancer cell that has lost phosphatase and tensin homologue (PTEN) function.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Evaluation of compounds with enhanced PI3Kα to PI3Kβ enzyme selectivity in cell proliferation assays showed a qualitative trend for a lesser effect on decreasing proliferation in the PC3 cell line (PTEN-null) relative to decreasing proliferation in the MCF7.1 cell line (PI3Kα mutant) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Specifically, in the thienopyrimidine series of molecules, the weakly selective <b>1</b> had close to equipotent activity in both cell lines, a trend that was also observed with the weakly selective benzoxepin <b>31</b>. Conversely, thienopyrimidines <b>6</b> and <b>13</b>, which displayed high levels of PI3Kβ/PI3Kα selectivity, were more potent in the MCF7.1 than the PC3 proliferation assay, with the same behavior observed with the structurally distinct benzoxepin <b>32</b>.</div><div class="NLM_table-wrap" id="tbl5">Table 5<div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα </th><th class="colsep0 rowsep0" align="center" char=".">PI3Kβ</th><th class="colsep0 rowsep0" align="center" char=".">MCF7.1</th><th class="colsep0 rowsep0" align="center" char=".">PC3</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub>(PI3Kβ)/IC<sub>50</sub>(PI3Kα)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub>(PC3)/ EC<sub>50</sub>(MCF7.1)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">332</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">0.97</td><td class="colsep0 rowsep0" align="char" char=".">111</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">204</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td></tr></tbody></table></div></div><div class="NLM_p">In addition to having high levels of PI3Kβ/PI3Kα selectivity, both series of molecules generally exhibit a very high level of selectivity over other kinases as well. In a panel of 101 kinases at Upstate, only one was inhibited by >80% by <b>6</b> when tested at 1 μM (CAMK2D). To represent the benzoxepin series of compounds, <b>21</b>, <b>22</b>, and <b>33</b> were each evaluated in a panel of 51 kinases provided by Invitrogen’s SelectScreen service. In each case no kinases were inhibited by >50% at 1 μM test compound.</div><div class="NLM_p last">Of the compounds that displayed significant PI3Kβ/PI3Kα selectivity, <b>6</b>, <b>7</b>, and <b>32</b> were evaluated in rodent pharmacokinetics studies. Compounds <b>7</b> and <b>32</b> each had a clearance rate greater than liver blood flow in rats (data not shown). On the other hand, compound <b>6</b> had attractive pharmacokinetic properties in rats as well as mice and so was selected for further study in in vivo efficacy models.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the furan analogue <b>7</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) commenced with furan-3-carboxylic acid which was converted to the requisite amino group by Curtius rearrangement to give the Boc-protected amine <b>36</b>. A methyl ester was introduced at the 2-position of the furan by lithiation followed by quenching of the reaction with dimethyl carbonate. After deprotection of the amino group, chlorosulfonyl isocyanate was used to convert the amine (<b>37</b>) to a urea which then underwent cyclization in basic methanolic medium. The resulting pyrimidinedione was converted to <b>38</b> by the action of POCl<sub>3</sub> followed by incorporation of morpholine. Formylation of <b>38</b> led to a mixture of the aldehyde <b>39</b> and hemiacetal <b>40</b>. This mixture smoothly underwent reductive amination to give <b>41</b> as a single product. Finally, Suzuki coupling yielded furanopyrimidine <b>7</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DPPA, Et<sub>3</sub>N, <i>t</i>-BuOH; (b) <i>n</i>-BuLi, TMEDA, CO(OMe)<sub>2</sub>; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (d) ClO<sub>2</sub>SNCO, CH<sub>2</sub>Cl<sub>2</sub>; (e) 1.5 M NaOH in MeOH; (f) POCl<sub>3</sub>, <i>i</i>-Pr<sub>2</sub>NEtN; (g) morpholine, MeOH; (h) <i>n</i>-BuLi, THF, −78 °C, DMF; (i) piperazinemethanesulfonamide HCl, CH(OMe)<sub>3</sub>, DCE; (j) NaBH(OAc)<sub>3</sub>; (k) indazole-4-boronic acid pinacol ester, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, toluene/EtOH/water (4:2:1).</p></p></figure><div class="NLM_p">A general synthetic approach to thienopyrimidine analogues (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) followed the course of the synthesis of <b>1</b> reported earlier.<a onclick="showRef(event, 'cit8a'); return false;" href="javascript:void(0);" class="ref cit8a">(8a)</a> The commercially available amino ester <b>42</b> was cyclized to the pyrimidinedione in molten urea. This dione was subsequently converted to the dichloropyrimidine, and then morpholine was incorporated to yield <b>43</b>. At this stage, the intermediate could be converted to the benzylic alcohol and subsequently to the chloride. This chloride enabled smooth conversion to interemediate amines and led to desired products after Suzuki coupling. Alternatively, iodine could be introduced on the thiophene intermediate <b>43</b> and sequential Suzuki coupling yielded <b>17</b>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClSO<sub>2</sub>NC, CH<sub>2</sub>Cl<sub>2</sub>, aq NaOH, aq HCl; (b) POCl<sub>3</sub>, CH<sub>3</sub>CN, reflux, 24 h; (c) morpholine, MeOH, 1 h; (d) <i>n</i>-BuLi, THF, −78 °C, DMF; (e) NaBH<sub>4</sub>, MeOH; (f) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (g) HNRR′, <i>i</i>-Pr<sub>2</sub>NEt, THF; (h) 2-aminopyrimidine-5-boronic acid pinacol ester, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M aq KOAc, CH<sub>3</sub>CN, microwave, 150 °C, 15 min; (i) HCl, MeOH; (j) MeSO<sub>2</sub>Cl, Et<sub>3</sub>N, THF; (k) <i>n</i>-BuLi, THF, −78 °C, I<sub>2</sub>; (l) 3-SO<sub>2</sub>Me phenylboronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M aq Na<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, microwave, 100 °C, 10 min.</p></p></figure><div class="NLM_p">A representative synthesis of benzoxepins began with alkylation of 3-bromophenol with ethyl 4-bromobutanoate (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The ester of the resulting ether was saponified and subjected to acidic conditions to facilitate acylation. Ketone <b>45</b> was then homologated to the β-chlorovinylaldehyde using the Vilsmeier reagent and subsequently cyclized to the thiophene. Saponification of the resulting ester afforded acid <b>46</b>. Amide coupling provided the versatile intermediate <b>47</b>. This intermediate was utilized in the synthesis of numerous final compounds.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl 4-bromobutanoate, K<sub>2</sub>CO<sub>3</sub>, cat. NaI, acetone; (b) LiOH, H<sub>2</sub>O, THF; (c) PPA, toluene; (d) POCl<sub>3</sub>, DMF; (e) K<sub>2</sub>CO<sub>3</sub>, methyl thioglycolate, DMF; (f) LiOH, H<sub>2</sub>O, THF; (g) SOCl<sub>2</sub>; (h) <i>N</i>-methyl-2-chloroaniline, NEt<sub>3</sub>, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (i) aryl boronate, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1 M aq Na<sub>2</sub>CO<sub>3</sub>, DMF; (j) CuCN, DMF; (k) NH<sub>2</sub>COCH<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub>, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, dioxane; (l) Mo(CO)<sub>6</sub>, MeOH, THF, amine, Herrmann’s catalyst, DBU.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Herein we have described two distinct approaches to achieving selectivity for PI3Kβ relative to PI3Kα. We suggest that the PI3Kβ/PI3Kα selectivity achieved in the thienopyrimidine series of inhibitors results from hydrogen bonding interactions between the ligand and Arg770 of PI3Kα that is not attained with the corresponding Lys777 of PI3Kβ. In the benzoxepin series of inhibitors, we postulate that the selectivity attained is a result of the difference in electrostatic potential between the two isoforms in a given region rather than any specific interaction or even the difference between one specific residue between the two enzyme isoforms. The approach to selectivity utilized in the benzoxepin series has the potential to be general and applicable to additional scaffolds as long as they contain the potential to occupy the critical space depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. Each of the two approaches described lends credibility to the use of our PI3Kβ homology model. The approaches to gaining selectivity presented here should aid in the design of additional compounds that achieve selectivity either for or against PI3Kβ. Our studies of the impact of the selectivity over PI3Kβ in comparison to the pan-inhibitors previously reported are ongoing.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div class="NLM_p">All solvents and reagents were used as obtained. <sup>1</sup>H NMR spectra were recorded with a Bruker Avance DPX400 spectrometer or a Varian Inova 400 NMR spectrometer and referenced to tetramethylsilane. Chemical shifts are expressed as δ units using tetramethylsilane as the external standard (in NMR description, s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; and br, broad peak). All final compounds were purified to >95% chemical purity, as assayed by HPLC (Waters Acquity UPLC column, 21 mm × 50 mm, 1.7 μm) with a gradient of 0–90% acetonitrile (containing 0.038% TFA) in 0.1% aqueous TFA, with UV detection at 254 and 210 nm and with CAD detection with an ESA Corona detector.</div><div class="NLM_p last">Compounds <b>1</b>–<b>4</b> have been described previously.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>tert</i>-Butyl Furan-3-ylcarbamate (<b>36</b>)</h3><div class="NLM_p last">3-Furoic acid (5.60 g, 1.0 equiv) was dissolved in <i>tert</i>-butanol (200 mL) and treated with triethylamine (10 mL, 1.4 equiv) and diphenylphosphorylazide (12 mL, 1.1 equiv). The mixture was heated at reflux for 18 h. The reaction mixture was cooled to room temperature, then concentrated to 50 mL and poured into saturated aqueous NaHCO<sub>3</sub>. The mixture was stirred at 0 °C for 2 h. Solid was collected by filtration and dried under high vacuum. The crude reaction mixture was purified by flash chromatography to yield <b>36</b> (6.95 g, 76%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.71 (br s, 1H), 7.27 (m, 1H), 6.27 (br s, 1H), 6.20 (br s, 1H), 1.50 (s, 9H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 184.1.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Methyl 3-Aminofuran-2-carboxylate (<b>37</b>)</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl furan-3-ylcarbamate (1.7 g, 1.0 equiv) in THF (50 mL) at −30 °C was added TMEDA (1.75 mL, 1.3 equiv) followed by 1.6 M solution of <i>n</i>-butyllithium (8.4 mL, 2.25 equiv, 1.6 M in hexanes). The reaction mixture was allowed to warm to 0 °C and stirred for 1 h before being cooled back to −30 °C. Dimethyl carbonate (2.4 mL, 3.0 equiv) was quickly added before the reaction mixture was allowed to warm to room temperature for 1 h. The reaction mixture was quenched with 2 M HCl, followed by addition of saturated aqueous NaCl. The mixture was extracted with ethyl acetate. The combined organic extracts were dried with Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude reaction mixture was purified by flash chromatography to yield methyl 3-(<i>tert</i>-butoxycarbonylamino)furan-2-carboxylate (1.14 g, 51%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.18 (br s, 1H), 7.38 (d, <i>J</i> = 1.9 Hz, 1H), 7.25 (br s, 1H), 3.92 (s, 3H), 1.52 (s, 9H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 242.1. This intermediate (1.14 g, 1.0 equiv) was dissolved in dichloromethane (8 mL) and treated with trifluoroacetic acid (5 mL). The reaction mixture was stirred at room temperature for 3 h and was then concentrated. Residue was dissolved in dichloromethane and washed with saturated aqueous NaHCO<sub>3</sub>. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The mixture was extracted with ethyl acetate. The combined organic extracts were dried with Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude reaction mixture was purified by flash chromatography to yield <b>37</b> (574 mg, 86%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.26 (m, 1H), 6.13 (d, <i>J</i> = 2.0 Hz, 1H), 4.57 (br s, 2H), 3.89 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 142.0.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 2-Chloro-4-morpholinofuro[3,2-<i>d</i>]pyrimidine (<b>38</b>)</h3><div class="NLM_p last">To a solution of <b>37</b> (100 mg, 1.0 equiv) in dichloromethane (3 mL) at −78 °C was added chlorosulfonyl isocyanate (0.09 mL, 1.4 equiv) dropwise. The mixture was slowly warmed to room temperature and stirred for 40 min. The reaction was concentrated. To the residue was added 6 N HCl (3.5 mL), and the mixture was heated to 100 °C for 20 min. The reaction mixture was allowed to cool to room temperature and was neutralized with saturated aqueous NaHCO<sub>3</sub>. Solid was collected by filtration to yield methyl 3-ureidofuran-2-carboxylate as a beige solid which was used in the next reaction without further purification (MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 185.1). The crude intermediate was suspended in methanol (6 mL) and treated with 1.5 M NaOH (1.5 mL). The reaction mixture was heated to reflux for 90 min. The reaction mixture was allowed to cool to room temperature and was acidified with 6 N HCl to pH 3. The mixture was concentrated. Methanol was added to the residue and the solid was filtered and dried at 95 °C under high vacuum for 24 h to yield furo[3,2-<i>d</i>]pyrimidine-2,4-diol (90 mg, 84% yield over two steps). <sup>1</sup>H NMR (300 MHz, DMSO) δ 11.22 (br s, 1H), 11.05 (br s, 1H), 8.01 (d, <i>J</i> = 2.0 Hz, 1H), 6.52 (d, <i>J</i> = 2.0 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 153.0. This intermediate (39 mg, 1.0 equiv) was dissolved in POCl<sub>3</sub> (1.8 mL). The mixture was cooled to −40 °C, and <i>N</i>,<i>N</i>-diisopropylethylamine (0.45 mL) was slowly added. The reaction mixture was then heated to reflux for 48 h, then cooled to room temperature. The reaction mixture was poured into ice–water. The mixture was extracted with ethyl acetate. The combined organic layers were washed with saturated aqueous NaHCO<sub>3</sub>, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to yield 2,4-dichlorofuro[3,2-<i>d</i>]pyrimidine (23 mg, 48%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10–8.08 (m, 1H), 7.04–7.02 (m, 1H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 153.0. This intermediate (23 mg, 1.0 equiv) was suspended in methanol (1.7 mL) and treated with morpholine (0.09 mL, 4.0 equiv). The reaction mixture was stirred at room temperature for 2 h before being quenched with saturated aqueous NaHCO<sub>3</sub>. The mixture was extracted with dichloromethane. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to yield <b>38</b> (14 mg, 48%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.74 (d, <i>J</i> = 2.2 Hz, 1H), 6.79 (d, <i>J</i> = 2.2 Hz, 1H), 4.10–3.96 (m, 4H), 3.83 (dd, <i>J</i> = 6.2, 3.6 Hz, 4H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 240.0.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 2-Chloro-4-morpholinofuro[3,2-<i>d</i>]pyrimidine-6-carbaldehyde (<b>39</b>)</h3><div class="NLM_p last">To a solution of <b>38</b> (40 mg, 1.0 equiv) in THF (1.7 mL) at −78 °C was added 1.6 M solution of <i>n</i>-butyllithium (0.14 mL, 1.3 equiv, 1.6 M in hexanes). The reaction mixture was stirred at −78 °C for 30 min. DMF (0.05 mL, 4.0 equiv) was added, and reaction mixture was allowed to slowly warm to room temperature and stirred for 90 min. The reaction was quenched with water, and the aqueous layer was extracted with dichloromethane. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The crude reaction mixture was purified by flash chromatography to yield <b>39</b> (22 mg, 50%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.92 (s, 1H), 7.48 (s, 1H), 4.19–4.00 (m, 4H), 3.92–3.81 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 268.0.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-Chloro-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinofuro[3,2-<i>d</i>]pyrimidine (<b>41</b>)</h3><div class="NLM_p last"><b>39</b> (65 mg) was dissolved in 1,2-dichloroethane (9.7 mL) and treated with the hydrochloride salt of 1-methanesulfonylpiperazine (69 mg), sodium acetate (28 mg), and trimethyl orthoformate (0.27 mL). The reaction mixture was stirred at room temperature for 12 h. Sodium triacetoxyborohydride (62 mg) was added, and reaction mixture was stirred at room temperature for 8 h. The reaction mixture was quenched with saturated aqueous NaHCO<sub>3</sub> and extracted with dichloromethane. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The crude reaction mixture was purified by flash chromatography to yield <b>41</b> (70 mg, 68%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.63 (s, 1H), 4.04–3.97 (m, 4H), 3.87–3.80 (m, 4H), 3.73 (s, 2H), 3.32–3.25 (m, 4H), 2.80 (s, 3H), 2.70–2.63 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 416.1.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-(1<i>H</i>-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinofuro[3,2-<i>d</i>]pyrimidine (<b>7</b>)</h3><div class="NLM_p last"><b>41</b> (40 mg, 1.0 equiv) was dissolved in toluene/ethanol/water (4:2:1, 1.6 mL) and treated with 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-indazole (59 mg, 2.5 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (6.8 mg, 0.10 equiv), and sodium carbonate (36 mg, 3.5 equiv). The vial was sealed and heated with stirring in the microwave to 150 °C for 15 min. The crude reaction mixture was concentrated and purified by reverse phase HPLC to afford <b>7</b> (42 mg, 88% yield). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 498.2.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-(2-Chlorothieno[<i>2,3-d</i>]pyrimidin-4-yl)morpholine (<b>43</b>)</h3><div class="NLM_p last">A 5 L reaction vial equipped with a mechanical stirrer, internal temperature probe, and a nitrogen bubbler was charged with <b>42</b> (95 g) and CH<sub>2</sub>Cl<sub>2</sub> (2.85 L), and the mixture was cooled to −60 °C. Chlorosulfonyl isocyanate was added at a rate such that the internal temperature remained at −60 to −55 °C. After completion of addition the mixture was allowed to warm to ambient temperature. The reaction was monitored for complete consumption of starting material by LC/MS. The reaction mixture was concentrated to dryness and the solid residue transferred back to the 5 L reaction vial by water (1.8 L). This mixture was heated at 75 °C for 1 h, then cooled to 30 °C. Next 10 M aqueous NaOH (200 mL) was added and this mixture was heated at 85 °C for 20 min before cooling to room temperature. The mixture was then acidified to pH 1 by the addition of concentrated HCl. The mixture was then stirred for 18 h at ambient temperature with a precipitate forming. This solid material was collected by vacuum filtration and the filter cake washed with water. The solid material was then dried in a vacuum oven at 55 °C for 24 h to afford thieno[2,3-<i>d</i>]pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione as an off white solid (80 g, 79%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.08 (d, <i>J</i> = 5.6 Hz, 1H), 7.12 (d, <i>J</i> = 5.6 Hz, 1H). ESI-MS: <i>m</i>/<i>z</i> = 169 [M + H]<sup>+</sup>. This intermediate (16.8 g, 0.1 mol) was added to POCl<sub>3</sub> (100 mL), and the mixture was heated at reflux overnight. After POCl<sub>3</sub> was removed under reduce pressure an aqueous NaHCO<sub>3</sub> solution was added and extracted with EtOAc (300 mL × 2). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtrate was concentrated to give 2,4-dichlorothieno[2,3-<i>d</i>]pyrimidine (17.1 g, 84% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.07 (d, <i>J</i> = 6.0 Hz, 1H), 7.52 (d, <i>J</i> = 6.0 Hz, 1H). ESI-MS: <i>m</i>/<i>z</i> = 204 [M + H]<sup>+</sup>. To a solution of the dichloropyrimidine intermediate (10.2 g, 50 mmol) in EtOH (100 mL), morpholine (6.1 g, 70 mmol) was added dropwise. The mixture was stirred at room temperature overnight. TLC showed that the reaction was completed. The reaction mixture was filtered and washed with a small amount of EtOH to give <b>43</b> (11.0 g, 85% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.78 (s,1H), 5.07 (s, 2H), 3.86 (t, <i>J</i> = 4.8 Hz, 4H), 3.72 (t, <i>J</i> = 4.8 Hz, 4H). ESI-MS: <i>m</i>/<i>z</i> = 255.8 [M + H]<sup>+</sup> .</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidine-6-carbaldehyde</h3><div class="NLM_p last">To a solution of 4-(2-chlorothieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (25.5 g, 0.1 mol) in THF (200 mL) was added <i>n</i>-BuLi (64 mL, 0.16 mol) at −78 °C. The mixture was stirred for 2 h at −78 °C under N<sub>2</sub>, and DMF (28 g, 0.4 mol) was added dropwsie. The reaction mixture was stirred for an additional hour at −78 °C, and the reaction was quenched by 0.5 M HCl. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (300 mL × 3), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residue was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/EtOAc = 4:1) to give the desired product (21 g, 75%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.00 (s, 1H), 8.01 (s, 1H), 4.08–4.03 (m, 4H), 3.91–3.86 (m, 4H). ESI-MS: <i>m</i>/<i>z</i> = 283.8 [M + H]<sup>+</sup><sub>.</sub></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (2-Chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methanol</h3><div class="NLM_p last">To a solution of 2-chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidine-6-carbaldehyde (21 g, 0.07 mol) in MeOH (200 mL), NaBH<sub>4</sub> (4.1 g, 0.11 mol) was added at 0 °C. The mixture was stirred for 1 h. The mixture was quenched by 0.1 M HCl and extracted with CH<sub>2</sub>Cl<sub>2</sub>. It was dried and concentrated to give the crude product, which was used for the next step without further purification (18 g, 84%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.48 (s,1H), 5.74 (s, 1H), 4.68 (s, 1H), 3.83 (t, <i>J</i> = 4.8 Hz, 4H), 3.70 (t, <i>J</i> = 4.8 Hz, 4H). ESI-MS: <i>m</i>/<i>z</i> = 285.8 [M + H]<sup>+</sup><sub>.</sub></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4-(2-Chloro-6-(chloromethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine</h3><div class="NLM_p last">To a solution of (2-chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methanol (18 g, 0.06 mol) in CH<sub>2</sub>Cl<sub>2</sub> (400 mL), SOCl<sub>2</sub> (17 g, 0.15 mol) was added dropwise at 0 °C. The mixture was stirred for 30 min, concentrated, and dissolved in CH<sub>2</sub>Cl<sub>2</sub> (200 mL). It was washed with aqueous NaHCO<sub>3</sub>, concentrated, and purified by column chromatography (EtOAc/hexanes = 1:3) to give the desired product (16 g, 89%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.81(s, 1H), 5.09 (s, 2H), 3.87–3.85 (m, 4H), 3.74–3.73 (m, 4H). ESI-MS: <i>m</i>/<i>z</i> = 308.3 [M + H]<sup>+</sup><sub>.</sub></div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>tert</i>-Butyl 4-((2-Chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methyl)piperazine-1-carboxylate</h3><div class="NLM_p last">To a solution of 4-(2-chloro-6-(chloromethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (1.5 g, 5.0 mmol) in THF (50 mL) was added <i>tert</i>-butyl piperazine-1-carboxylate (1.86 g, 10 mmol) at room temperature. <i>i</i>-Pr<sub>2</sub>NEt (1.3 g, 10 mmol) was added dropwise after 20 min, and the mixture was stirred at 70 °C overnight. The mixture was concentrated and purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 40:1) to give the desired product (1.4 g, 65%). ESI-MS: <i>m</i>/<i>z</i> = 454.1 [M + H]<sup>+</sup><sub>.</sub></div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-(2-Chloro-6-(piperazin-1-ylmethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl 4-((2-chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methyl)piperazine-1-carboxylate (1.4 g, 3.2 mmol) in MeOH (20 mL) was added MeOH/HCl (4 M, 20 mL) at 0 °C. The reaction mixture was stirred for 2 h at room temperature. TLC showed the reaction was completed. The mixture was concentrated to afford the desired product as HCl salt, which was used for the next step without further purification (1.04 g, 87% yield). ESI-MS: <i>m</i>/<i>z</i> = 354.1 [M + H]<sup>+</sup><sub>.</sub></div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-(2-Chloro-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine</h3><div class="NLM_p last">To a solution of 4-(2-chloro-6-(piperazin-1-ylmethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (1.4 g, 3.2 mmol) in THF (80 mL) was added Et<sub>3</sub>N (1.29 g, 12.8 mmol) and MeSO<sub>2</sub>Cl (0.9 g, 8 mmol) at 0 °C. The reaction mixture was stirred for 12 h at room temperature. The mixture was quenched with ice–water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL × 3). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give the crude product which was used for the next step without further purification (0.65 g, 42% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.77 (s, 1H), 4.49 (s, 2H), 3.97–3.67 (m, 6H), 3.56–3.40 (m, 6H), 3.07–2.99 (m, 4H), 2.35 (s, 3 H). ESI-MS: <i>m</i>/<i>z</i> = 432.0 [M + H]<sup>+</sup><sub>.</sub></div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-(2-(1<i>H</i>-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (<b>6</b>)</h3><div class="NLM_p last">4-(2-Chloro-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (412 mg) was combined with 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-indazole (327 mg), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (33 mg), 1 M aqueous sodium carbonate (3 mL), and acetonitrile (3 mL). The mixture was heated to 140 °C in a microwave reactor for 20 min. The contents were extracted with EtOAc, concentrated, then purified by reverse phase HPLC to yield <b>6</b> (193 mg, 39% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 2.67 (m, 4H), 2.81 (s, 3H), 3.30 (m, 4H), 3.83 (s, 2H), 3.92–3.94 (m, 4H), 3.98–4.00 (m, 4H), 7.17 (s,1H), 7.50 (t, <i>J</i> = 7.8 Hz, 1H), 7.59 (d, <i>J</i> = 8.3 Hz, 1H), 8.31 (d, <i>J</i> = 7.0 Hz, 1H), 10.12 (br s,1H). ESI-MS: <i>m</i>/<i>z</i> = 514.10 [M + H]<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-(6-((4-(Methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-2-yl)pyrimidin-2-amine (<b>8</b>)</h3><div class="NLM_p last">4-(2-Chloro-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (150 mg, 0.35 mmol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine (144 mg, 0.7 mmol), Cs<sub>2</sub>CO<sub>3</sub> (228 mg, 0.7 mmol), and dioxane/H<sub>2</sub>O (3 mL/1 mL) were combined in a microwave tube. The mixture was purged with N<sub>2</sub> for 20 min. Then Pd(dppf)Cl<sub>2</sub> (51 mg, 0.07 mmol) was added. The reaction mixture was heated to 120 °C for 20 min under microwave irradiation. It was diluted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL), washed with water, and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed by underduced pressure, and the residue was purified by HPLC to give the desired product (28 mg, 16%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.12 (s, 2H), 7.77 (s, 1H), 7.31 (s, 2H), 4.49 (s, 2H), 3.97–3.77 (m, 8H), 3.37–3.35 (m, 8H), 2.99 (s, 3H). LCMS (ESI): <i>m</i>/<i>z</i> = 491.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 4-(2-(1<i>H</i>-Indazol-4-yl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (<b>9</b>)</h3><div class="NLM_p last">4-(2-Chlorothieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (255 mg, 1 mmol), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-indazole (366 mg, 1.5 mmol), Cs<sub>2</sub>CO<sub>3</sub> (652 mg, 2 mmol), and dioxane/H<sub>2</sub>O (3 mL/1 mL) were combined in a microwave tube. It was bubbled with N<sub>2</sub> for 20 min. Pd(dppf)Cl<sub>2</sub> (146 mg, 0.2 mmol) was added, and the mixture was heated under microwave irradiation to 120 °C for 30 min. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL), washed with water, and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure, and the residue was purified by HPLC to give the desired product (41 mg, 14% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.98 (s, 1H), 8.28 (d, <i>J</i> = 0.8 Hz, 1H), 7.55–7.26 (m, 4H), 3.72 (t, <i>J</i> = 4.8 Hz, 4H), 3.72 (t, <i>J</i> = 4.8 Hz, 4H). ESI-MS: <i>m</i>/<i>z</i> = 337.8 [M + H]<sup>+</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5-(4-Morpholinothieno[2,3-<i>d</i>]pyrimidin-2-yl)pyrimidin-2-amine (<b>10</b>)</h3><div class="NLM_p last">To a solution of <b>43</b> (0.256 g) and 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine (263 mg) in acetonitrile (2.0 mL) was added 1 M aqueous sodium carbonate (1 mL). The reaction mixture was sealed with a rubber septum and degassed by purging nitrogen through the mixture via a syringe. Next bis(triphenyphosphine)palladium dichloride (35 mg) was added under a nitrogen flush and the reaction vessel was sealed. The reaction mixture was heated on a Biotage Emrys Optimizer microwave at 160 °C for 10 min and then cooled to room temperature. The reaction mixture was diluted with EtOAc and neutralized by titration with concentrated HCl. A dark solid was removed from this reaction mixture by vacuum filtration through a small bed of Celite. The filtration pad was then flushed with EtOAc and water. The filtrate was transferred to a separatory funnel, and the organic layer was separated from the aqueous. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), the solvent was removed in vacuo, and the residue was purified by RP-HPLC to give <b>10</b> (66 mg, 17% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.30 (s, 2H), 7.34 (d, <i>J</i> = 6.1 Hz, 1H), 7.26 (d, <i>J</i> = 6.1 Hz, 1H), 4.01–3.96 (m, 4H), 3.90–3.86 (m, 4H). ESI-MS: MH + 1 = 315.1.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 5-(6-((4-Methylpiperazin-1-yl)methyl)-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-2-yl)pyrimidin-2-amine (<b>11</b>)</h3><div class="NLM_p last">To a solution of 4-(2-chloro-6-(chloromethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (1.5 g, 5.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added 1-methylpiperazine (0.5 g, 5.0 mmol) at room temperature. <i>i</i>-Pr<sub>2</sub>NEt (0.78 g, 6.0 mmol) was added dropwise after 20 min, and the mixture was stirred at 40 °C for 3 h. LCMS showed that the reaction was completed. The mixture was concentrated and purified by silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 40:1) to give 4-(2-chloro-6-((4-methylpiperazin-1-yl)methyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (1 g, 83% yield). ESI-MS: <i>m</i>/<i>z</i> = 367.9 [M + H]<sup>+</sup>. <b>11</b> was prepared as described for <b>10</b> from 4-(2-chloro-6-((4-methylpiperazin-1-yl)methyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (15% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.31 (s, 2H), 8.16 (s, 1H), 4.7 (s, 2H), 4.02–3.78 (m, 8H), 3.62–3.48 (m, 8H), 3.56 (t, <i>J</i> = 9.6 Hz, 4H), 3.33–3.11 (m, 8H), 2.81 (s, 3H). LCMS (ESI): <i>m</i>/<i>z</i> = 427.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Diethyl (2-Chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methylphosphonate</h3><div class="NLM_p last">A solution of 4-(2-chloro-6-(chloromethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (5.0 g, 16.5 mmol) in P(OEt)<sub>3</sub> (30 mL) was heated to 150 °C for 5 h. LCMS showed that the reaction was completed. The mixture was concentrated and purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/EtOAc = 1:2) to give the desired product (6.0 g, 95% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.22 (s, 1H), 4.12 (q, <i>J</i> = 7.6 Hz, 4H), 3.93 (t, <i>J</i> = 4.4 Hz, 4H), 3.82 (t, <i>J</i> = 4.4 Hz, 4H), 3.34 (d, <i>J</i> = 22.0 Hz, 2H), 1.31 (t, <i>J</i> = 7.6 Hz, 6H).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl 4-((2-Chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methylene)piperidine-1-carboxylate</h3><div class="NLM_p last">To a mixture of sodium hydride (746 mg, 31 mmol) in THF at 0 °C under N<sub>2</sub> was added diethyl (2-chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methylphosphonate (4.20 g, 10 mmol) in THF. The mixture was stirred for 30 min at 0 °C, and <i>tert</i>-butyl 4-oxopiperidine-1-carboxylate (2.0 g, 12 mmol) in THF was added. The mixture was stirred at room temperature for 3 h. TLC showed the reaction was completed. The mixture was filtered through Celite. The filtrate was concentrated and purified by chromatography to give the desired product (4.42 g, 93% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.03 (s, 1H), 6.40 (s, 1H), 3.94–3.92 (m, 4H), 3.84–3.82 (m, 4H), 3.53–3.48 (m, 4H), 2.65–2.60 (m, 2H), 2.40–2.35 (m, 2H), 1.49 (s, 9H). LCMS (ESI): <i>m</i>/<i>z</i> = 451.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-(2-Chloro-6-(piperidin-4-ylidenemethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl 4-((2-chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methylene)piperidine-1-carboxylate (4.42 g, 9.4 mmol) in methanol (10 mL) was added HCl/MeOH, and the reaction mixture was stirred at room temperature for 4 h. LCMS showed the reaction was completed. Solvent was removed under reduced pressure to give the product without further purification (3.5 g, 96% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.18 (s, 2H), 7.58 (s, 1H), 6.51 (s, 1H), 3.67 (t, <i>J</i> = 4.4 Hz, 4H), 3.73 (t, <i>J</i> = 4.4 Hz, 4H), 3.15 (m, 4H), 2.81 (d, <i>J</i> = 6.4 Hz, 2H), 2.50 (d, <i>J</i> = 6.4 Hz, 2H).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-(2-Chloro-6-(piperidin-4-ylmethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine</h3><div class="NLM_p last">A mixture of 4-(2-chloro-6-(piperidin-4-ylidenemethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (3.4 g, 9.7 mmol) and Pd/C (170 mg) in methanol was stirred at room temperature under H<sub>2</sub> (1 atm) for 4 h. LCMS showed that the reaction was completed. Solvent was removed under reduced pressure to give the product without further purification (3.2 g, 90% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 7.31 (s, 1H), 3.95 (t, <i>J</i> = 4.4 Hz, 4H), 3.80 (t, <i>J</i> = 4.4 Hz, 4H), 3.40–3.20 (m, 2H), 3.01–2.90 (m, 4H), 1.97–1.93 (m, 3H), 1.53–1.43 (m, 2H). LCMS (ESI): <i>m</i>/<i>z</i> = 352.9 [M + H]<sup>+</sup><sub>.</sub></div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-(2-Chloro-6-((1-(2,2,2-trifluoroethyl)piperidin-4-yl)methyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine</h3><div class="NLM_p last">To a solution of 4-(2-chloro-6-(piperidin-4-ylmethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (0.6 g, 1.4 mmol) and <i>i</i>-Pr<sub>2</sub>NEt (0.54 g, 4.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added 2,2,2-trifluoroacetic anhydride (0.5 g, 2.8 mmol) at room temperature. The resulting mixture was stirred at room temperature overnight. The mixture was purified by column chromatography (petroleum ether/ethyl acetate, 5:1 to 2:1) to give crude 1-(4-((2-chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methyl)piperidin-1-yl)-2,2,2-trifluoroethanone. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.96 (s, 1H), 4.57–4.54 (m, 1H), 3.92–3.89 (m, 4H), 3.82–3.85 (m, 4H), 3.14–3.07 (m, 1H), 2.82–2.74 (m, 3H), 1.95–1.83 (m, 3H), 1.38–1.21 (m, 3H). LCMS (ESI): M + H<sup>+</sup> = 449.1. To a solution of this intermediate intermediate (600 mg, 1.34 mmol) in THF was added BH<sub>3</sub>/CH<sub>3</sub>SCH<sub>3</sub> (10 M, 20 mL) dropwise at 0 °C. The mixture was stirred at room temperature for 2 h. MeOH (75 mL) was added dropwise to the mixture at −15 °C. Solvent was removed under reduced pressure and the crude product was purified by column chromatography (hexanes/EtOAc = 5:1 to 3:1) to afford 4-(2-chloro-6-((1- (2,2,2-trifluoroethyl)piperidin-4-yl)methyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (250 mg, 41% yield over two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.92 (s, 1H), 3.92–3.89 (m, 4H), 3.85–3.82 (m, 4H), 2.93–2.90 (m, 4H), 2.77–2.75 (d, 2H), 2.36–2.31 (m, 2H), 1.71–1.61 (m, 2H), 1.61–1.57 (m, 1H), 1.40–1.34 (m, 2H). LCMS (ESI): M + H<sup>+</sup> = 435.1.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5-(4-Morpholino-6-((1-(2,2,2-trifluoroethyl)piperidin-4-yl)methyl)thieno[2,3-<i>d</i>]pyrimidin-2-yl)pyrimidin-2-amine (<b>12</b>)</h3><div class="NLM_p last"><b>12</b> was prepared as described for <b>10</b> from 4-(2-chloro-6-((1-(2,2,2-trifluoroethyl)piperidin-4-yl)methyl)thieno [2,3-<i>d</i>] pyrimidin-4-yl)morpholine (14% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.26 (s, 2H), 6.94 (s, 1H), 5.30–5.29 (d, 2H), 3.94–3.91 (m, 4H), 3.91–3.86 (m, 4H), 2.99–2.92 (m, 4H), 2.81–2.79 (m, 2H), 2.36–2.30 (m, 2H), 1.74–1.70 (m, 2H), 1.42–1.39 (m, 2H), 1.42 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> = 494.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5-(6-((1-(Methylsulfonyl)piperidin-4-yl)methyl)-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-2-yl)pyrimidin-2-amine (<b>13</b>)</h3><div class="NLM_p last">4-(2-Chloro-6-(piperidin-4-ylmethyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (100 mg) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) and cooled to 0 °C. Triethylamine (270 μL) and methanesulfonyl chloride (36 μL) were added, and the mixture was allowed to warm to room temperature and stirred for 2 h. The reaction was quenched with saturated aqueous NaHCO<sub>3</sub>, and the aqueous layer was extracted with ethyl acetate. The combined organics were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was utilized in a Suzuki coupling according to the procedure described for <b>10</b> to yield <b>13</b> (6 mg, 5% yield over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.08 (s, 2H), 7.37 (s, 1H), 7.07 (s, 2H), 3.92–3.88 (m, 4H), 3.80–3.75 (m, 4H), 3.60–3.50 (m, 2H), 2.85 (app q, <i>J</i> = 12, 4 Hz), 2.83 (s, 3H), 2.69 (app t, <i>J</i> = 11.2 Hz), 1.75 (app t, <i>J</i> = 11.1 Hz, 3H), 1.33–1.20 (m, 2H). LCMS (ESI): <i>m</i>/<i>z</i> = 490.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-(6-((4-(Methylsulfonyl)piperidin-1-yl)methyl)-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-2-yl)pyrimidin-2-amine (<b>14</b>)</h3><div class="NLM_p last">A mixture of 4-methanesulfonyloxypiperidine-1-carboxylic acid <i>tert</i>-butyl ester (1.01 g) and sodium thiomethoxide (635 mg) was heated to 80 °C in DMF (10 mL). After 4 h, the reaction mixture was diluted with water, extracted with ethyl acetate, dried over MgSO<sub>4</sub>, filtered, and concentrated to give 4-methylsulfanylpiperidine-1-carboxylic acid <i>tert</i>-butyl ester (600 mg). This intermediate was dissolved in chloroform (15 mL), and m-CPBA (1.46 g) was added. After being stirred for 48 h, the reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated aqueous NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, filtered, and concentrated to afford 4-methanesulfonylpiperidine-1-carboxylic acid <i>tert</i>-butyl ester (505 mg). Treatment of this intermediate with HCl in CH<sub>2</sub>Cl<sub>2</sub> and MeOH yielded crude 4-methanesulfonylpiperidine as its HCl salt. This intermediate (252 mg) was added to 2-chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidine-6-carbaldehyde (250 mg) in 1,2-DCE (5 mL). Subsequently, triethyl orthoformate (330 μL) was added. After the mixture was stirred for 6 h, Na(OAc)<sub>3</sub>BH (530 mg) was added. The mixture was stirred overnight. The reaction was quenched by pouring onto water. The aqueous layer was extracted with dichloromethane, and the combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. This intermediate was reacted with 2-amino-5-boronic acid according to a similar Suzuki coupling procedure as described for compound <b>10</b> to afford <b>14</b> (12% yield over two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.88–2.00 (m, 2H), 2.04–2.20 (m, 4H), 2.83–2.86 (m, 4H), 3.13–3.20 (m, 2H), 3.81 (s, 2H), 3.88–3.90 (m, 4H), 3.92–3.96 (m, 4H), 5.25 (br s, 2H), 7.18 (s, 1H), 9.37 (s, 1H). LCMS (ESI): <i>m</i>/<i>z</i> = 490.34 [M + H]<sup>+</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-((2-(2-Aminopyrimidin-5-yl)-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methyl)-<i>N</i>-methylmethanesulfonamide</h3><div class="NLM_p last">To a solution of 2-chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidine-6-carbaldehyde (100 mg., 0.350 mmol) in anhydrous THF (0.500 mL) was added methylamine as a 2.0 M solution in THF (0.700 mL, 2.0 equiv). This reaction mixture was stirred overnight at room temperature under nitrogen. The reaction mixture was concentrated in vacuo, and the resulting solid residue was taken into MeOH/THF, 1/1 (0.500 mL). Next, NaBH<sub>3</sub> was added as a solid in several aliquots. The resulting slurry was stirred at room temperature for 2 h. The reaction mixture was quenched with a minimum of dilute aqueous HCl. The reaction mixture was then diluted with excess EtOAc and washed with water (×1) and saline (×1). The organic was dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvent was removed in vacuo. The crude product was carried forward with out purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.17 (s, 1H), 3.98 (s, 2H), 3.95–3.90 (m, 4H), 3.86–3.81 (m, 4H), 2.51 (s, 3H). LCMS (ESI): <i>m</i>/<i>z</i> = 299.0 [M + H]<sup>+</sup>. The crude amine was dissolved in methylene chloride (5 mL), and the mixture was cooled to 0 °C under nitrogen. Methanesulfonyl chloride (130 μL) was added, and the mixture was stirred for 12 h at room temperature. The mixture was diluted with water and 1 M HCl, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The sample was dried over MgSO<sub>4</sub> and concentrated. Purification was by silica gel chromatography (0–5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give the title compound (108 mg, 84% yield). <sup>1</sup>H NMR (400 MHz, C<sub>6</sub>D<sub>6</sub>) δ 6.91 (s, 1H), 4.00 (s, 2H), 3.45–3.38 (m, 4H), 3.35–3.28 (m, 4H), 2.44 (s, 3H), 2.18 (s, 3H). LCMS (ESI): <i>m</i>/<i>z</i> = 377.0 [M + H]<sup>+</sup><sub>.</sub></div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-((2-(2-Aminopyrimidin-5-yl)-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methyl)-<i>N</i>-methylmethanesulfonamide (<b>15</b>)</h3><div class="NLM_p last"><b>15</b> was prepared as described for <b>9</b> from <i>N</i>-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methyl)-<i>N</i>-methylmethanesulfonamide (9% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.10 (s, 2H), 7.61 (s, 1H), 4.51 (s, 2H), 3.97–3.87 (m, 4H), 3.82–3.68 (m, 4H), 3.00 (s, 3H), 2.88 (s, 3H). LCMS (ESI): <i>m</i>/<i>z</i> = 436.5 [M + H]<sup>+</sup>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-((2-Chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methyl)-<i>N</i>,<i>N</i>-dimethylpiperazine-1-carboxamide</h3><div class="NLM_p last">To a solution of 2-chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidine-6-carbaldehyde (200 mg) in 1,2-dichlorethane (10 mL) was added piperazine-1-carboxylic acid dimethylamide hydrochloride (291 mg) and triethyl orthoformate (390 μL). The mixture was stirred for 2 h at room temperature. Na(OAc)<sub>3</sub>BH (674 mg) was added, and the resulting reaction mixture was stirred for 16 h at room temperature. The reaction was quenched with water, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude compound was purified by silica gel chromatography (4% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to yield the desired compound (0.12 g, 27% yield).</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4-((2-(2-Aminopyrimidin-5-yl)-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methyl)-<i>N</i>,<i>N</i>-dimethylpiperazine-1-carboxamide (<b>16</b>)</h3><div class="NLM_p last">4-((2-Chloro-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-6-yl)methyl)-<i>N</i>,<i>N</i>-dimethylpiperazine-1-carboxamide was reacted with 2-amino-5-boronic acid according to a similar Suzuki coupling procedure as described for compound <b>11</b> to afford <b>16</b> (47% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.55 (m, 4H), 2.84 (s, 6H), 3.32 (m, 4H), 3.79 (s, 2H), 3.89–3.91 (m, 4H), 3.95–3.97 (m, 4H), 5.24 (br s, 2H), 7.14 (s, 1H), 9.30 (s, 2H). MS (ESI+): (M + H)<sup>+</sup> 484.31.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-(2-Chloro-5-iodothieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine</h3><div class="NLM_p last">4-(2-Chlorothieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (500 mg) in THF (50 mL) was cooled to −78 °C. <i>n</i>-BuLi (2 mL, 2.5 M in hexane) was added, and the reaction mixture was warmed to −40 °C and stirred for 50 min. The mixture was then recooled to −78 °C, and a solution of I<sub>2</sub> (1000 mg) in THF (30 mL) was added. The reaction mixture was warmed to room temperature and after 30 min was quenched with water and diluted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, washed with saturated aqueous Na<sub>2</sub>SO<sub>3</sub> and brine, then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to yield the desired compound (650 mg, 90% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.53 (s, 1H), 3.94–3.82 (m, 4H). MS (ESI+): (M + H)<sup>+</sup> 382.2.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-(6-(3-(Methylsulfonyl)phenyl)-4-morpholinothieno[2,3-<i>d</i>]pyrimidin-2-yl)pyrimidin-2-amine (<b>17</b>)</h3><div class="NLM_p last">2-Chloro-6-iodo-4-morpholinothieno[2,3-<i>d</i>]pyrimidine (525 mg), 3-(methylsulfonyl)phenylboronic acid (303 mg), and bis(triphenylphosphine)palladium(II) dichloride (96 mg) in 1 M Na<sub>2</sub>CO<sub>3</sub> aqueous solution (4.2 mL) and acetonitrile (9 mL) were heated to 100 °C in a sealed microwave reactor for 30 min. Upon completion, the mixture was extracted with dichloromethane (3 × 15 mL). The combined organic layers were dried with sodium sulfate, filtered, and concentrated. The crude mixture was purified by flash chromatography to yield 4-(2-chloro-6-(3-(methylsulfonyl)phenyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine which was used in the next step (MS (ESI+): (M + H)<sup>+</sup> 410.0). <b>17</b> was prepared as described for <b>10</b> from 4-(2-chloro-6-(3-(methylsulfonyl)phenyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)morpholine (7% yield over two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.13 (s, 2H), 8.29–8.25 (m, 1H), 8.22–8.18 (m, 1H), 8.15 (s, 1H), 7.95–7.91 (m, 1H), 7.77 (t, <i>J</i> = 8 Hz, 1H), 7.24 (br s, 2H), 4.06–3.98 (m, 4H), 3.86–3.78 (m, 4H). MS (ESI+): (M + H)<sup>+</sup> 469.1.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4,5-Dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxylic Acid</h3><div class="NLM_p last">POCl<sub>3</sub> (4.66 mL, 51.2 mmol) was added dropwise to 12 mL of DMF at 0 °C. After 30 min, 3,4-dihydrobenzo[<i>b</i>]oxepin-5(2<i>H</i>)-one (3.32 g, 20.5 mmol) was added as a solution in 15 mL of DMF. The solution was stirred, warming to room temperature over 2 h. The mixture was poured over ice–water, and the aqueous layer was extracted with EtOAc. The combined organics were washed with brine, dried over sodium sulfate, and concentrated. The residue was taken up in DMF (20 mL) and treated sequentially with potassium carbonate (5.66 g, 41 mmol) and then methyl thioglycolate (2.05 mL, 22.6 mmol). The mixture was heated at 50 °C overnight. Water was added and the mixture extracted with EtOAc. The combined organics were washed with brine, dried over sodium sulfate, and concentrated. Purification by flash column chromatography gave 4.22 g of the methyl ester as a light yellow solid. Then 3.0 g of the methyl ester (11.5 mmol) was taken up in 20 mL of THF and 10 mL of water and treated with LiOH (monohydrate, 970 mg, 2 equiv). The mixture was heated at 50 °C for 3 h. The solution was acidified with 2 N HCl and extracted with EtOAc and the combined organics were washed with brine, dried over sodium sulfate, and concentrated to give the acid as a colorless solid (2.64 g, 73% yield over two steps). <sup>1</sup>H NMR (500 MHz, DMSO) δ 13.11 (br s, 1H), 7.79–7.64 (m, 1H), 7.60 (s, 1H), 7.27 (ddd, <i>J</i> = 8.1, 7.3, 1.6 Hz, 1H), 7.11 (ddd, <i>J</i> = 7.9, 7.3, 1.3 Hz, 1H), 7.04 (dd, <i>J</i> = 8.1, 1.2 Hz, 1H), 4.31–4.26 (t, <i>J</i> = 5.2 Hz, 2H), 3.20 (t, <i>J</i> = 5.2 Hz, 2H).</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(2-Chlorophenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (<b>18</b>)</h3><div class="NLM_p last">A solution of the carboxylic acid (94 mg) was heated with 2 mL of SOCl<sub>2</sub> at 80 °C for 2 h. The mixture was concentrated by rotoevaporation, dissolved in 2 mL of CH<sub>2</sub>Cl<sub>2</sub>, and treated with a solution of 2-chloro-<i>N</i>-methylaniline (59 mg), Et<sub>3</sub>N (0.11 mL), and a trace amount of DMAP. The mixture was allowed to warm to room temperature to stir overnight. The mixture was diluted with saturated NaHCO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined extracts were concentrated and the residue was purified by flash column chromatography (24 g SiO<sub>2</sub>, 10–50% EtOAc in hexanes) to give <b>18</b> as a colorless solid (58 mg, 41% yield). <sup>1</sup>H NMR (500 MHz, DMSO) δ 7.69–7.60 (m, 2H), 7.57–7.48 (m, 2H), 7.41 (br d, <i>J</i> = 8.1 Hz, 1H), 7.23–7.18 (m, 1H), 7.06–7.01 (m, 1H), 6.98 (d, <i>J</i> = 8.1 Hz, 1H), 6.61 (br s, 1H), 4.17 (t, <i>J</i> = 5.0 Hz, 2H), 3.27 s, 3H), 2.95 (br s, 2H). LCMS: (M)<sup>+</sup> 370.1.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 8-Bromo-3,4-dihydrobenzo[<i>b</i>]oxepin-5(2<i>H</i>)-one (<b>45</b>)</h3><div class="NLM_p last">Solid 3-bromophenol (10.0 g, 58 mmol) was added portionwise to a stirred suspension of K<sub>2</sub>CO<sub>3</sub> in acetone (100 mL) at room temperature. Sodium iodide (NaI, 1.0 g) was added, followed by ethyl 4-bromobutyrate (9.2 mL, 64 mmol). The reaction mixture was heated at 80 °C overnight, cooled to room temperature, diluted with water, and extracted with ethyl acetate to give crude ethyl 4-(3-bromophenoxy)butanoate that was used in the next saponification without purification. The above crude residue was taken up in 100 mL of THF and 50 mL of water and treated with lithium hydroxide LiOH (hydrate, 4.9 g). The whole was heated at 50 °C for 2 days. The mixture was cooled to room temperature and acidified to pH 1 with 2 N HCl. The aqueous layer was extracted with ethyl acetate. The combined organics were washed with brine and dried over sodium sulfate to give crude 4-(3-bromophenoxy)butanoic acid as a sticky solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) 7.24 (m, 1H), 7.13 (m, 1H), 7.11 (m, 1H), 6.95 (m, 1H), 3.99 (m, 2H), 2.37 (m, 2H), 1.94 (m, 2H). To a stirred suspension of polyphosphoric acid (PPA, ∼60 g) and Celite (∼40 g) in 100 mL of toluene were added crude 4-(3-bromophenoxy)butanoic acid (∼58 mmol) in one portion and 10 mL of toluene rinse. The resultant suspension was heated at 110 °C for 5 h. The toluene was decanted through a plug of Celite, and the remaining slurry was washed repeatedly with toluene and ethyl acetate. The eluent was concentrated and purified by flash column chromatography (4:1 hexane/EtOAc) to give <b>45</b> (7 g, ∼50% yield over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 7.55 (d, <i>J</i> = 8.5 Hz, 1H), 7.37 (d, <i>J</i> = 1.5 Hz, 1H), 7.35 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 4.24 (t, <i>J</i> = 6.5 Hz, 2H), 2.79 (t, <i>J</i> = 7.0 Hz, 2H), 2.14 (m, 2H).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Methyl 8-Bromo-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxylate (<b>46</b>)</h3><div class="NLM_p last">Phosphorus oxychloride (1.88 mL, 20.8 mmol) was added dropwise to DMF (5 mL) at 0 °C. After 30 min a solution of 8-bromo-3,4-dihydrobenzo[<i>b</i>]oxepin-5(2<i>H</i>)-one (2.0 g, 8. 3 mmol) in 8 mL of DMF was added dropwise. The reaction mixture was allowed to reach room temperature and was stirred for 2 h, then poured slowly over rapidly stirred ice–water. The aqueous layer was extracted with ethyl acetate and the combined organics were washed with brine, dried over sodium sulfate, and concentrated to give a crude residue which was used in the next step without purification. The residue was dissolved in 10 mL of DMF and treated sequentially with potassium carbonate (2.20 g, 16.6 mmol) and methyl thioglycolate (0.83 mL). The whole was heated at 50 °C overnight, cooled to room temperature, and diluted with water. The aqueous layer was extracted with ethyl acetate. The combined organics were washed with brine, dried over sodium sulfate, and concentrated. The crude residue was purified by flash column chromatography (20–50% ethyl acetate in hexanes) to give <b>46</b> (2.20 g, 78% yield) as a colorless solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 7.70 (s, 1H), 7.67 (d, <i>J</i> = 8.5 Hz, 1H), 7.31–7.28 (m, 2H), 4.32 (t, <i>J</i> = 5.0 Hz, 2H), 3.84 (s, 3H), 3.21 (t, <i>J</i> = 5.0 Hz, 2H).</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 8-Bromo-<i>N</i>-(2-chlorophenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (<b>47</b>)</h3><div class="NLM_p last">A solution of <b>46</b> (2.0 g, 5.9 mmol) was suspended in 5 mL of THF and 5 mL of water. LiOH (monohydrate, 620 mg) was added in one portion. The mixture was heated at 50 °C for 3 h. The mixture was cooled to room temperature and acidified with 2 N HCl. The mixture was extracted with EtOAc and the combined organics were washed with brine and dried over sodium sulfate. The crude residue was dissolved in 7 mL of SOCl<sub>2</sub> and heated at 80 °C for 2 h. The mixture was cooled to room temperature and concentrated. The crude yellow residue was diluted with CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and cooled to 0°C. A solution of 2-chloro-<i>N</i>-methyaniline (963 mg) and Et<sub>3</sub>N (1.64 mL) in 5 mL of CH<sub>2</sub>Cl<sub>2</sub> was added over a few minutes. The mixture was allowed to warm to room temperature and was stirred overnight. The mixture was diluted with saturated NaHCO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined extracts were concentrated and the residue was purified by flash column chromatography (80 g SiO<sub>2</sub>, 10–50% EtOAc in hexanes) to give <b>47</b> as a colorless solid (2.10 g, 79% over three steps.). <sup>1</sup>H NMR (500 MHz, DMSO) δ 7.70–7.60 (m, 2H), 7.56–7.47 (m, 2H), 7.35 (br d, <i>J</i> = 8.2 Hz, 1H), 7.26–7.18 (overlapping m, 2H), 6.56 (br s, 1H), 4.19 (br t, <i>J</i> = 4.8 Hz, 2H), 3.31 (s, 3H), 2.94 (br s, 2H). MS (ESI+): (M + H)<sup>+</sup> 449.9.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-(2-Chlorophenyl)-<i>N</i>-methyl-8-(1<i>H</i>-pyrazol-5-yl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (<b>19</b>)</h3><div class="NLM_p last">A solution of <b>47</b> (200 mg, 0.47 mmol) in MeCN (1.5 mL) and water (1.5 mL) was treated with 3-pyrazoleboronic acid (65 mg) and potassium acetate (150 mg). The mixture was purged with nitrogen and then charged with Pd(PPh<sub>3</sub>)<sub>4</sub> (41 mg). The mixture was heated by microwave irradiation at 140 °C for 20 min. The mixture was diluted with water and extracted with ethyl acetate. Purification by reverse phase HPLC gave <b>19</b> as a colorless solid (194 mg, 83% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 13.30, 12.93 (br s, 0.2 + 0.8H, pyrazole tautomer NHs), 7.76–7.34 (overlapping m, 8H), 6.73 (s, 1H), 6.59 (br s, 1H), 4.20 (br s, 2H), 3.30 (s, 3H, obstructed by water), 2.97 (br s, 2H). LCMS: (M)<sup>+</sup> 436.1.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-(2-Chlorophenyl)-8-cyano-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (<b>20</b>)</h3><div class="NLM_p last">A solution of <b>47</b> (50 mg, 0.11 mmol) in 1 mL of DMF was treated with CuCN (30 mg, 3 equiv). The mixture was heated by microwave irradiation at 250 °C for 20 min. Saturated ammonium chloride was added and the mixture extracted with ethyl acetate. The combined extracts were filtered over Celite, concentrated and the residue was purified by reverse phase HPLC to give <b>20</b> (16 mg, 36% yield). <sup>1</sup>H NMR (500 MHz, DMSO) δ 7.66 (br s, 2H), 7.62–7.45 (overlapping m, 4H), 6.65 (br s, 1H), 4.23 (br s, 2H), 3.29 (br s, 3H), 3.01 (br s, 2H). LCMS: (M)<sup>+</sup> 395.1.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 8-Acetamido-<i>N</i>-(2-chlorophenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (<b>21</b>)</h3><div class="NLM_p last">A solution of <b>47</b> (100 mg, 0.22 mmol), cesium carbonate (158 mg, 2.2 equiv), acetamide (20 mg, 1.5 equiv), and xantphos (13 mg, 0.10 equiv) in 2 mL of dioxane was sparged with nitrogen. Pd<sub>2</sub>dba<sub>3</sub> (10 mg, 0.05 equiv) was added and the mixture heated at 100 °C in a sealed tube for 8 h. Water was added and the mixture extracted with EtOAc. Concentration and purification by reverse phase HPLC gave <b>21</b> (53 mg, 56% yield). <sup>1</sup>H NMR (500 MHz, DMSO) δ 10.03 (s, 1H), 7.65 (m, 2H), 7.52 (m, 2H), 7.36 (m, 2H), 7.18 (m, 1H), 6.50 (br s, 1H), 4.15 (br s, 2H), 3.27 (s, 3H), 2.91 (br s, 2H), 2.03 (s, 3H). LCMS: (M)<sup>+</sup> 427.1.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl 2-((2-Chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-8-carboxylate (<b>22</b>)</h3><div class="NLM_p last">Under ambient atmosphere, a solution of <b>47</b> (100 mg, 0.22 mmol) in 2 mL of THF was treated sequentially with molybdenum hexacarbonyl (58 mg, 0.22 mmol), methylamine (2.0 M in THF, 0.33 mL, 0.66 mmol), and Hermann’s catalyst (31 mg, 15 mol %). DBU (0.02 mL, 0.11 mmol) was added and the vial quickly sealed. The mixture was heated by microwave irradiation at 150 °C for 20 min. The mixture was diluted with EtOAc and filtered over Celite. Concentration and purification by flash column chromatography and then reverse-phase HPLC gave <b>22</b> (25 mg, 26% yield). <sup>1</sup>H NMR (500 MHz, DMSO) δ 8.42 (br q, 1H), 7.70–7.60 (m, 2H), 7.57–7.50 (m, 2H), 7.49 (s, 1H), 7.43 (s, 1H), 6.56 (br s, 1H), 4.20 (br s, 2H), 3.28 (s, 3H), 2.97 (br s, 2H), 2.75 (d, <i>J</i> = 4.5 Hz, 3H). LCMS: (M)<sup>+</sup> 427.1.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Methyl 2-((2-Chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-8-carboxylate</h3><div class="NLM_p last">A mixture of 8-bromo-<i>N</i>-(2-chlorophenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (10 g, 0.022 mol), Pd(OAc)<sub>2</sub> (2.47 g, 0.011 mmol), dppf (10 g, 0.018 mol), and triethylamine (4.45 g, 0.044 mol) in DMF (50 mL) and MeOH (100 mL) was stirred under CO atmosphere (50 psi) at 70 °C for 2 days. After it was filtered and concentrated, the crude product was purified by column chromatography (hexanes/EtOAc = 5:1) to give the desired product (6.59 g, 69% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (dd, <i>J</i> = 1.6, 7.2 Hz, 2H), 7.48–7.42 (m, 2H), 7.35–7.30 (m, 3H), 6.72 (s, 1H), 4.18 (t, <i>J</i> = 5.2 Hz, 2H), 3.83 (s, 3H), 3.33 (s, 3H), 2.99 (t, <i>J</i> = 5.2 Hz, 2H). MS (ESI+): (M + H)<sup>+</sup> 428.0.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-[(2-Chlorophenyl)methylcarbamonyl]-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-8-carboxylic Acid</h3><div class="NLM_p last">To a solution of methyl 2-((2-chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[b]thieno[2,3-<i>d</i>]oxepine-8-carboxylate (6.59 g, 15.4 mmol) in THF (25 mL) and water (25 mL) was added LiOH monohydrate (1.29 g). After the solution was heated at 50 °C for 2 h, it was cooled to room temperature and acidified with 2 N HCl. The precipitate was separated and dried to give the desired product (6.06 g, 95% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.62 (dd, <i>J</i> = 1.2, 8.0 Hz, 2H), 7.48–7.44 (m, 2H), 7.37–7.30 (m, 3H), 6.75 (s, 1H), 4.19 (t, <i>J</i> = 5.2 Hz, 2H), 3.33 (s, 3H), 3.00 (t, <i>J</i> = 5.2 Hz, 2H). MS (ESI+): (M + H)<sup>+</sup> 414.0.</div></div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-((2-Chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-8-carbonyl Chloride</h3><div class="NLM_p last">A solution of 2-[(2-chlorophenyl)methylcarbamonyl]-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-8-carboxylic acid (200 mg, 0.24 mmol) in SOCl<sub>2</sub> (4 mL) was heated at 80 °C for 2 h. It was concentrated to give the crude acid chloride, which used in the next step without further purification.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i><sup>2</sup>-(2-Chlorophenyl)-<i>N</i><sup>8</sup>-ethyl-<i>N</i><sup>2</sup>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2,8-dicarboxamide (<b>23</b>)</h3><div class="NLM_p last">A solution of 2-[(2-chloro-phenyl)methylcarbamonyl]-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-8-carboxylic acid (200 mg, 0.24 mmol) in SOCl<sub>2</sub> (4 mL) was heated at 80 °C for 2 h. It was concentrated to give the crude acid chloride. The crude acid chloride was taken up in THF (20 mL) and added to a solution of CH<sub>3</sub>CH<sub>2</sub>NH<sub>2</sub> (42 mg, 0.92 mmol) and pyridine (0.2 mL) in THF (5 mL). After the mixture was stirred at room temperature overnight, it was concentrated, dissolved in EtOAc, washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the desired product (119 mg, 27% yield over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.53–7.47 (m, 2H), 7.42–7.33 (m, 2H), 6.73 (s, 1H), 6.03 (s, 1H), 4.23 (t, <i>J</i> = 4.8 Hz, 2H), 3.50–3.42 (m, 2H), 3.38 (s, 3H), 3.03 (t, <i>J</i> = 4.8 Hz, 2H), 1.27–1.21 (m, 3H). MS (ESI+): (M + H)<sup>+</sup> 441.0.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 8-Bromomethyl-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azuene-2-carboxylic Acid (2-Chlorophenyl)methylamide</h3><div class="NLM_p last">A mixture of 2-[(2-chlorophenyl)methylcarbamonyl]-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-8-carboxylic acid methyl ester (1 g, 2.3 mmol) and lithium aluminum hydride in dry THF (30 mL) was stirred at 0 °C under nitrogen for 30 min and monitored by LCMS. The reaction mixture was quenched by the slow addition of water with stirring and warmed to room temperature. The aqueous layer was extracted with EtOAc, and the combined organics were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was recrystallized from MeOH to give crude 8-hydromethyl-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azuene-2-carboxylic acid (2-chlorophenyl)methylamide as a yellow solid (LCMS (ESI+): (M + H)<sup>+</sup> 399.9). To a solution of this intermediate (1.25 g, 3.13 mmol) in THF (20 mL) was added a solution of PBr<sub>3</sub> (0.88 mL) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) dropwise. The resulting mixture was stirred at room temperature overnight. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum to give a yellow oil. The crude product was recrystallized from MeOH to give the titled product as a yellow solid (1.4 g, 48% yield over two steps). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.51 (d, <i>J</i> = 7.6 Hz, 1H), 7.41–7.33 (m, 4H), 6.98 (dd, J = 2.4, 4.0 Hz, 2H), 6.73 (s, 1H), 4.38 (s, 2H), 4.21 (t, <i>J</i> = 5.2 Hz, 2H), 3.37 (s, 3H), 3.00 (t, <i>J</i> = 5.2 Hz, 2H). LCMS (ESI+): (M + H)<sup>+</sup> 461.8.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-(2-Chlorophenyl)-<i>N</i>-methyl-8-((methylamino)methyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (<b>24</b>)</h3><div class="NLM_p last">To a solution of CH<sub>3</sub>NH<sub>2</sub> (0.25 mL) in EtOH was added Et<sub>3</sub>N (0.5 mL) and 8-bromomethyl-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azuene-2-carboxylic acid (2-chlorophenyl)methylamide (250 mg, 0.55 mmol). The reaction mixture was stirred at 60 °C for 2 h. The reaction mixture was added to water, and the aqueous layer was extracted with EtOAc (20 mL × 3). The sample was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified by silica gel flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 10:1) to give <b>24</b> as a light yellow solid (96 mg, 43%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.73 (br, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 1H), 7.37–7.29 (m, 4H), 7.15 (d, <i>J</i> = 8.0 Hz, 1H), 7.02 (s, 1H), 6.82 (s, 1H), 4.12 (t, <i>J</i> = 4.8 Hz, 2H), 3.90 (s, 2H), 3.31 (s, 3H), 2.94 (t, <i>J</i> = 4.8 Hz, 2H), 2.45 (s, 3H). LCMS (ESI+): (M + H)<sup>+</sup> 412.9.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i><sup>8</sup>-(2-Aminoethyl)-<i>N</i><sup>2</sup>-(2-chlorophenyl)-<i>N</i><sup>2</sup>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2,8-dicarboxamide (<b>25</b>)</h3><div class="NLM_p last"><b>25</b> was prepared according to the procedure described for <b>23</b> from 2-((2-chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-8- carbonyl chloride (30% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30–8.10 (m, 3H), 7.45–7.19 (m, 5H), 6.30 (s, 1H), 3.92 (s, 2H), 3.57–3.10 (m, 9H), 2.70–2.59 (m, 2H). MS (ESI+): (M + H)<sup>+</sup> 456.0.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (3-Bromophenyl)acetic Acid Methyl Ester</h3><div class="NLM_p last">A solution of (3-bromophenyl)acetic acid (5 g, 23.3 mmol) and concentrated H<sub>2</sub>SO<sub>4</sub> (2 mL) in CH<sub>3</sub>OH (100 mL) was stirred at reflux for 3 h. The solution was cooled, concentrated, and diluted with water and EtOAc. The organic layer was washed with water and dried to give (3-bromophenyl)acetic acid methyl ester (5.1 g, 96%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.47 (s, 1H), 7.40 (m, 1H), 7.25 (m, 2H), 3.68 (s, 2H), 3.58 (s, 3H). ESI-MS, <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 228.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> [3-(4,4,5,5-Tetramethyl[1,3,2]dioxaborolan-2-yl)phenyl]acetic Acid Methyl Ester</h3><div class="NLM_p last">A mixture of (3-bromophenyl)acetic acid methyl ester (2.0 g, 8.7 mmol), 4,4,5,5,4′,4′,5′,5′-octamethyl[2,2′]bi[[1,3,2]dioxaborolanyl] (3.33 g, 13.1 mmol), KOAc (2.56 g, 26.1 mmol), and Pd(dppf)Cl<sub>2</sub> (400 mg) in DMSO (40 mL) was stirred at 80 °C for 4 h. The cooled solution was poured into water and extracted with EtOAc. The organic layer was washed with water, dried, concentrated, and purified by column to afford the crude product [3-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenyl]acetic acid methyl ester (1.6 g). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.56 (s, 1H), 7.54 (d, <i>J</i> = 1.2 Hz, 1H), 7.3 (m, 2H), 3.7 (s, 2H), 3.6 (s, 3H), 1.28 (s, 12H).</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Methyl 2-(3-(2-((2-Chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepin-8-yl)phenyl)acetate</h3><div class="NLM_p last">A mixture of 8-bromo-<i>N</i>-(2-chlorophenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]voxepine-2-carboxamide (500 mg, 1.11 mmol), [3-(4,4,5,5-tetramethyl[1, 3, 2]dioxaborolan-2-yl)phenyl]acetic acid methyl ester (615 mg, 2.23 mmol), sodium carbonate (460 mg, 3.33 mmol), and Pd(dppf)Cl<sub>2</sub> (40 mg) in CH<sub>3</sub>CN (4 mL) was heated under microwave irradiation at 100 °C for 50 min. The mixture was filtered through Celite, concentrated, and purified by preparative HPLC to afford the product methyl 2-(3-(2-((2-chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepin-8-yl)phenyl)acetate (200 mg, 35% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.65–7.63 (m, 2H), 7.62–7.48 (m, 5H), 7.47–7.32 (m, 2H), 7.24–7.22 (m, 2H), 6.57 (s, 1H), 4.19 (t, <i>J</i> = 4.8 Hz, 2H), 3.72 (s, 2H), 3.59 (s, 3H), 3.25 (s, 3H), 2.95(s, 2H). LCMS (ESI+): (M + H)<sup>+</sup> 518.2.</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 2-(3-(2-((2-Chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepin-8-yl)phenyl)acetic Acid (<b>26</b>)</h3><div class="NLM_p last">A mixture of methyl 2-(3-(2-((2-chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepin-8-yl)phenyl)acetate (100 mg, 2.4 mmol) and LiOH (16.2 mg, 0.39 mmol) in THF/H<sub>2</sub>O (10 mL/10 mL) was stirred at 50 °C for 2 h. After the solution was cooled, it was adjusted to pH 2 with HCl (aqueous, 6 N). The resulting solution was concentrated and extracted with EtOAc. The combined organic layer was washed with water and concentrated to afford the product (90 mg, 92% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.47–7.41 (m, 4H), 7.34–7.29 (m, 4H), 7.19 (s, 1H), 7.15–7.13 (m, 2H), 6.71 (s, 1H), 4.20 (t, <i>J</i> = 5.2 Hz, 2H), 3.64 (s, 2H), 3.33 (s, 3H), 2.98 (t, <i>J</i> = 5.2 Hz, 2H). LCMS (ESI+): (M + H)<sup>+</sup> 501.7.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>N</i>-(2-Chlorophenyl)-8-(3-cyanophenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide</h3><div class="NLM_p last">A mixture of 8-bromo-<i>N</i>-(2-chlorophenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno [2,3-<i>d</i>]oxepine-2-carboxamide (500 mg, 1.11 mmol), 3-cyanophenylboronic acid (200 mg, 1.25 mmol), sodium carbonate (400 mg, 3 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>(100 mg) in CH<sub>3</sub>CN (4 mL) was heated under microwave irradiation at 100 °C for 40 min. The mixture was filtered through Celite, concentrated, and purified by column to afford the product (400 mg, 69% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.18 (s, 1H), 8.05 (d, <i>J</i> = 8.4 Hz, 1H), 7.85 (d, <i>J</i> = 8.0 Hz, 1H), 7.70–7.59 (m, 3H), 7.58–7.42 (m, 4H), 7.40 (s, 1H), 6.65 (s, 1H), 4.28–4.19 (m, 2H), 3.25 (s, 3H), 2.98–2.90 (m, 2H). LCMS (ESI+): (M + H)<sup>+</sup> 471.1.</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 8-(3-(Aminomethyl)phenyl)-<i>N</i>-(2-chlorophenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[b]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (<b>27</b>)</h3><div class="NLM_p last">A solution of <i>N</i>-(2-chlorophenyl)-8-(3-cyanophenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (300 mg, 0.63 mmol), Raney Ni (1 g), and NH<sub>3</sub>·H<sub>2</sub>O (2.5 mL) in MeOH (50 mL) was stirred at 30 °C under hydrogen atmosphere (50 psi). The reaction mixture was filtered through Celite, concentrated, washed with water, and purified by preparative TLC to afford <b>27</b> (34 mg, 11% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.38 (s, 2H), 7.87 (s, 1H), 7.71–7.65 (m, 3H), 7.34–7.41 (m, 6H), 7.35 (s, 1H), 6.59 (s, 1H), 4.22 (s, 2H), 4.07 (s, 2H), 3.33 (s, 3H), 2.98 (s, 2H). LCMS (ESI+): (M + H)<sup>+</sup> 475.1.</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>N</i><sup>2</sup>-(2-Chlorophenyl)-<i>N</i><sup>2</sup>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2,9-dicarboxamide (<b>28</b>)</h3><div class="NLM_p last">To a mixture of <b>30</b> (120 mg) and K<sub>2</sub>CO<sub>3</sub> (49 mg) in dry DMSO (2 mL) was added 33% H<sub>2</sub>O<sub>2</sub> (40 μL). The reaction mixture stirred overnight at room temperature. Ice was added to the resulting solution, and the solid formed was collected, washed with water, and dried to afford <b>30</b> (119 mg, 95% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.99 (d, <i>J</i> = 1.81 Hz, 1H), 7.60–7.55 (m, 2H), 7.45–7.39 (m, 3H), 7.03 (d, <i>J</i> = 8.44 Hz, 1H), 6.71 (s, 1H), 5.75 (br s, 2H-NH<sub>2</sub>), 4.28 (t, <i>J</i> = 5.06 Hz, 2H), 3.42 (s, 3H), 3.04 (t, <i>J</i> = 5.02, 2H). LCMS (ESI+): (M + H)<sup>+</sup> 413.14.</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i><sup>2</sup>-(2-Chlorophenyl)-<i>N</i><sup>9</sup>-ethyl-<i>N</i><sup>2</sup>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2,9-dicarboxamide (<b>29</b>)</h3><div class="NLM_p last">A mixture of <b>28</b> (70 mg), TFA (37.5 μL), triethylsilane (80 μL), and acetaldehyde (28 μL) in acetonitrile was stirred at room temperature overnight and then was concentrated. Purification on silica yielded <b>29</b> (34 mg, 46% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.81 (m, 1H), 7.47–7.44 (m, 2H), 7.36–7.29 (m, 3H), 6.91 (d, <i>J</i> = 8.41 Hz, 1H), 6.59 (s, 1H), 5.94 (m, 1H), 4.17 (t, <i>J</i> = 5.10 Hz, 2H), 3.43 (m, 2H), 3.32 (s, 3H), 2.93 (t, <i>J</i> = 5.07 Hz, 2H), 1.21 (t, <i>J</i> = 7.28, 3H). LCMS (ESI+): (M + H)<sup>+</sup> 482.15.</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 3-Bromo-4-(2-thiophen-3-ylethoxy)benzonitrile</h3><div class="NLM_p last">To a solution of 3-bromo-4-hydroxybenzonitrile (8.50 g) in THF (200 mL) were added 2-(3-thienyl)ethanol (4.42 mL) and triphenylphosphine (11.80 g). The mixture was cooled to 0 °C, and diethylazodicarboxylate (7.09 mL) was added dropwise. The mixture was stirred at room temperature for 16 h. The reaction mixture was concentrated and the residue redissolved in diethyl ether (100 mL). The mixture was stirred for 10 min at 0 °C and then filtered. The filtrate was washed with saturated aqueous sodium carbonate (80 mL), 1 M HCl (80 mL), and brine, dried over MgSO<sub>4</sub>, concentrated, then purified on silica gel to afford the desired compound (11.7 g, 95% yield).</div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 4,5-Dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-9-carbonitrile</h3><div class="NLM_p last">To a solution of 3-bromo-4-(2-thiophen-3-ylethoxy)benzonitrile (3.08 g) in DMF (20 mL) was added palladium acetate (224 mg), PPh<sub>3</sub> (525 mg), and K<sub>2</sub>CO<sub>3</sub> (2.76 g), and the mixture was heated at 90 °C for 16 h. After cooling to room temperature, the mixture was diluted with ethyl acetate (60 mL) and filtered. The filtrate was washed with brine, dried over MgSO<sub>4</sub>, concentrated, and purified by silica gel chromatography to afford the title compound (1.75 g, 77% yield).</div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2-Bromo-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-9-carbonitrile</h3><div class="NLM_p last">To a solution of 4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-9-carbonitrile (4.58 g) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and acetic acid (30 mL) was added <i>N</i>-bromosuccinimide (3.95 g), and the mixture was stirred for 16 h at room temperature. Water (100 mL) was added and the solid collected by filtration and air-dried to give the title compound (3.0 g, 49% yield).</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 9-Cyano-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-2-carboxylic Acid</h3><div class="NLM_p last">To a solution of 2-bromo-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-9-carbonitrile (1.0 g) in THF (25 mL) at −78 °C was added <i>n</i>-BuLi (1.44 mL), and the mixture was allowed to warm to −10 °C over 1 h. The mixture was then recooled to −78 °C, and carbon dioxide was bubbled through the solution for 15 min. The mixture was then allowed to warm to room temperature over 4 h. The reaction was quenched with water (5 mL) and the product extracted into saturated aqueous Na<sub>2</sub>CO<sub>3</sub> (30 mL). The aqueous layer was washed with ethyl acetate (30 mL) and then acidified to pH 2–3 with 2 M HCl. The product was then extracted into ethyl acetate and the organic layers were dried over MgSO<sub>4</sub> and concentrated to give the title compound (0.43 g, 48% yield).</div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>N</i>-(2-Chlorophenyl)-9-cyano-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (<b>30</b>)</h3><div class="NLM_p last">To a solution of 9-cyano-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-2-carboxylic acid (300 mg) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added DMF (1 drop) and oxalyl chloride (0.165 mL), and the mixture was stirred for 30 min at room temperature. The mixture was concentrated, and the residue was dissolved in acetonitrile (10 mL). To this solution were added 2-chloro-<i>N</i>-methylaniline (0.165 mL) and K<sub>2</sub>CO<sub>3</sub> (308 mg), and the mixture was stirred for 16 h at room temperature. The mixture was partitioned between water (40 mL) and ethyl acetate (30 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified on silica to afford <b>30</b> (149 mg, 34% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.72 (d, <i>J</i> = 1.65 Hz, 1H), 7.57 (m, 1H), 7.47–7.38 (m, 4 H), 7.03 (d, <i>J</i> = 8.4 Hz, 1H), 6.92 (s, 1H), 4.29 (t, <i>J</i> = 5.02 Hz, 2 H), 3.41 (s, 3H), 3.08 (t, <i>J</i> = 5.00 Hz, 2H). LCMS (ESI+): (M + H)<sup>+</sup> 395.</div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 4-Amino-3-chloro-<i>N</i>,<i>N</i>-dimethylbenzamide</h3><div class="NLM_p last"><i>i</i>-Pr<sub>2</sub>NEt (116 mL, 699.5 mmol) was added to a suspension of dimethylamine hydrochloride (28.51 g, 349.6 mmol) in THF (600 mL). The mixture was stirred at room temperature for 0.5 h. Then 4-amino-3-chlorobenzoic acid (30.00 g, 174.8 mmol) and HATU (86.41 g, 227.2 mmol) were added to the above suspension separately. The reaction mixture was stirred for an additional 1.5 h. It was concentrated, and the residue was partitioned between EtOAc (300 mL) and water (150 mL). The organic phase was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuum. The crude product was purified by silica gel chromatography (hexanes/EtOAc = 1:1) to afford the pure product (34.72 g, 89% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.39 (s, 1H), 7.19 (d, <i>J</i> = 8.4 Hz, 1H), 6.74 (d, <i>J</i> = 8.4 Hz, 1H), 4.24 (br, 2H), 3.05 (s, 6H).</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 8-Bromo-<i>N</i>-(2-chloro-4-(dimethylcarbamoyl)phenyl)-4,5-dihydrobenzo[b]thieno[2,3-<i>d</i>]oxepine-2-carboxamide</h3><div class="NLM_p last">A solution of 8-bromo-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxylic acid (25.00 g, 76.9 mmol) in SOCl<sub>2</sub> (200 mL) was heated at 90–100 °C for 3 h. It was concentrated to give the crude acid chloride. A suspension of the acid chloride in THF (600 mL) was treated with a solution of 4-amino-3-chloro-<i>N</i>,<i>N</i>-dimethylbenzamide (18.23 g, 92.3 mmol) and pyridine (14 mL) in THF (200 mL) at 0 °C. The mixture was warmed to room temperature and stirred overnight. After it was concentrated, water (200 mL) was added to the mixture. The resulting precipitate was collected by filtration, washed with water, and dried to give the desired product (29.88 g, 77% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.14 (s, 1H), 7.86 (s, 1H), 7.67–7.57 (m, 3H), 7.40–7.25 (m, 3H), 4.32 (t, <i>J</i> = 5.2 Hz, 2H), 3.21 (t, <i>J</i> = 5.2 Hz, 2H), 2.95 (s, 3H), 2.92 (s, 3H).</div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 8-Bromo-<i>N</i>-(2-chloro-4-(dimethylcarbamoyl)phenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide</h3><div class="NLM_p last">To solution of 8-bromo-<i>N</i>-(2-chloro-4-(dimethylcarbamoyl)phenyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (29.0 g, 57.3 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (37.40 g, 114.7 mmol) in DMF (600 mL) was slowly added CH<sub>3</sub>I (30 mL, 479.8 mmol). The reaction mixture was stirred at room temperature overnight. DMF (about 200 mL) was removed under reduced pressure, and water (100 mL) was added to the mixture.. The resulting precipitate was filtered, washed with water, and dried to give the desired product (29.50 g, 99% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.72–7.68 (m, 2H), 7.52–7.49 (m, 1H), 7.30–7.20 (m, 3H), 6.76 (s, 1H), 4.19 (s, 2H), 3.29 (s, 3H), 3.00 (s, 3H), 2.96 (s, 2H), 2.93 (s, 3H).</div></div><div id="sec6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Methyl 2-((2-Chloro-4-(dimethylcarbamoyl)phenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-8-carboxylate</h3><div class="NLM_p last">A mixture of 8-bromo-<i>N</i>-(2-chloro-4-(dimethylcarbamoyl)phenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (27.0 g, 51.9 mmol), dppf (23.20 g, 41.9 mmol), Pd(OAc)<sub>2</sub> (5.8 g, 25.8 mmol), and Et<sub>3</sub>N (27 mL) in DMF (270 mL) and MeOH (400 mL) was stirred under a CO atmosphere (50 psi) at 70 °C for 2 days. The reaction mixture was filtered, and the filtrate was concentrated. The crude product was purified by silica gel chromatography (hexanes/EtOAc = 1:1) to give the product (23.0 g, 89% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.74–7.69 (m, 2H), 7.58–7.47 (m, 4H), 6.79 (s, 1H), 4.23 (t, <i>J</i> = 4.8 Hz, 2H), 3.83 (s, 3H), 3.31 (s, 3H), 3.01 (br, 5H, CH<sub>2</sub>), 2.94 (s, 3H).</div></div><div id="sec6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 2-((2-Chloro-4-(dimethylcarbamoyl)phenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-8-carboxylic Acid</h3><div class="NLM_p last">Methyl 2-((2-chloro-4-(dimethylcarbamoyl)phenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-8-carboxylate (25.0 g, 50.1 mmol) was dissolved in THF (50 mL) and water (50 mL). The solution was treated with LiOH·H<sub>2</sub>O (5.26 g, 125.3 mmol). The reaction mixture was stirred at room temperature for 2 h. THF was removed under reduced pressure, and the mixture was acidified by HCl (2 N). The resulting precipitate was filtered, washed with water, and dried to give desired product (20.00 g, 82% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.66–7.60 (m, 3H), 7.46–7.42 (m, 3H), 6.99 (s, 1H), 4.23 (t, <i>J</i> = 5.0 Hz, 2H), 3.39 (s, 3H), 3.14 (s, 3H), 3.07 (t, <i>J</i> = 5.0 Hz, 2H), 3.02 (s, 3H).</div></div><div id="sec6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>N</i><sup>2</sup>-(2-Chloro-4-(dimethylcarbamoyl)phenyl)-<i>N</i><sup>2</sup>,<i>N</i><sup>8</sup>-dimethyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2,8-dicarboxamide (<b>31</b>)</h3><div class="NLM_p last">To a suspension of H<sub>2</sub>NMe·HCl (5.02 g, 74.4 mmol) in THF (180 mL), <i>i</i>-Pr<sub>2</sub>NEt (16.83 g, 130.2 mmol) was added. The mixture was stirred at room temperature for 0.5 h. Then 2-((2-chloro-4-(dimethylcarbamoyl)phenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-8-carboxylic acid (9.00 g, 18.6 mmol) and HATU (21.22 g, 55.8 mmol) were added to the above suspension separately. The reaction mixture was stirred at room temperature for 2 h. Solvent was removed, and the resulting mixture was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (200 mL), washed with HCl (2 N, 200 mL) and water (100 mL), and dried over Na<sub>2</sub>SO<sub>4</sub>. The crude product was purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 10:1) to give the product (3.70 g, 40% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.58 (s, 1H), 7.42–7.29 (m, 4H), 6.92 (s, 1H,), 6.34 (d, <i>J</i> = 4.0 Hz, 1H), 4.20 (t, <i>J</i> = 5.0 Hz, 2H), 3.37 (s, 3H), 3.12 (s, 3H), 3.04–2.98 (m, 8H, CH<sub>2</sub>). LCMS (ESI+): (M + H)<sup>+</sup> 498.2.</div></div><div id="sec6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 3-Amino-4-chloro-<i>N</i>,<i>N</i>-dimethylbenzamide</h3><div class="NLM_p last">3-Amino-4-chlorobenzoic acid (3.11 g), dimethylamine hydrochloride (2.96 g), <i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-<i>O</i>-(7-azabenzotriazol-1-yl)uronium hexofluorophosphate (8.09 g), and <i>N</i>,<i>N</i>-diisopropylethylamine (12.6 mL) were combined in 50 mL of anhydrous tetrahydrofuran, and the mixture was allowed to stir for 12 h. The reaction mixture was partitioned with saturated sodium bicarbonate and ethyl acetate. The organic layer was concentrated and then purified by silica gel chromatography on a Teledyne ISCO 140 g functionalized amine column to give the desired compound (3.5 g, 97% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.26–7.21 (d, <i>J</i> = 8.1 Hz, 1H), 6.84–6.79 (d, <i>J</i> = 1.7 Hz, 1H), 6.72–6.66 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 4.40–3.90 (s, 2H), 3.07 (s, 3H), 2.97 (s, 3H). LCMS (ESI+): (M + H)<sup>+</sup> = 199.0</div></div><div id="sec6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 8-Bromo-<i>N</i>-(2-chloro-5-(dimethylcarbamoyl)phenyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide</h3><div class="NLM_p last">8-Bromo-4,5-dihydrothieno[3,2-<i>d</i>][1]benzoxepine-2-carboxylic acid (816 mg) was suspended in thionyl chloride (10 mL) and heated at 85 °C with a Vigreux condensation column attached for 2 h. The mixture was cooled to room temperature and concentrated. Then 35 mL of anhydrous THF was added and the mixture was cooled to 0 °C. 3-Amino4-chloro-<i>N</i>,<i>N</i>-dimethylbenzamide (548.3 mg) in 5 mL of anhydrous THF and pyridine (0.609 mL) were added. The mixture was allowed to warm to room temperature and was stirred for 12 h. The reaction mixture was concentrated and purified by silica gel chromatography (0–100% ethyl acetate in heptanes) to give the desired product (1.09 g, 86% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.68–8.49 (br s, 1H), 7.65–7.59 (d, <i>J</i> = 8.5 Hz, 1H), 7.51–7.6 (d, 1H), 7.49–7.46 (br s, 1H), 7.28–7.25 (m, 2H), 7.25–7.23 (d, <i>J</i> = 1.7 Hz, 1H), 7.23–7.21 (br s, 1H), 4.42–4.34 (t, <i>J</i> = 5.1 Hz, 2H), 3.33–3.23 (t, <i>J</i> = 5.1 Hz, 2H), 3.14–3.08 (br s, 6H). LCMS (ESI+): (M + H)<sup>+</sup> = 506.1.</div></div><div id="sec6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 8-Bromo-<i>N</i>-(2-chloro-5-(dimethylcarbamoyl)phenyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide</h3><div class="NLM_p last">8-Bromo-<i>N</i>- [2-chloro-5-(dimethylcarbamoyl)phenyl]-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (1.09 g) was dissolved in DMF (50 mL), and cesium carbonate (843 mg) was added followed by methyl iodide (0.15 mL). The mixture was stirred at room temperature overnight. The mixture was diluted with water, and the aqueous layer was extracted with ethyl acetate. The sample was purified by silica gel chromatography (25–100% ethyl acetate in heptanes) and concentrated to give the desired compound (1.12 g, 89% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.61–7.54 (d, <i>J</i> = 8.2 Hz, 1H), 7.49–7.43 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 7.41–7.37 (d, <i>J</i> = 1.9 Hz, 1H), 7.25–7.22 (d, <i>J</i> = 3.6 Hz, 1H), 7.17–7.12 (d, <i>J</i> = 2.0 Hz, 1H), 7.10–7.02 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.93–6.87 (s, 1H), 4.25–4.16 (t, <i>J</i> = 5.2 Hz, 2H), 3.44–3.34 (s, 3H), 3.09–3.05 (s, 3H), 3.03–2.99 (m, <i>J</i> = 2.9 Hz, 3H), 2.88–2.84 (br s, 3H). LCMS (ESI+): (M + H)<sup>+</sup> = 520.0.</div></div><div id="sec6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Methyl 2-(2-Chloro-5-(dimethylcabamoyl)phenylcarbamoyl)-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-8-carboxylate (<b>32</b>)</h3><div class="NLM_p last"><b>32</b> was prepared in analogy to <b>22</b> (33% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.56–8.37 (d, <i>J</i> = 4.6 Hz, 1H), 7.79–7.64 (m, 2H), 7.61–7.37 (m, <i>J</i> = 36.2, 11.3 Hz, 4H), 6.78–6.64 (s, 1H), 4.23–4.16 (t, J = 4.0 Hz, 2H), 3.31–3.27 (s, 3H), 3.03–2.98 (d, <i>J</i> = 5.9 Hz, 5H), 2.98–2.95 (s, 3H), 2.89–2.85 (s, 3H), 2.78–2.73 (d, <i>J</i> = 4.5 Hz, 3H). LCMS (ESI+): (M + H)<sup>+</sup> = 498.9</div></div><div id="sec6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Methyl 4-Amino-3-chlorobenzoate</h3><div class="NLM_p last">SOCl<sub>2</sub> (42.7 mL, 585 mmol) was slowly added into MeOH (300 mL) at 0 °C, and the solution was stirred for 1 h at 0 °C. Then 4-amino-3-chlorobenzoic acid (20.0 g, 117 mmol) was added into the above solution in one portion at 0 °C. After addition, it was allowed to reach room temperature and stirred for 2 days. The reaction mixture was concentrated to remove the solvent and the remaining SOCl<sub>2</sub>. Water (200 mL) was added to the residue, and NaHCO<sub>3</sub> (11.80 g, 140 mmol) was added in one portion. The mixture was stirred at room temperature for half an hour, and it was extracted with EtOAc (150 mL × 2). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the desired product (20.45 g, 94% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.95 (s, 1H), 7.76–7.73 (m, 1H), 6.72 (d, <i>J</i> = 8.4 Hz, 1H), 4.48 (s, 2H), 3.84 (s, 3H). LCMS (ESI+): (M + H)<sup>+</sup> 185.8.</div></div><div id="sec6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Methyl 4-(8-Bromo-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-3-chlorobenzoate</h3><div class="NLM_p last">8-Bromo-4,5-dihydrobenzo[b]thieno[2,3-<i>d</i>]oxepine-2-carboxylic acid (25.0 g, 77 mmol) was dissolved in SOCl<sub>2</sub> (300 mL). After the reaction mixture was heated at reflux for 4 h it was concentrated to remove the remaining SOCl<sub>2</sub> to give the crude 8-bromo-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carbonyl chloride. NaH (6.15 g, 154 mmol, 60% in mineral oil) was slowly added to the solution of methyl 4-amino-3-chlorobenzoate (25.55 g, 154 mmol) in THF (200 mL). The suspension of the above acid chloride (25.42 g, 77 mmol) in THF (300 mL) was added into the above solution at 0 °C. After addition, the reaction mixture was stirred at room temperature overnight. Solvent was removed and the residue was washed with water and dried to give the desired product (15.5 g, 49% yield). LCMS (ESI+): (M + H)<sup>+</sup> 506.0.</div></div><div id="sec6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Methyl 4-(8-Bromo-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-3-chlorobenzoate</h3><div class="NLM_p last">To a solution of methyl 4-(8-bromo-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-3-chlorobenzoate (18.16 g, 37 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (24.01 g, 74 mmol) in DMF (500 mL) was added CH<sub>3</sub>I (23 mL, 368 mmol). The reaction mixture was stirred at room temperature overnight. DMF was removed under reduced pressure, and water (200 mL) was added to the mixture. The resulting precipitate was filtered, washed with water, and dried to give the desired product (15.0 g, 80% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.18 (d, <i>J</i> = 1.6 Hz, 1H), 7.99 (dd, <i>J</i><sub>1</sub> = 1.6 Hz, <i>J</i><sub>2</sub> = 8.0 Hz, 1H), 7.43–7.08 (m, 4H), 6.73 (s, 1H), 4.21 (t, <i>J</i> = 5.2 Hz, 2H), 3.96 (s, 3H), 3.39 (s, 3H), 2.99 (t, <i>J</i> = 5.2 Hz, 2H). LCMS (ESI+): (M + H)<sup>+</sup> 506.0.</div></div><div id="sec6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 4-(8-Bromo-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-3-chlorobenzoic Acid</h3><div class="NLM_p last">To the suspension of methyl 4-(8-bromo-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno [2,3-<i>d</i>]oxepine-2-carboxamido)-3-chlorobenzoate (1.0 g, 1.97 mmol) in THF (8 mL) and H<sub>2</sub>O (8 mL) was added LiOH·H<sub>2</sub>O (166 mg, 3.96 mmol). The reaction mixture was stirred at room temperature overnight. It was acidified with HCl (2 N) to pH 2–3 and concentrated to remove most of the solvent. The resulting precipitate was washed with water and dried to give the desired product (0.58 g, 57% yield). LCMS (ESI+): (M + H)<sup>+</sup> 491.8.</div></div><div id="sec6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 8-Bromo-<i>N</i>-(2-chloro-4-(4-methylpiperazine-1-carbonyl)phenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide</h3><div class="NLM_p last">To a mixture of 1-methylpiperazine (0.32 g, 3.2 mmol), <i>i</i>-Pr<sub>2</sub>NEt (1.2 mL, 6.9 mmol), and HATU (0.79 g, 2.08 mmol) in THF (20 mL) was added 4-(8-bromo-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-3-chlorobenzoic acid (0.79 g, 1.6 mmol) under nitrogen at room temperature. The reaction mixture was stirred overnight, diluted with water, and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by silica gel flash column chromatography (hexanes/EtOAc = 2:1) to give the titled product (0.82 g, 89% yield). LCMS (ESI+): (M + H)<sup>+</sup> 573.9.</div></div><div id="sec6_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> <i>N</i><sup>2</sup>-(2-Chloro-4-(4-methylpiperazine-1-carbonyl)phenyl)-<i>N</i><sup>2</sup>,<i>N</i><sup>8</sup>-dimethyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2,8-dicarboxamide (<b>33</b>)</h3><div class="NLM_p last">A suspension of 8-bromo-<i>N</i>-(2-chloro-4-(4-methylpiperazine-1-carbonyl)phenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (450 mg, 0.78 mmol), Pd(OAc)<sub>2</sub> (9 mg, 0.039 mmol), Xantphos (45 mg, 0.078 mmol), MeNH<sub>2</sub>·HCl (79 mg, 1.15 mmol), and Na<sub>2</sub>CO<sub>3</sub> (240 mg, 2.3 mmol) in toluene (10 mL) was heated at 80 °C under an atmosphere of CO (balloon) overnight. Then it was filtered, concentrated, and purified by silica gel flash column chromatography (hexanes/EtOAc = 1:3) to give the titled product (162 mg, 38% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.57 (s, 1H), 7.43–7.31 (m, 5H), 6.97 (s, 1H), 6.35 (q, <i>J</i> = 4.8 Hz, 1H), 4.24 (t, <i>J</i> = 5.2 Hz, 2H), 3.80 (s, 2H), 3.45 (s, 2H), 3.39 (s, 3H), 3.07 (t, <i>J</i> = 5.2 Hz, 2H), 2.99 (d, <i>J</i> = 4.8 Hz, 3H), 2.52 (s, 2H), 2.32 (s, 5H). LCMS (ESI+): (M + H)<sup>+</sup> 553.0.</div></div><div id="sec6_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Methyl 3-Amino-4-chlorobenzoate</h3><div class="NLM_p last">SOCl<sub>2</sub> (107 mL, 1.47 mol) was slowly added to MeOH (800 mL) at 0 °C, and the solution was stirred for 1 h at 0 °C. Then 3-amino-4-chlorobenzoic acid (50.0 g, 0.29 mmol) was added to the above solution in one portion at 0 °C. It was allowed to reach room temperature and stirred for 2 days. The reaction mixture was concentrated to remove the solvent and remaining SOCl<sub>2</sub>. Water (200 mL) was added to the residue and basified with saturated NaHCO<sub>3</sub> solution to pH > 7, and the resulting precipitate was filtered and dried to give the desired product (49 g, 91% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.44–7.26 (m, 3H), 4.18 (br, 2H), 3.88 (s, 3H).</div></div><div id="sec6_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Methyl 3-(8-Bromo-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-4-chlorobenzoate</h3><div class="NLM_p last">A solution of 8-bromo-4,5-dihydro-6-oxa-1-thiabenzo[<i>e</i>]azulene-2-carboxylic acid (25 g) in SOCl<sub>2</sub> (200 mL) was heated at 80°C for 3 h. It was concentrated to give the crude acid chloride. A suspension of the crude acid chloride (∼0.077 mol) from the above in THF (1000 mL) at 0 °C was treated with a solution of 3-amino-4-chlorobenzoic acid methyl ester (15.7 g, 1.1 equiv) and pyridine (30 mL) in THF (100 mL). The mixture was allowed to reach room temperature overnight. The volume of reaction mixture was reduced by 50% under reduced pressure, and it was diluted with water. The resulting precipitate was filtered and washed with water and Et<sub>2</sub>O. The filter cake was dried to a constant weight under vacuum to give the desired product (32.9 g, 87% yield). LCMS: (ESI, <i>m</i>/<i>z</i>) = 494 [M + H]<sup>+</sup>.</div></div><div id="sec6_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Methyl 3-(8-Bromo-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-4-chlorobenzoate</h3><div class="NLM_p last">To a solution of methyl 3-(8-bromo-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-4-chlorobenzoate (32 g, 65 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (42.4 g, 130 mmol) in DMF (500 mL) was added CH<sub>3</sub>I (12 mL, 195 mmol). The reaction mixture was stirred at room temperature overnight. DMF was removed under reduced pressure, and water was added to the mixture. The resulting precipitate was filtered, washed with water, and dried to give the desired product (31 g, 94% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.07–7.08 (m, 6H), 6.81 (s, 1H), 4.22 (t, <i>J</i> = 5.2 Hz, 2H), 3.94 (s, 3H), 3.40 (s, 3H), 3.01 (t, <i>J</i> = 5.2 Hz, 2H).</div></div><div id="sec6_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 3-(8-Bromo-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-4-chlorobenzoic Acid</h3><div class="NLM_p last">To a suspension of methyl 3-(8-bromo-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-4-chlorobenzoate (31 g, 61 mmol) in THF (200 mL) and H<sub>2</sub>O (100 mL) was added LiOH·H<sub>2</sub>O (6.42 g, 153 mmol). The reaction mixture was stirred at room temperature overnight. Then it was acidified with HCl (2 N) to pH 2–3 and concentrated. The resulting precipitate was washed with water and dried to give the desired product (27.3 g, 91% yield). LC-MS: (ESI, <i>m</i>/<i>z</i>) = 494 [M + H]<sup>+</sup>.</div></div><div id="sec6_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 8-Bromo-<i>N</i>-(2-chloro-5-(4-methylpiperazine-1-carbonyl)phenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide</h3><div class="NLM_p last">To a mixture of 1-methylpiperazine (1.22 g, 12.18 mmol), <i>i</i>-Pr<sub>2</sub>NEt (3 mL), and HATU (2.78 g, 7.31 mmol) in THF (60 mL) was added 3-(8-bromo-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamido)-4-chlorobenzoic acid (3.0 g, 6.09 mmol) under nitrogen at room temperature. The reaction mixture was stirred overnight, diluted with water, and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give the titled product (3.3 g, 94% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 7.74–7.21 (m, 6H), 6.67 (s, 1H), 4.18 (t, <i>J</i> = 4.4 Hz, 2H), 3.31–2.12 (m, 16H). LCMS: (ESI, <i>m</i>/<i>z</i>) = 574.0 [M + H]<sup>+</sup>.</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> <i>N</i><sup>2</sup>-(2-Chloro-5-(4-methylpiperazine-1-carbonyl)phenyl)-<i>N</i><sup>2</sup>,<i>N</i><sup>8</sup>-dimethyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2,8-dicarboxamide (<b>34</b>)</h3><div class="NLM_p last">A suspension of 8-bromo-<i>N</i>-(2-chloro-5-(4-methylpiperazine-1-carbonyl)phenyl)-<i>N</i>-methyl-4,5-dihydrobenzo[<i>b</i>]thieno[2,3-<i>d</i>]oxepine-2-carboxamide (500 mg, 0.87 mmol), Pd(OAc)<sub>2</sub> (10 mg, 0.0435 mmol), Xantphos (50 mg, 0.087 mmol), MeNH<sub>2</sub>·HCl (88 mg, 1.30 mmol), and Na<sub>2</sub>CO<sub>3</sub> (277 mg, 2.61 mmol) in toluene (10 mL) was heated at 80 °C under CO (1 atm) overnight. It was filtered and concentrated, and the crude product was purified by silica gel flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 40:1 to 20: 1) to give <b>33</b> (149 mg, 31%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.60–6.94 (m, 7H), 6.23 (s, 1H), 4.23 (t, <i>J</i> = 4.8 Hz, 2H), 3.79–2.09 (m, 19H). LCMS: (ESI, <i>m</i>/<i>z</i>) = 553 [M + H]<sup>+</sup>.</div></div><div id="sec6_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Characterization of Biochemical and Cellular Activity in Vitro</h3><div class="NLM_p">Enzymatic activity of the class I PI3K isoforms was measured using a fluorescence polarization assay that monitors formation of the product 3,4,5-inositol triphosphate molecule (PIP3), as it competes with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidylinositide 3-phosphate product results in a decrease in fluorescence polarization signal as the labeled fluorophore is displaced from the GRP-1 protein binding site. Class I PI3K isoforms were purchased from Perkin-Elmer or were expressed and purified as heterodimeric recombinant proteins. Tetramethylrhodamine-labeled PIP3 (TAMRA-PIP3), di-C8-PIP2, and PIP3 detection reagents were purchased from Echelon Biosciences. PI3K isoforms were assayed under initial rate conditions in the presence of 10 mM Tris (pH 7.5), 25 μM ATP, 9.75 μM PIP2, 5% glycerol, 4 mM MgCl<sub>2</sub>, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 2% (v/v) DMSO at the following concentrations for each isoform: PI3Kα,β at 60 ng/mL; PI3Kγ at 8 ng/mL; PI3Kδ at 45 ng/mL. After assay for 30 min at 25 °C, reactions were terminated with a final concentration of 9 mM EDTA, 4.5 nM TAMRA-PIP3, and 4.2 μg/mL GRP-1 detector protein before reading fluorescence polarization on an Envision plate reader. IC<sub>50</sub> values were calculated from the fit of the dose–response curves to a four-parameter equation. Apparent <i>K</i><sub>i</sub> values were determined at a fixed concentration of ATP near the measured <i>K</i><sub>m</sub> for ATP for each isoenzyme and were calculated by fitting of the dose–response curves to an equation for tight-binding competitive inhibition. All IC<sub>50</sub> and apparent <i>K</i><sub>i</sub> values represent geometric mean values of a minimum of three determinations. These assays generally produced results within 2-fold of the reported mean.</div><div class="NLM_p last">Antiproliferative cellular assays were conducted using PC3 and MCF7.1 human tumor cell lines provided by the ATCC or Genentech Research Laboratories, respectively. MCF7.1 is an in vivo selected line developed at Genentech and originally derived from the parental human MCF7 breast cancer cell line (ATCC, Manassas, VA). Cell lines were cultured in RPMI supplemented with 10% fetal bovine serum, 100 units/mL penicillin, 100 μg/mL streptomycin, 10 mM HEPES, and 2 mM glutamine at 37 °C under 5% CO<sub>2</sub>. MCF7.1 cells or PC3 cells were seeded in 384-well plates in medium at 1000 or 3000 cells/well, respectively, and incubated overnight prior to the addition of compounds to a final DMSO concentration of 0.5% v/v. MCF7.1 cells and PC3 cells were incubated for 3 and 4 days, respectively, prior to the addition of CellTiter-Glo reagent (Promega) and reading of luminescence using an Analyst plate reader. For antiproliferative assays, a cytostatic agent such as aphidicolin and a cytotoxic agent such as staurosporine were included as controls. Dose–response curves were fit to a four-parameter equation, and relative EC<sub>50</sub> values were calculated using the Assay Explorer software. All cellular EC<sub>50</sub> values represent geometric mean values of a minimum of two determinations, and these assays generally produced results within 3-fold of the reported mean.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96"><a href="/doi/suppl/10.1021/jm2007084">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">A homology model of human PI3Kβ in PDB format and the sequence alignment of human PI3Kβ and mouse PI3Kδ that was used for model building. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2007084/suppl_file/jm2007084_si_001.pdb">jm2007084_si_001.pdb (1.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2007084/suppl_file/jm2007084_si_002.pdf">jm2007084_si_002.pdf (44.53 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm2007084" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy P. Heffron</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#82f6eae7e4e4f0edecc2e5e7ece7ace1edef"><span class="__cf_email__" data-cfemail="94e0fcf1f2f2e6fbfad4f3f1faf1baf7fbf9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">BinQing Wei</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Olivero</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven T. Staben</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vickie Tsui</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Do</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennafer Dotson</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrian J. Folkes</span> - <span class="hlFld-Affiliation affiliation">Piramed Pharma, 957 Buckingham
Avenue, Slough, Berks SL1 4NL, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Goldsmith</span> - <span class="hlFld-Affiliation affiliation">Piramed Pharma, 957 Buckingham
Avenue, Slough, Berks SL1 4NL, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Goldsmith</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janet Gunzner</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Lesnick</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Lewis</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Mathieu</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim Nonomiya</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Shuttleworth</span> - <span class="hlFld-Affiliation affiliation">Piramed Pharma, 957 Buckingham
Avenue, Slough, Berks SL1 4NL, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel P. Sutherlin</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nan Chi Wan</span> - <span class="hlFld-Affiliation affiliation">Piramed Pharma, 957 Buckingham
Avenue, Slough, Berks SL1 4NL, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shumei Wang</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Wiesmann</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing-Yan Zhu</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack" id="ACK-d145e5637-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Mengling Wong, Chris Hamman, Michael Hayes, Steve Huhn, and Wen Chiu for compound purification and determination of purity by HPLC, mass spectrometry, and <sup>1</sup>H NMR. The authors also thank Krista K. Bowman, Alberto Estevez, Kyle Mortara, and Jiansheng Wu for technical assistance of protein expression and purification, and Jeremy Murray for depositing structures to the PDB.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i98" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i98"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i99" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i99"> Abbreviations Used</h2><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">CAMK2D</td><td class="NLM_def"><p class="first last">calcium/calmodulin-dependent protein kinase type II δ</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyl carbamate</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenylphosphorylazide</p></td></tr><tr><td class="NLM_term">TMEDA</td><td class="NLM_def"><p class="first last">tetramethylethylenediamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">1,2-dichloroethane</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">PPA</td><td class="NLM_def"><p class="first last">polyphosphoric acid</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">diazobicyloundecane</p></td></tr><tr><td class="NLM_term">m-CPBA</td><td class="NLM_def"><p class="first last">3-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-<i>O</i>-(7-azabenzotiazol-1-yl)uronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">PIP3</td><td class="NLM_def"><p class="first last">3,4,5-inositol triphosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i100">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="note"><p class="first last">Recent reviews that discuss the isoform selectivity of PI3K inhibitors include the following: </p></div><div class="NLM_citation" id="cit1a"><span><span class="NLM_contrib-group">Marone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cmiljanovic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span> </span><span class="NLM_article-title">Targeting Phosphoinositide 3-Kinase: Moving towards Therapy</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1784</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1784&publication_year=2008&pages=159-185&author=R.+Maroneauthor=V.+Cmiljanovicauthor=B.+Gieseauthor=M.+P.+Wymann&title=Targeting+Phosphoinositide+3-Kinase%3A+Moving+towards+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DCmiljanovic%26aufirst%3DV.%26aulast%3DGiese%26aufirst%3DB.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DTargeting%2520Phosphoinositide%25203-Kinase%253A%2520Moving%2520towards%2520Therapy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1784%26spage%3D159%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Chemically Targetting the PI3K Family</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1042%2FBST0350245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=17371250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=245-249&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Chemically+Targetting+the+PI3K+Family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically targeting the PI3K family</span></div><div class="casAuthors">Knight, Z. A.; Shokat, K. M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-249</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  PI3K (phosphoinositide 3-kinase) is a key regulator of cell growth, metab., and survival.  The frequent activation of the PI3K pathway in cancer has stimulated widespread interest in identifying potent and selective inhibitors of PI3K isoforms.  The present paper highlights recent progress in identifying such mols. and the challenges that remain for efforts to pharmacol. target the PI3K family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtmivxnuTfQ7Vg90H21EOLACvtfcHk0lj10EoZikF7tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrsb4%253D&md5=b7243ad076ba15f65214acc8a3b09d65</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1042%2FBST0350245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0350245%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DChemically%2520Targetting%2520the%2520PI3K%2520Family%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26spage%3D245%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_contrib-group">Ward, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span> </span><span class="NLM_article-title">Isoform-Specific Phosphoinositide 3-Kinase Inhibitors as Therapeutic Agents</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2FS1471-4892%2803%2900078-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=12901953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFGju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=426-434&author=S.+G.+Wardauthor=P.+Finan&title=Isoform-Specific+Phosphoinositide+3-Kinase+Inhibitors+as+Therapeutic+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents</span></div><div class="casAuthors">Ward, Stephen G.; Finan, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">426-434</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) family of enzymes consists of several closely related isoforms that are thought to have distinct biol. roles.  Until now, researchers have been frustrated by poor selectivity of the available pharmacol. inhibitors, which are unable to distinguish adequately the activities of different PI3K isoforms.  Recently published patent specifications describe new PI3K inhibitors, including several that are selective for the PI3Kδ isoform.  There is now cautious optimism that isoform-selective PI3K inhibitors will provide new avenues for therapeutic applications in a range of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoooGyT_yJeLLVg90H21EOLACvtfcHk0li8Zl-CF5nlOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFGju7c%253D&md5=301655ddf3635b506ddb01a95d608f1d</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2803%2900078-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252803%252900078-X%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BG.%26aulast%3DFinan%26aufirst%3DP.%26atitle%3DIsoform-Specific%2520Phosphoinositide%25203-Kinase%2520Inhibitors%2520as%2520Therapeutic%2520Agents%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D426%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_contrib-group">Sundstrom, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D. L.</span><span> </span><span class="NLM_article-title">Inhibitors of Phosphoinositide-3-Kinase: A Structure-Based Approach to Understanding Potency and Selectivity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">840</span><span class="NLM_x">–</span> <span class="NLM_lpage">850</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1039%2Fb819067b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=19225663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFGru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=840-850&author=T.+J.+Sundstromauthor=A.+C.+Andersonauthor=D.+L.+Wright&title=Inhibitors+of+Phosphoinositide-3-Kinase%3A+A+Structure-Based+Approach+to+Understanding+Potency+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of phosphoinositide-3-kinase: a structure-based approach to understanding potency and selectivity</span></div><div class="casAuthors">Sundstrom, Teather J.; Anderson, Amy C.; Wright, Dennis L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">840-850</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide-3-kinase is a pivotal protein involved in a wide variety of signaling cascades and there has been a great deal of interest in the development of potent and selective inhibitors of this enzyme.  In this review, the potency and selectivity of the known inhibitors is presented along with key structural information that helps rationalize the obsd. trends.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1X1C0qBQxy7Vg90H21EOLACvtfcHk0li8Zl-CF5nlOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFGru70%253D&md5=77356f92a07e4314aa2bd90e2382c7c0</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1039%2Fb819067b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb819067b%26sid%3Dliteratum%253Aachs%26aulast%3DSundstrom%26aufirst%3DT.%2BJ.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26aulast%3DWright%26aufirst%3DD.%2BL.%26atitle%3DInhibitors%2520of%2520Phosphoinositide-3-Kinase%253A%2520A%2520Structure-Based%2520Approach%2520to%2520Understanding%2520Potency%2520and%2520Selectivity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D840%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenwaelder, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goncalves, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesbitt, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dopheide, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgeon, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabaharan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniele, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saylik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, H. H.</span><span> </span><span class="NLM_article-title">PI 3-Kinase p110β: A New Target for Antithrombotic Therapy</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnm1232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=15834429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=507-514&author=S.+P.+Jacksonauthor=S.+M.+Schoenwaelderauthor=I.+Goncalvesauthor=W.+S.+Nesbittauthor=C.+L.+Yapauthor=C.+E.+Wrightauthor=V.+Kencheauthor=K.+E.+Andersonauthor=S.+M.+Dopheideauthor=Y.+Yuanauthor=S.+A.+Sturgeonauthor=H.+Prabaharanauthor=P.+E.+Thompsonauthor=G.+D.+Smithauthor=P.+R.+Shepherdauthor=N.+Danieleauthor=S.+Kulkarniauthor=B.+Abbottauthor=D.+Saylikauthor=C.+Jonesauthor=L.+Luauthor=S.+Giulianoauthor=S.+C.+Hughanauthor=J.+A.+Angusauthor=A.+D.+Robertsonauthor=H.+H.+Salem&title=PI+3-Kinase+p110%CE%B2%3A+A+New+Target+for+Antithrombotic+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PI 3-kinase p110β: a new target for antithrombotic therapy</span></div><div class="casAuthors">Jackson, Shaun P.; Schoenwaelder, Simone M.; Goncalves, Isaac; Nesbitt, Warwick S.; Yap, Cindy L.; Wright, Christine E.; Kenche, Vijaya; Anderson, Karen E.; Dopheide, Sacha M.; Yuan, Yuping; Sturgeon, Sharelle A.; Prabaharan, Hishani; Thompson, Philip E.; Smith, Gregg D.; Shepherd, Peter R.; Daniele, Nathalie; Kulkarni, Suhasini; Abbott, Belinda; Saylik, Dilek; Jones, Catherine; Lu, Lucy; Giuliano, Simon; Hughan, Sascha C.; Angus, James A.; Robertson, Alan D.; Salem, Hatem H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-514</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelet activation at sites of vascular injury is essential for the arrest of bleeding; however, excessive platelet accumulation at regions of atherosclerotic plaque rupture can result in the development of arterial thrombi, pptg. diseases such as acute myocardial infarction and ischemic stroke.  Rheol. disturbances (high shear stress) have an important role in promoting arterial thrombosis by enhancing the adhesive and signaling function of platelet integrin αIIbβ3 (GPIIb-IIIa).  In this study we have defined a key role for the Type Ia phosphoinositide 3-kinase (PI3K) p110β isoform in regulating the formation and stability of integrin αIIbβ3 adhesion bonds, necessary for shear activation of platelets.  Isoform-selective PI3K p110β inhibitors have been developed which prevent formation of stable integrin αIIbβ3 adhesion contacts, leading to defective platelet thrombus formation.  In vivo, these inhibitors eliminate occlusive thrombus formation but do not prolong bleeding time.  These studies define PI3K p110β as an important new target for antithrombotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYYnYolzsDrrVg90H21EOLACvtfcHk0liLZ1YX9wLinQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D&md5=c8dc7ba1955e86104ae913d39f22674b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnm1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1232%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DSchoenwaelder%26aufirst%3DS.%2BM.%26aulast%3DGoncalves%26aufirst%3DI.%26aulast%3DNesbitt%26aufirst%3DW.%2BS.%26aulast%3DYap%26aufirst%3DC.%2BL.%26aulast%3DWright%26aufirst%3DC.%2BE.%26aulast%3DKenche%26aufirst%3DV.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DDopheide%26aufirst%3DS.%2BM.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DSturgeon%26aufirst%3DS.%2BA.%26aulast%3DPrabaharan%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DSmith%26aufirst%3DG.%2BD.%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26aulast%3DDaniele%26aufirst%3DN.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DAbbott%26aufirst%3DB.%26aulast%3DSaylik%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DGiuliano%26aufirst%3DS.%26aulast%3DHughan%26aufirst%3DS.%2BC.%26aulast%3DAngus%26aufirst%3DJ.%2BA.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DSalem%26aufirst%3DH.%2BH.%26atitle%3DPI%25203-Kinase%2520p110%25CE%25B2%253A%2520A%2520New%2520Target%2520for%2520Antithrombotic%2520Therapy%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D507%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><div class="note"><p class="first last">For a report of PI3Kβ/PI3Kδ dual inhibitors see the following: </p></div><span class="NLM_contrib-group">Kinght, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alaimo, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenski, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Isoform-Specific Phosphoinositide 3-Kinase Inhibitors from an Arylmorpholine Scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4749</span><span class="NLM_x">–</span> <span class="NLM_lpage">4759</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=4749-4759&author=Z.+A.+Kinghtauthor=G.+G.+Chiangauthor=P.+J.+Alaimoauthor=D.+M.+Kenskiauthor=C.+B.+Hoauthor=K.+Coanauthor=R.+T.+Abrahamauthor=K.+M.+Shokat&title=Isoform-Specific+Phosphoinositide+3-Kinase+Inhibitors+from+an+Arylmorpholine+Scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKinght%26aufirst%3DZ.%2BA.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAlaimo%26aufirst%3DP.%2BJ.%26aulast%3DKenski%26aufirst%3DD.%2BM.%26aulast%3DHo%26aufirst%3DC.%2BB.%26aulast%3DCoan%26aufirst%3DK.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DIsoform-Specific%2520Phosphoinositide%25203-Kinase%2520Inhibitors%2520from%2520an%2520Arylmorpholine%2520Scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D4749%26epage%3D4759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_contrib-group">Sadhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tino, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staunton, D. E.</span><span> </span><span class="NLM_article-title">Selective Role of PI3Kδ in Neutrophil Inflammatory Responses</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2003&pages=764-769&author=C.+Sadhuauthor=K.+Dickauthor=W.+T.+Tinoauthor=D.+E.+Staunton&title=Selective+Role+of+PI3K%CE%B4+in+Neutrophil+Inflammatory+Responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSadhu%26aufirst%3DC.%26aulast%3DDick%26aufirst%3DK.%26aulast%3DTino%26aufirst%3DW.%2BT.%26aulast%3DStaunton%26aufirst%3DD.%2BE.%26atitle%3DSelective%2520Role%2520of%2520PI3K%25CE%25B4%2520in%2520Neutrophil%2520Inflammatory%2520Responses%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D308%26spage%3D764%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_contrib-group">Fruman, D. A.</span><span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase and Its Targets in B-Cell and T-Cell Signaling</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2Fj.coi.2004.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=15134780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVamtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=314-320&author=D.+A.+Fruman&title=Phosphoinositide+3-Kinase+and+Its+Targets+in+B-Cell+and+T-Cell+Signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling</span></div><div class="casAuthors">Fruman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-320</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide 3-kinase (PI3K) activation is essential for lymphocyte proliferation driven by receptors for antigen, costimulatory ligands and cytokines.  The lipid products of PI3K contribute to the assembly of membrane-assocd. signaling complexes by promoting recruitment of selected proteins from the cytoplasm.  Many proteins possess domains that are able to bind selectively to PI3K products.  Different 'PI3K effector' proteins are coupled to distinct biol. responses, depending on cell type and on the receptor that is engaged.  In B cells and T cells, Tec-family tyrosine kinases and Akt serine/threonine kinases are emerging as crucial mediators of proliferation and survival signals downstream of PI3K.  Of particular interest is recent evidence that PI3K signaling controls increases in lymphocyte size and metabolic activity that accompany cell cycle progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnOMRHTLdWzbVg90H21EOLACvtfcHk0liQtvIf2WmCBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVamtr4%253D&md5=18b4b46533f2d49312f123a4c72915b8</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2004.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2004.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DFruman%26aufirst%3DD.%2BA.%26atitle%3DPhosphoinositide%25203-Kinase%2520and%2520Its%2520Targets%2520in%2520B-Cell%2520and%2520T-Cell%2520Signaling%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2004%26volume%3D16%26spage%3D314%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesbroeck, B.</span><span> </span><span class="NLM_article-title">PI3K in Lymphocyte Development, Differentiation, and Activation</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnri1056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=12669022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFWku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=317-330&author=K.+Okkenhaugauthor=B.+Vanhaesbroeck&title=PI3K+in+Lymphocyte+Development%2C+Differentiation%2C+and+Activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K in lymphocyte development, differentiation and activation</span></div><div class="casAuthors">Okkenhaug, Klaus; Vanhaesebroeck, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide 3-kinases (PI3K) regulate numerous biol. processes, including cell growth, differentiation, survival, proliferation, migration, and metab.  In the immune system, impaired PI3K signaling leads to immunodeficiency, whereas unrestrained PI3K signaling contributes to autoimmunity and leukemia.  New insights into the role of PI3K in lymphocyte biol. have been derived from gene-targeting studies, which have identified the PI3K subunits that are involved in B-cell and T-cell signaling.  In particular, the catalytic subunit p110δ seems to be adapted to transmit antigen receptor signaling in B and T cells.  Addnl. recent work has provided new insights into the mol. interactions that lead to PI3K activation and the signaling pathways that are regulated by PI3K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqMNzLr_tCL7Vg90H21EOLACvtfcHk0liQtvIf2WmCBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFWku70%253D&md5=97161849a1a965ce48f2641ec19c7941</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1038%2Fnri1056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1056%26sid%3Dliteratum%253Aachs%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DVanhaesbroeck%26aufirst%3DB.%26atitle%3DPI3K%2520in%2520Lymphocyte%2520Development%252C%2520Differentiation%252C%2520and%2520Activation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D3%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span> </span><span class="NLM_article-title">PI3Kδ and PI3Kγ: Partners in Crime in Inflammation in Rheumatoid Arthritis and Beyond?</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnri2036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=17290298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVGrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=191-201&author=C.+Rommelauthor=M.+Campsauthor=H.+Ji&title=PI3K%CE%B4+and+PI3K%CE%B3%3A+Partners+in+Crime+in+Inflammation+in+Rheumatoid+Arthritis+and+Beyond%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?</span></div><div class="casAuthors">Rommel, Christian; Camps, Montserrat; Ji, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-201</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dysregulated signal transduction in innate and adaptive immune cells is known to be assocd. with the development of various autoimmune and inflammatory diseases.  Consequently, targeting intracellular signaling of the pro-inflammatory cytokine network heralds hope for the next generation of anti-inflammatory drugs.  Phosphoinositide 3-kinases (PI3Ks) generate lipid-based second messengers that control an array of intracellular signaling pathways that are known to have important roles in leukocytes.  In light of the recent progress in the development of selective PI3K inhibitors, and the beneficial effects of these inhibitors in models of acute and chronic inflammatory disorders, the authors discuss the therapeutic potential of blocking PI3K isoforms for the treatment of rheumatoid arthritis and other immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKSAduhwUrPrVg90H21EOLACvtfcHk0lgiCHWwyG21XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVGrtbk%253D&md5=2fdb3507d06ddf7d5485185f4573790f</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1038%2Fnri2036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2036%26sid%3Dliteratum%253Aachs%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DPI3K%25CE%25B4%2520and%2520PI3K%25CE%25B3%253A%2520Partners%2520in%2520Crime%2520in%2520Inflammation%2520in%2520Rheumatoid%2520Arthritis%2520and%2520Beyond%253F%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D7%26spage%3D191%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4e"><span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span> </span><span class="NLM_article-title">PI3Kγ Inhibition: Towards an Aspirin for the 21st Century?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=903-918&author=T.+Ruckleauthor=M.+K.+Schwarzauthor=C.+Rommel&title=PI3K%CE%B3+Inhibition%3A+Towards+an+Aspirin+for+the+21st+Century%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DRommel%26aufirst%3DC.%26atitle%3DPI3K%25CE%25B3%2520Inhibition%253A%2520Towards%2520an%2520Aspirin%2520for%2520the%252021st%2520Century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D903%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4f"><span><span class="NLM_contrib-group">Barbier, D. F</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barolome, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redondo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Arias, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balomenos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, A. C.</span><span> </span><span class="NLM_article-title">PI3Kγ Inhibition Blocks Glomerulonephritis and Extends Lifespan in a Mouse Model of Systemic Lupus</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=16127435" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=933-935&author=D.+F+Barbierauthor=A.+Barolomeauthor=C.+Hernandezauthor=J.+M.+Floresauthor=C.+Redondoauthor=C.+Fernandez-Ariasauthor=M.+Campsauthor=T.+Ruckleauthor=M.+K.+Schwarzauthor=S.+Rodriguezauthor=C.+Martinezauthor=D.+Balomenosauthor=C.+Rommelauthor=A.+C.+Carrera&title=PI3K%CE%B3+Inhibition+Blocks+Glomerulonephritis+and+Extends+Lifespan+in+a+Mouse+Model+of+Systemic+Lupus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarbier%26aufirst%3DD.%2BF%26aulast%3DBarolome%26aufirst%3DA.%26aulast%3DHernandez%26aufirst%3DC.%26aulast%3DFlores%26aufirst%3DJ.%2BM.%26aulast%3DRedondo%26aufirst%3DC.%26aulast%3DFernandez-Arias%26aufirst%3DC.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DRodriguez%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DC.%26aulast%3DBalomenos%26aufirst%3DD.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DCarrera%26aufirst%3DA.%2BC.%26atitle%3DPI3K%25CE%25B3%2520Inhibition%2520Blocks%2520Glomerulonephritis%2520and%2520Extends%2520Lifespan%2520in%2520a%2520Mouse%2520Model%2520of%2520Systemic%2520Lupus%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D933%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4g"><span><span class="NLM_contrib-group">Wymann, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklof, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trifilieff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altruda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laffargue, M.</span><span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase γ: A Key Modulator in Inflammation and Allergy</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4g&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1042%2FBST0310275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4g&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=12546701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4g&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=275-280&author=M.+P.+Wymannauthor=K.+Bjorklofauthor=R.+Calvezauthor=P.+Finanauthor=M.+Thomasauthor=A.+Trifilieffauthor=M.+Barbierauthor=F.+Altrudaauthor=E.+Hirschauthor=M.+Laffargue&title=Phosphoinositide+3-Kinase+%CE%B3%3A+A+Key+Modulator+in+Inflammation+and+Allergy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4gR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoinositide 3-kinase γ: a key modulator in inflammation and allergy</span></div><div class="casAuthors">Wymann, M. P.; Bjoerkloef, K.; Calvez, R.; Finan, P.; Thomast, M.; Trifilieff, A.; Barbier, M.; Altruda, F.; Hirsch, E.; Laffargue, M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">275-280</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic inflammation and allergy involve the activation of tissue-resident cells and, later on, the invasion of effector cells.  We have previously shown that the loss of phosphoinositide 3-kinase (PI3K) γ impairs chemokine-dependent migration of neutrophils and macrophages both in vitro and in vivo .  On the other hand, PI3Kγ is not required either during phagocytic processes or in the activation of bactericidal activities like granule secretion and particle-mediated respiratory burst in neutrophils.  Tissue mast cells are key regulators in allergy and inflammation and release histamine upon clustering of their IgE receptors.  We have demonstrated that murine mast cell responses are exacerbated in vitro and in vivo by autocrine signals, and require functional PI3Kγ.  Adenosine, acting through the A3 adenosine receptor, as well as other agonists of Gαi-coupled receptors, transiently increased PtdIns(3,4,5) P 3 exclusively via PI3Kγ.  PI3Kγ-derived PtdIns(3,4,5) P 3 was instrumental for initiation of a sustained influx of external Ca2+ and degranulation.  Mice that lacked PI3Kγ did not form edema when challenged by passive systemic anaphylaxis.  PI3Kγ thus relays inflammatory signals through various GPCRs, and is thus central to mast cell function.  Taken together, this suggests that pharmaceutical targeting of PI3Kγ might alleviate inflammation at both early and late stages of the allergic response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSxvbIu0vVf7Vg90H21EOLACvtfcHk0lhvHNxWt3kW6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptF2qtw%253D%253D&md5=5163ba45e24d7304db751f5beb16556f</span></div><a href="/servlet/linkout?suffix=cit4g&amp;dbid=16384&amp;doi=10.1042%2FBST0310275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0310275%26sid%3Dliteratum%253Aachs%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DBjorklof%26aufirst%3DK.%26aulast%3DCalvez%26aufirst%3DR.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DTrifilieff%26aufirst%3DA.%26aulast%3DBarbier%26aufirst%3DM.%26aulast%3DAltruda%26aufirst%3DF.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DLaffargue%26aufirst%3DM.%26atitle%3DPhosphoinositide%25203-Kinase%2520%25CE%25B3%253A%2520A%2520Key%2520Modulator%2520in%2520Inflammation%2520and%2520Allergy%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D275%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4h"><span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katanaev, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garlanda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzolino, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silengo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sozzani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantovani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altruda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span> </span><span class="NLM_article-title">Central Role for G Protein-Coupled Phosphoinositide 3-Kinase γ in Inflammation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=1049-1053&author=E.+Hirschauthor=V.+L.+Katanaevauthor=C.+Garlandaauthor=O.+Azzolinoauthor=L.+Pirolaauthor=L.+Silengoauthor=S.+Sozzaniauthor=A.+Mantovaniauthor=F.+Altrudaauthor=M.+P.+Wymann&title=Central+Role+for+G+Protein-Coupled+Phosphoinositide+3-Kinase+%CE%B3+in+Inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DKatanaev%26aufirst%3DV.%2BL.%26aulast%3DGarlanda%26aufirst%3DC.%26aulast%3DAzzolino%26aufirst%3DO.%26aulast%3DPirola%26aufirst%3DL.%26aulast%3DSilengo%26aufirst%3DL.%26aulast%3DSozzani%26aufirst%3DS.%26aulast%3DMantovani%26aufirst%3DA.%26aulast%3DAltruda%26aufirst%3DF.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DCentral%2520Role%2520for%2520G%2520Protein-Coupled%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520in%2520Inflammation%26jtitle%3DScience%26date%3D2000%26volume%3D287%26spage%3D1049%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4i"><span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rückle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardissone, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rintelen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillieron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitte, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span> </span><span class="NLM_article-title">Blockade of PI3Kγ Suppresses Joint Inflammation and Damage in Mouse Models of Rheumatoid Arthritis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4i&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnm1284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4i&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=16127437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4i&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslelur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=936-943&author=M.+Campsauthor=T.+R%C3%BCckleauthor=H.+Jiauthor=V.+Ardissoneauthor=F.+Rintelenauthor=J.+Shawauthor=C.+Ferrandiauthor=C.+Chabertauthor=C.+Gillieronauthor=B.+Franconauthor=T.+Martinauthor=D.+Gretenerauthor=D.+Perrinauthor=D.+Leroyauthor=P.-A.+Vitteauthor=E.+Hirschauthor=M.+P.+Wymannauthor=R.+Cirilloauthor=M.+K.+Schwarzauthor=C.+Rommel&title=Blockade+of+PI3K%CE%B3+Suppresses+Joint+Inflammation+and+Damage+in+Mouse+Models+of+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4iR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis</span></div><div class="casAuthors">Camps, Montserrat; Rueckle, Thomas; Ji, Hong; Ardissone, Vittoria; Rintelen, Felix; Shaw, Jeffrey; Ferrandi, Chiara; Chabert, Christian; Gillieron, Corine; Francon, Bernard; Martin, Thierry; Gretener, Denise; Perrin, Dominique; Leroy, Didier; Vitte, Pierre-Alain; Hirsch, Emilio; Wymann, Matthias P.; Cirillo, Rocco; Schwarz, Matthias K.; Rommel, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">936-943</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3K) have long been considered promising drug targets for the treatment of inflammatory and autoimmune disorders as well as cancer and cardiovascular diseases.  But the lack of specificity, isoform selectivity and poor biopharmaceutical profile of PI3K inhibitors have so far hampered rigorous disease-relevant target validation.  Here we describe the identification and development of specific, selective and orally active small-mol. inhibitors of PI3Kγ (encoded by Pik3cg).  We show that Pik3cg-/- mice are largely protected in mouse models of rheumatoid arthritis; this protection correlates with defective neutrophil migration, further validating PI3Kγ as a therapeutic target.  We also describe that oral treatment with a PI3Kγ inhibitor suppresses the progression of joint inflammation and damage in two distinct mouse models of rheumatoid arthritis, reproducing the protective effects shown by Pik3cg-/- mice.  Our results identify selective PI3Kγ inhibitors as potential therapeutic mols. for the treatment of chronic inflammatory disorders such as rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEyzzdnR3FXLVg90H21EOLACvtfcHk0lhJiLN50W8B-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslelur8%253D&md5=1fed7126427b519a4a457a8bf31ade7d</span></div><a href="/servlet/linkout?suffix=cit4i&amp;dbid=16384&amp;doi=10.1038%2Fnm1284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1284%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DArdissone%26aufirst%3DV.%26aulast%3DRintelen%26aufirst%3DF.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DFerrandi%26aufirst%3DC.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DGillieron%26aufirst%3DC.%26aulast%3DFrancon%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DT.%26aulast%3DGretener%26aufirst%3DD.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DVitte%26aufirst%3DP.-A.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DCirillo%26aufirst%3DR.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DRommel%26aufirst%3DC.%26atitle%3DBlockade%2520of%2520PI3K%25CE%25B3%2520Suppresses%2520Joint%2520Inflammation%2520and%2520Damage%2520in%2520Mouse%2520Models%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D936%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, J. D.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) δ and γ</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.2174%2F156802609789044434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=19689378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=738-753&author=M.+K.+Ameriksauthor=J.+D.+Venable&title=Small+Molecule+Inhibitors+of+Phosphoinositide+3-Kinase+%28PI3K%29+%CE%B4+and+%CE%B3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of phosphoinositide 3-kinase (PI3K) δ and γ</span></div><div class="casAuthors">Ameriks, Michael K.; Venable, Jennifer D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">738-753</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, pharmaceutical companies have increasingly focused on phosphoinositide 3-kinases delta (PI3Kδ) and gamma (PI3Kγ) as therapeutic targets for the treatment of inflammatory and autoimmune diseases.  All class 1 PI3-kinases (α/β/γ/δ) generate phospholipid second messengers that help govern cellular processes such as migration, proliferation, and apoptosis.  PI3K δ/γ lipid kinases are mainly restricted to the hematopoetic system whereas PI3Kα/β are ubiquitously expressed, thus raising potential toxicity concerns for chronic indications such as asthma and rheumatoid arthritis.  Therefore, the challenge in developing a small mol. inhibitor of PI3K is to define and attain the appropriate isoform selectivity profile.  Significant advances in the design of such compds. have been achieved by utilizing x-ray crystal structures of various inhibitors bound to PI3Kγ in conjunction with pharmacophore modeling and high-throughput screening.  Herein, we review the history and challenges involved with the discovery of small mol. isoform-specific PI3K inhibitors.  Recent progress in the design of selective PI3Kδ, PI3Kγ, and PI3Kδ/γ dual inhibitors will be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeoiBWisF3T7Vg90H21EOLACvtfcHk0lgs_SwMXJK1lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLnP&md5=1cae29b32c03158fe8b933fabe8b7a2b</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.2174%2F156802609789044434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789044434%26sid%3Dliteratum%253Aachs%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DVenable%26aufirst%3DJ.%2BD.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%2528PI3K%2529%2520%25CE%25B4%2520and%2520%25CE%25B3%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D738%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_contrib-group">Sadhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masinovsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowell, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staunton, D. E.</span><span> </span><span class="NLM_article-title">Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=2647-2654&author=C.+Sadhuauthor=B.+Masinovskyauthor=K.+Dickauthor=C.+G.+Sowellauthor=D.+E.+Staunton&title=Essential+Role+of+Phosphoinositide+3-Kinase+%CE%B4+in+Neutrophil+Directional+Movement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSadhu%26aufirst%3DC.%26aulast%3DMasinovsky%26aufirst%3DB.%26aulast%3DDick%26aufirst%3DK.%26aulast%3DSowell%26aufirst%3DC.%2BG.%26aulast%3DStaunton%26aufirst%3DD.%2BE.%26atitle%3DEssential%2520Role%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%2520in%2520Neutrophil%2520Directional%2520Movement%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_contrib-group">Pomel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgat-Charvillon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valognes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillieron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rückle, T.</span><span> </span><span class="NLM_article-title">Furan-2-ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase γ</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3857</span><span class="NLM_x">–</span> <span class="NLM_lpage">3871</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0601598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3857-3871&author=V.+Pomelauthor=J.+Klicicauthor=D.+Coviniauthor=D.+D.+Churchauthor=J.+P.+Shawauthor=K.+Roulinauthor=F.+Burgat-Charvillonauthor=D.+Valognesauthor=M.+Campsauthor=C.+Chabertauthor=C.+Gillieronauthor=B.+Franconauthor=D.+Perrinauthor=D.+Leroyauthor=D.+Gretenerauthor=A.+Nicholsauthor=P.+A.+Vitteauthor=S.+Carboniauthor=C.+Rommelauthor=M.+K.+Schwarzauthor=T.+R%C3%BCckle&title=Furan-2-ylmethylene+Thiazolidinediones+as+Novel%2C+Potent%2C+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Fjm0601598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601598%26sid%3Dliteratum%253Aachs%26aulast%3DPomel%26aufirst%3DV.%26aulast%3DKlicic%26aufirst%3DJ.%26aulast%3DCovini%26aufirst%3DD.%26aulast%3DChurch%26aufirst%3DD.%2BD.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DRoulin%26aufirst%3DK.%26aulast%3DBurgat-Charvillon%26aufirst%3DF.%26aulast%3DValognes%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DGillieron%26aufirst%3DC.%26aulast%3DFrancon%26aufirst%3DB.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DGretener%26aufirst%3DD.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DVitte%26aufirst%3DP.%2BA.%26aulast%3DCarboni%26aufirst%3DS.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26atitle%3DFuran-2-ylmethylene%2520Thiazolidinediones%2520as%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3857%26epage%3D3871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_contrib-group">Pereira, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strangman, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, R. J.</span><span> </span><span class="NLM_article-title">Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8523</span><span class="NLM_x">–</span> <span class="NLM_lpage">8533</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100531u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFShtb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8523-8533&author=A.+R.+Pereiraauthor=W.+K.+Strangmanauthor=F.+Marionauthor=L.+Feldbergauthor=D.+Rollauthor=R.+Mallonauthor=I.+Hollanderauthor=R.+J.+Andersen&title=Synthesis+of+Phosphatidylinositol+3-Kinase+%28PI3K%29+Inhibitory+Analogues+of+the+Sponge+Meroterpenoid+Liphagal"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal</span></div><div class="casAuthors">Pereira, Alban R.; Strangman, Wendy K.; Marion, Frederic; Feldberg, Larry; Roll, Deborah; Mallon, Robert; Hollander, Irwin; Andersen, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8523-8533</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sponge meroterpenoid liphagal (+)-I and racemic and nonracemic analogs such as (±)-II were prepd. and their inhibition of phosphatidylinositol-3-kinases α and γ (PI3Kα and PI3Kγ, resp.) was detd.  II inhibited PI3Kα and PI3Kγ with IC50 values of 66 nM and 1840 nM, resp., showing a 27-fold preference for PI3Kα; in addn., II exhibited enhanced chem. stability and modestly enhanced potency and selectivity compared with those of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dJ0WNMQ0nrVg90H21EOLACvtfcHk0lilBd8erBnr7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFShtb7F&md5=fe31011bbe5e502c62daf12167cea734</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1021%2Fjm100531u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100531u%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DA.%2BR.%26aulast%3DStrangman%26aufirst%3DW.%2BK.%26aulast%3DMarion%26aufirst%3DF.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DRoll%26aufirst%3DD.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAndersen%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520of%2520Phosphatidylinositol%25203-Kinase%2520%2528PI3K%2529%2520Inhibitory%2520Analogues%2520of%2520the%2520Sponge%2520Meroterpenoid%2520Liphagal%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8523%26epage%3D8533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">The Phosphatidylinositol 3-Kinase-AKT Pathway in Human Cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnrc839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=12094235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=489-501&author=I.+Vivancoauthor=C.+L.+Sawyers&title=The+Phosphatidylinositol+3-Kinase-AKT+Pathway+in+Human+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-Kinase-AKT pathway in human cancer</span></div><div class="casAuthors">Vivanco, Igor; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One signal that is overactivated in a wide range of tumor types is the prodn. of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K).  This lipid and the protein kinase that is activated by it, AKT, trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumor progression.  Small-mol. therapeutics that block PI3K signaling might deal a severe blow to cancer cells by blocking many aspects of the tumor-cell phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAQ-0qeD7pLVg90H21EOLACvtfcHk0lilBd8erBnr7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D&md5=c6762d32f9f1281632f4ccdbcd29268c</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnrc839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc839%26sid%3Dliteratum%253Aachs%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DThe%2520Phosphatidylinositol%25203-Kinase-AKT%2520Pathway%2520in%2520Human%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The Phosphoinositide 3-Kinase Pathway</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1126%2Fscience.296.5573.1655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=12040186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1655-1657&author=L.+C.+Cantley&title=The+Phosphoinositide+3-Kinase+Pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphoinositide 3-kinase pathway</span></div><div class="casAuthors">Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1655-1657</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 8 refs.  Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components.  The role of phosphoinositide 3-kinase (PI3K), which catalyzes the prodn. of phosphatidylinositol 3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metab.; and cytoskeletal rearrangements are highlighted.  The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9pxSplxmS1rVg90H21EOLACvtfcHk0limFwr3wEc3yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D&md5=110c8a351448aed6ab938b9ccf90a655</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1126%2Fscience.296.5573.1655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.296.5573.1655%26sid%3Dliteratum%253Aachs%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520Phosphoinositide%25203-Kinase%2520Pathway%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D1655%26epage%3D1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the Role of mTOR in Cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+Role+of+mTOR+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520Role%2520of%2520mTOR%2520in%2520Cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_contrib-group">Fasolo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessa, C.</span><span> </span><span class="NLM_article-title">mTOR Inhibitors in the Treatment of Cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1717-1734&author=A.+Fasoloauthor=C.+Sessa&title=mTOR+Inhibitors+in+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFasolo%26aufirst%3DA.%26aulast%3DSessa%26aufirst%3DC.%26atitle%3DmTOR%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1717%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_contrib-group">Bellacosa, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cristofano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span> </span><span class="NLM_article-title">Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2FS0065-230X%2805%2994002-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=16095999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=29-86&author=A+Bellacosaauthor=C.+C.+Kumarauthor=A.+Di+Cristofanoauthor=J.+R.+Testa&title=Activation+of+AKT+Kinases+in+Cancer%3A+Implications+for+Therapeutic+Targeting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of AKT kinases in cancer: implications for therapeutic targeting</span></div><div class="casAuthors">Bellacosa, Alfonso; Kumar, C. Chandra; Di Cristofano, Antonio; Testa, Joseph Robert</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-86</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The AKT1, AKT2, and AKT3 kinases have emerged as crit. mediators of signal transduction pathways downstream of activated tyrosine kinases and phosphatidylinositol 3-kinase.  An ever-increasing list of AKT substrates has precisely defined the multiple functions of this kinase family in normal physiol. and disease states.  Cellular processes regulated by AKT include cell proliferation and survival, cell size and response to nutrient availability, intermediary metab., angiogenesis, and tissue invasion.  All these processes represent hallmarks of cancer, and a burgeoning literature has defined the importance of AKT alterations in human cancer and exptl. models of tumorigenesis, continuing the legacy represented by the original identification of v-Akt as the transforming oncogene of a murine retrovirus.  Many oncoproteins and tumor suppressors intersect in the AKT pathway, finely regulating cellular functions at the interface of signal transduction and classical metabolic regulation.  This careful balance is altered in human cancer by a variety of activating and inactivating mechanisms that target both AKT and interrelated proteins.  Reprogramming of this altered circuitry by pharmacol. modulation of the AKT pathway represents a powerful strategy for rational cancer therapy.  In this review, we summarize a large body of data, from many types of cancer, indicating that AKT activation is one of the most common mol. alterations in human malignancy.  We also review mechanisms of activation of AKT kinases, examples of therapeutic modulation of the AKT pathway in animal models, and the current status of efforts to target mol. components of the AKT pathway for cancer therapy and, possibly, cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtUdzglK927Vg90H21EOLACvtfcHk0ljvTTFuEY3L5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D&md5=556e3c5787e0179786db3cb2e2f1dcf6</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2805%2994002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252805%252994002-5%26sid%3Dliteratum%253Aachs%26aulast%3DBellacosa%26aufirst%3DA%26aulast%3DKumar%26aufirst%3DC.%2BC.%26aulast%3DDi%2BCristofano%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DActivation%2520of%2520AKT%2520Kinases%2520in%2520Cancer%253A%2520Implications%2520for%2520Therapeutic%2520Targeting%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2005%26volume%3D94%26spage%3D29%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6f"><span><span class="NLM_contrib-group">Ihle, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">Take Your PIK: Phosphatidylinositol 3-Kinase Inhibitors Race through the Clinic toward Cancer Therapy</span> <span class="citation_source-journal">Mol. Cancer. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1158%2F1535-7163.MCT-08-0801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=19139107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1-9&author=N.+T.+Ihleauthor=G.+Powis&title=Take+Your+PIK%3A+Phosphatidylinositol+3-Kinase+Inhibitors+Race+through+the+Clinic+toward+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6fR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy</span></div><div class="casAuthors">Ihle, Nathan T.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is currently one of the most exciting drug targets in oncol.  However, only a short time ago, the paradigm existed that drugs targeted to the four PI3K class I isoforms would be too toxic for use in cancer therapy due to effects on physiol. signaling.  Since that time, studies have delineated the roles of these four isoforms in nonpathol. signaling as well as their roles in cancer.  An extensive effort has gone into developing agents that inhibit one or more PI3K isoforms, as well as closely related proteins implicated in cancer.  These agents have proved to be tolerable and therapeutically beneficial in animal studies, and a no. are in clin. testing.  The agents, their properties, and their mol. targets are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtwozBC-h437Vg90H21EOLACvtfcHk0ljFvomPCNNqZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D&md5=4bc339da7fdd1dc74e13eadf76ae53ce</span></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0801%26sid%3Dliteratum%253Aachs%26aulast%3DIhle%26aufirst%3DN.%2BT.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DTake%2520Your%2520PIK%253A%2520Phosphatidylinositol%25203-Kinase%2520Inhibitors%2520Race%2520through%2520the%2520Clinic%2520toward%2520Cancer%2520Therapy%26jtitle%3DMol.%2520Cancer.%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6g"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J. J.</span><span> </span><span class="NLM_article-title">Targeting the Phosphoinositide 3-Kinase Pathway in Cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhou&title=Targeting+the+Phosphoinositide+3-Kinase+Pathway+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6gR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0ljFvomPCNNqZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhou%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520Phosphoinositide%25203-Kinase%2520Pathway%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Imidazo[1,2-<i>a</i>]pyridine Derivatives as Novel PI3 Kinase p110α Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=403-412&author=M.+Hayakawaauthor=H.+Kaizawaauthor=K.+Kawaguchiauthor=N.+Ishikawaauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Yamanoauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamotoauthor=F.+I.+Raynaudauthor=M.+D.+Waterfieldauthor=P.+Parkerauthor=P.+Workman&title=Synthesis+and+Biological+Evaluation+of+Imidazo%5B1%2C2-a%5Dpyridine+Derivatives+as+Novel+PI3+Kinase+p110%CE%B1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DN.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DYamano%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Imidazo%255B1%252C2-a%255Dpyridine%2520Derivatives%2520as%2520Novel%2520PI3%2520Kinase%2520p110%25CE%25B1%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D403%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_contrib-group">Pereira, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strangman, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, R.</span><span> </span><span class="NLM_article-title">Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8523</span><span class="NLM_x">–</span> <span class="NLM_lpage">8533</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100531u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFShtb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8523-8533&author=A.+R.+Pereiraauthor=W.+K.+Strangmanauthor=F.+Marionauthor=L.+Feldbergauthor=D.+Rollauthor=R.+Mallonauthor=I.+Hollanderauthor=R.+Andersen&title=Synthesis+of+Phosphatidylinositol+3-Kinase+%28PI3K%29+Inhibitory+Analogues+of+the+Sponge+Meroterpenoid+Liphagal"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal</span></div><div class="casAuthors">Pereira, Alban R.; Strangman, Wendy K.; Marion, Frederic; Feldberg, Larry; Roll, Deborah; Mallon, Robert; Hollander, Irwin; Andersen, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8523-8533</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sponge meroterpenoid liphagal (+)-I and racemic and nonracemic analogs such as (±)-II were prepd. and their inhibition of phosphatidylinositol-3-kinases α and γ (PI3Kα and PI3Kγ, resp.) was detd.  II inhibited PI3Kα and PI3Kγ with IC50 values of 66 nM and 1840 nM, resp., showing a 27-fold preference for PI3Kα; in addn., II exhibited enhanced chem. stability and modestly enhanced potency and selectivity compared with those of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dJ0WNMQ0nrVg90H21EOLACvtfcHk0lhtYfeeAogfOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFShtb7F&md5=fe31011bbe5e502c62daf12167cea734</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fjm100531u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100531u%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DA.%2BR.%26aulast%3DStrangman%26aufirst%3DW.%2BK.%26aulast%3DMarion%26aufirst%3DF.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DRoll%26aufirst%3DD.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAndersen%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520Phosphatidylinositol%25203-Kinase%2520%2528PI3K%2529%2520Inhibitory%2520Analogues%2520of%2520the%2520Sponge%2520Meroterpenoid%2520Liphagal%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8523%26epage%3D8533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span> </span><span class="NLM_article-title">Novel Purine and Pyrazolo[3,4-<i>d</i>]pyrimidine Inhibitors of PI3 Kinase-α: Hit to Lead Studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=636-639&author=A.+M.+Gilbertauthor=P.+Nowakauthor=N.+Brooijmansauthor=M.+G.+Bursavichauthor=C.+Dehnhardtauthor=E.+Delos+Santosauthor=L.+R.+Feldbergauthor=I.+Hollanderauthor=S.+Kimauthor=S.+Lombardiauthor=K.+Parkauthor=A.+M.+Venkatesanauthor=R.+Mallon&title=Novel+Purine+and+Pyrazolo%5B3%2C4-d%5Dpyrimidine+Inhibitors+of+PI3+Kinase-%CE%B1%3A+Hit+to+Lead+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DFeldberg%26aufirst%3DL.%2BR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLombardi%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DVenkatesan%26aufirst%3DA.%2BM.%26aulast%3DMallon%26aufirst%3DR.%26atitle%3DNovel%2520Purine%2520and%2520Pyrazolo%255B3%252C4-d%255Dpyrimidine%2520Inhibitors%2520of%2520PI3%2520Kinase-%25CE%25B1%253A%2520Hit%2520to%2520Lead%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D636%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_contrib-group">Kendall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baguley, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaussade, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, P. R.</span><span> </span><span class="NLM_article-title">Synthesis, Biological Evaluation and Molecular Modeling of Sulfonohydrazides as Selective PI3K p110α Inhibitors</span> <span class="citation_source-journal">Biol. Org. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7677</span><span class="NLM_x">–</span> <span class="NLM_lpage">7687</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2Fj.bmc.2007.08.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=17869522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2msLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7677-7687&author=J.+D.+Kendallauthor=G.+W.+Rewcastleauthor=R.+Frederickauthor=C.+Mawsonauthor=W.+A.+Dennyauthor=E.+S.+Marshallauthor=B.+C.+Baguleyauthor=C.+Chaussadeauthor=S.+P.+Jacksonauthor=P.+R.+Shepherd&title=Synthesis%2C+Biological+Evaluation+and+Molecular+Modeling+of+Sulfonohydrazides+as+Selective+PI3K+p110%CE%B1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110α inhibitors</span></div><div class="casAuthors">Kendall, Jackie D.; Rewcastle, Gordon W.; Frederick, Raphael; Mawson, Claire; Denny, William A.; Marshall, Elaine S.; Baguley, Bruce C.; Chaussade, Claire; Jackson, Shaun P.; Shepherd, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7677-7687</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 2-methyl-5-nitrobenzenesulfonohydrazides were prepd. and evaluated as inhibitors of PI3K.  An isoquinoline deriv. shows good selectivity for the p110α isoform over p110β and p110δ, and also demonstrates good in vitro activity in a cell proliferation assay.  Mol. modeling provides a rationalisation for the obsd. SAR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry8V-UY9ZUwrVg90H21EOLACvtfcHk0lhjfDq4N8MO8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2msLzI&md5=c797f6d91f0a9c0ac29b66a790becade</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.08.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.08.062%26sid%3Dliteratum%253Aachs%26aulast%3DKendall%26aufirst%3DJ.%2BD.%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DMawson%26aufirst%3DC.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DMarshall%26aufirst%3DE.%2BS.%26aulast%3DBaguley%26aufirst%3DB.%2BC.%26aulast%3DChaussade%26aufirst%3DC.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26atitle%3DSynthesis%252C%2520Biological%2520Evaluation%2520and%2520Molecular%2520Modeling%2520of%2520Sulfonohydrazides%2520as%2520Selective%2520PI3K%2520p110%25CE%25B1%2520Inhibitors%26jtitle%3DBiol.%2520Org.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7677%26epage%3D7687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_contrib-group">Jamieson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baguley, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, P. R.</span><span> </span><span class="NLM_article-title">A Drug Targeting Only p110α Can Block Phosphoinositide 3-Kinase Signaling and Tumour Growth in Certain Cell Types</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2011&pages=53-62&author=S.+Jamiesonauthor=J.+U.+Flanaganauthor=S.+Kolekarauthor=S.+Buchananauthor=J.+D.+Kendallauthor=W.-J.+Leeauthor=G.+W.+Rewcastleauthor=W.+A.+Dennyauthor=R.+Singhauthor=J.+Dicksonauthor=B.+C.+Baguleyauthor=P.+R.+Shepherd&title=A+Drug+Targeting+Only+p110%CE%B1+Can+Block+Phosphoinositide+3-Kinase+Signaling+and+Tumour+Growth+in+Certain+Cell+Types"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DS.%26aulast%3DFlanagan%26aufirst%3DJ.%2BU.%26aulast%3DKolekar%26aufirst%3DS.%26aulast%3DBuchanan%26aufirst%3DS.%26aulast%3DKendall%26aufirst%3DJ.%2BD.%26aulast%3DLee%26aufirst%3DW.-J.%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DDickson%26aufirst%3DJ.%26aulast%3DBaguley%26aufirst%3DB.%2BC.%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26atitle%3DA%2520Drug%2520Targeting%2520Only%2520p110%25CE%25B1%2520Can%2520Block%2520Phosphoinositide%25203-Kinase%2520Signaling%2520and%2520Tumour%2520Growth%2520in%2520Certain%2520Cell%2520Types%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D438%26spage%3D53%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7f"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2Fj.cell.2006.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=16647110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+Pharmacological+Map+of+the+PI3-K+Family+Defines+a+Role+for+p110%CE%B1+in+Insulin+Signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span></div><div class="casAuthors">Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">733-747</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined.  We describe here an approach to pharmacol. interrogate the PI3-K family.  A chem. diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochem. enumerated, revealing cryptic homologies across targets and chemotypes.  Crystal structures of three inhibitors bound to p110γ identify a conformationally mobile region that is uniquely exploited by selective compds.  This chem. array was then used to define the PI3-K isoforms required for insulin signaling.  We find that p110α is the primary insulin-responsive PI3-K in cultured cells, whereas p110β is dispensable but sets a phenotypic threshold for p110α activity.  Compds. targeting p110α block the acute effects of insulin treatment in vivo, whereas a p110β inhibitor has no effect.  These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozjvOeMXP3bVg90H21EOLACvtfcHk0lhWAhxM6xfupQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D&md5=b95a8cb433927ff9a75b33fc4ac2c8a0</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520Pharmacological%2520Map%2520of%2520the%2520PI3-K%2520Family%2520Defines%2520a%2520Role%2520for%2520p110%25CE%25B1%2520in%2520Insulin%2520Signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26spage%3D733%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The Identification of 2-(1<i>H</i>-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=P.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+Identification+of+2-%281H-Indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+Potent%2C+Selective%2C+Orally+Bioavailable+Inhibitor+of+Class+I+PI3+Kinase+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0lgZiXN-kCr_HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DP.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520Identification%2520of%25202-%25281H-Indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520Potent%252C%2520Selective%252C%2520Orally%2520Bioavailable%2520Inhibitor%2520of%2520Class%2520I%2520PI3%2520Kinase%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901284w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1086-1097&author=D.+P.+Sutherlinauthor=D.+Sampathauthor=M.+Berryauthor=G.+Castanedoauthor=Z.+Changauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=L.+Friedmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=C.+Wiesmannauthor=S.+Wongauthor=B.-Y.+Zhu&title=Discovery+of+%28Thienopyrimidin-2-yl%29aminopyrimidines+as+Potent%2C+Selective%2C+and+Orally+Available+Pan-PI3-Kinase+and+Dual+Pan-PI3-Kinase%2FmTOR+Inhibitors+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.-Y.%26atitle%3DDiscovery%2520of%2520%2528Thienopyrimidin-2-yl%2529aminopyrimidines%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520Pan-PI3-Kinase%2520and%2520Dual%2520Pan-PI3-Kinase%252FmTOR%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B. Y.</span><span> </span><span class="NLM_article-title">Identification of GNE-477, a Potent and Efficacious Dual PI3K/mTOR Inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2408</span><span class="NLM_x">–</span> <span class="NLM_lpage">2411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2408-2411&author=T.+P.+Heffronauthor=M.+Berryauthor=G.+Castanedoauthor=C.+Changauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=J.+Gunznerauthor=J.+D.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=D.+Petersonauthor=L.+Salphatiauthor=D.+Sampathauthor=S.+Siderisauthor=D.+P.+Sutherlinauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=S.+Wongauthor=B.+Y.+Zhu&title=Identification+of+GNE-477%2C+a+Potent+and+Efficacious+Dual+PI3K%2FmTOR+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DGunzner%26aufirst%3DJ.%26aulast%3DLesnick%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DD.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.%2BY.%26atitle%3DIdentification%2520of%2520GNE-477%252C%2520a%2520Potent%2520and%2520Efficacious%2520Dual%2520PI3K%252FmTOR%2520Inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2408%26epage%3D2411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_contrib-group">Staben, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plise, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weismann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B. Z.</span><span> </span><span class="NLM_article-title">Structure-Based Optimization of Pyrazolo–Pyrimidine and –Pyridine Inhibitors of PI3 Kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6048</span><span class="NLM_x">–</span> <span class="NLM_lpage">6051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6048-6051&author=S.+T.+Stabenauthor=T.+P.+Heffronauthor=D.+P.+Sutherlinauthor=S.+R.+Bhatauthor=G.+M.+Castanedoauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=L.+Friedmanauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=E.+Pliseauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=L.+Rougeauthor=D.+Sampathauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=C.+Weismannauthor=P.+Wuauthor=B.+Z.+Zhu&title=Structure-Based+Optimization+of+Pyrazolo%E2%80%93Pyrimidine+and+%E2%80%93Pyridine+Inhibitors+of+PI3+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DBhat%26aufirst%3DS.%2BR.%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DRouge%26aufirst%3DL.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWeismann%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DB.%2BZ.%26atitle%3DStructure-Based%2520Optimization%2520of%2520Pyrazolo%25E2%2580%2593Pyrimidine%2520and%2520%25E2%2580%2593Pyridine%2520Inhibitors%2520of%2520PI3%2520Kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6048%26epage%3D6051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_contrib-group">Staben, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Thienobenzoxepin Inhibitors of PI3-Kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4054</span><span class="NLM_x">–</span> <span class="NLM_lpage">4058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2Fj.bmcl.2011.04.124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=21636270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVCisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4054-4058&author=S.+T.+Stabenauthor=M.+Siuauthor=R.+Goldsmithauthor=A.+G.+Oliveroauthor=S.+Doauthor=D.+Burdickauthor=T.+P.+Heffronauthor=D.+P.+Sutherlinauthor=B.-Y.+Zhuauthor=V.+Tsuiauthor=H.+Leauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=J.+M.+Murrayauthor=J.+Nonomiyaauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=L.+Rougeauthor=D.+Sampathauthor=C.+Wiesmannauthor=P.+Wu&title=Structure-Based+Design+of+Thienobenzoxepin+Inhibitors+of+PI3-Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of thienobenzoxepin inhibitors of PI3-kinase</span></div><div class="casAuthors">Staben, Steven T.; Siu, Michael; Goldsmith, Richard; Olivero, Alan G.; Do, Steven; Burdick, Daniel J.; Heffron, Timothy P.; Dotson, Jenna; Sutherlin, Daniel P.; Zhu, Bing-Yan; Tsui, Vickie; Le, Hoa; Lee, Leslie; Lesnick, John; Lewis, Cristina; Murray, Jeremy M.; Nonomiya, Jim; Pang, Jodie; Prior, Wei Wei; Salphati, Laurent; Rouge, Lionel; Sampath, Deepak; Sideris, Steve; Wiesmann, Christian; Wu, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4054-4058</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Starting from thienobenzopyran HTS hit 1 (I), co-crystn., mol. modeling and metabolic anal. were used to design potent and metabolically stable inhibitors of PI3-kinase.  Compd. 15 demonstrated PI3K pathway suppression in a mouse MCF7 xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK5PrbzVKCkbVg90H21EOLACvtfcHk0lgaJ-cWDFF3Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVCisLs%253D&md5=9b807be1ac4093a6f139c0304757037a</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.124%26sid%3Dliteratum%253Aachs%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DBurdick%26aufirst%3DD.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DZhu%26aufirst%3DB.-Y.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DRouge%26aufirst%3DL.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DP.%26atitle%3DStructure-Based%2520Design%2520of%2520Thienobenzoxepin%2520Inhibitors%2520of%2520PI3-Kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4054%26epage%3D4058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><div class="note"><p class="first last">There have been reports suggesting that inhibition of PI3Kβ might contribute to insulin resistance, while other reports indicate a minor role of PI3Kβ in insulin signaling. For a recent review including discussion of the role of PI3Kβ in metabolism see the following: </p></div><span class="NLM_contrib-group">Costa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span> </span><span class="NLM_article-title">More Than Just Kinases: The Scaffolding Function of PI3K</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2011&pages=171-182&author=C.+Costaauthor=E.+Hirsch&title=More+Than+Just+Kinases%3A+The+Scaffolding+Function+of+PI3K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DC.%26aulast%3DHirsch%26aufirst%3DE.%26atitle%3DMore%2520Than%2520Just%2520Kinases%253A%2520The%2520Scaffolding%2520Function%2520of%2520PI3K%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2011%26volume%3D346%26spage%3D171%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><div class="note"><p class="first last">The first crystal structure of PI3Kβ was reported after the completion of our studies: </p></div><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vadas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perisic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=567-578&author=X.+Zhangauthor=O.+Vadasauthor=O.+Perisicauthor=K.+E.+Andersonauthor=J.+Clarkauthor=P.+T.+Hawkinsauthor=L.+R.+Stephensauthor=R.+L.+Williams&title=Structure+of+Lipid+Kinase+p110%CE%B2%2Fp85%CE%B2+Elucidates+an+Unusual+SH2-Domain-Mediated+Inhibitory+Mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DVadas%26aufirst%3DO.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DStructure%2520of%2520Lipid%2520Kinase%2520p110%25CE%25B2%252Fp85%25CE%25B2%2520Elucidates%2520an%2520Unusual%2520SH2-Domain-Mediated%2520Inhibitory%2520Mechanism%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D41%26spage%3D567%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Walker, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perisic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2FS1097-2765%2805%2900089-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=11090628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=909-919&author=E.+H.+Walkerauthor=M.+E.+Pacoldauthor=O.+Perisicauthor=L.+Stephensauthor=P.+T.+Hawkinsauthor=M.+P.+Wymannauthor=R.+L.+Williams&title=Structural+Determinants+of+Phosphoinositide+3-Kinase+Inhibition+by+Wortmannin%2C+LY294002%2C+Quercetin%2C+Myricetin%2C+and+Staurosporine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine</span></div><div class="casAuthors">Walker, Edward H.; Pacold, Michael E.; Perisic, Olga; Stephens, Len; Hawkins, Philip T.; Wymann, Matthias P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">909-919</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The specific phosphoinositide 3-kinase (P13K) inhibitors wortmannin and LY294002 have been invaluable tools for elucidating the roles of these enzymes in signal transduction pathways.  The X-ray crystallog. structures of P13K bound to these lipid kinase inhibitors and to the broad-spectrum protein kinase inhibitors quercetin, myricetin, and staurosporine reveal how these compds. fit into the ATP binding pocket.  With a nanomolar IC50, wortmannin most closely fits and fills the active site and induces a conformational change in the catalytic domain.  Surprisingly, LY294002 and the lead compd. on which it was designed, quercetin, as well as the closely related flavonoid myricetin bind P13K in remarkably different orientations that are related to each other by 1800 rotations.  Staurosporine/P13K interactions are reminiscent of low-affinity protein kinase/staurosporine complexes.  These results provide a rich basis for development of isoform-specific P13K inhibitors with therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgIbTky2xQmbVg90H21EOLACvtfcHk0lhz-THAAuwSdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D&md5=5dd92f9b48c437e43c0023fdff10c1ac</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2805%2900089-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252805%252900089-4%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DE.%2BH.%26aulast%3DPacold%26aufirst%3DM.%2BE.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DStephens%26aufirst%3DL.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DStructural%2520Determinants%2520of%2520Phosphoinositide%25203-Kinase%2520Inhibition%2520by%2520Wortmannin%252C%2520LY294002%252C%2520Quercetin%252C%2520Myricetin%252C%2520and%2520Staurosporine%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D909%26epage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Berndt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hon, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rückle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">The p110δ Structure: Mechanisms for Selectivity and Potency of New PI(3)K Inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.-C.+Honauthor=P.+Renauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+R%C3%BCckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williams&title=The+p110%CE%B4+Structure%3A+Mechanisms+for+Selectivity+and+Potency+of+New+PI%283%29K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110δ.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110δ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110δ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0lhz-THAAuwSdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.-C.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DThe%2520p110%25CE%25B4%2520Structure%253A%2520Mechanisms%2520for%2520Selectivity%2520and%2520Potency%2520of%2520New%2520PI%25283%2529K%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D117%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, L.</span><span> </span><span class="NLM_article-title">The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1744</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1744-1748&author=C.+H.+Huangauthor=D.+Mandelkerauthor=O.+Schmidt-Kittlerauthor=J.+Zhuauthor=C.+Huangauthor=K.+Kinslerauthor=B.+Vogelsteinauthor=L.+Amzel&title=The+Structure+of+a+Human+p110%CE%B1%2Fp85%CE%B1+Complex+Elucidates+the+Effects+of+Oncogenic+PI3K%CE%B1+Mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DKinsler%26aufirst%3DK.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DAmzel%26aufirst%3DL.%26atitle%3DThe%2520Structure%2520of%2520a%2520Human%2520p110%25CE%25B1%252Fp85%25CE%25B1%2520Complex%2520Elucidates%2520the%2520Effects%2520of%2520Oncogenic%2520PI3K%25CE%25B1%2520Mutations%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1744%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">For a comparative analysis of the binding sites of the four class I PI3Ks see the following: </p></div><div class="NLM_citation" id="cit14a"><span><span class="NLM_contrib-group">Amzel, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabelli, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span> </span><span class="NLM_article-title">Structural Comparisons of Class I Phosphoinositide-3-Kinases</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnrc2443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=18633356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWksLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=665-669&author=L.+M.+Amzelauthor=C.-H.+Huangauthor=D.+Mandelkerauthor=C.+Lengauerauthor=S.+B.+Gabelliauthor=B.+Vogelstein&title=Structural+Comparisons+of+Class+I+Phosphoinositide-3-Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural comparisons of class I phosphoinositide 3-kinases</span></div><div class="casAuthors">Amzel, L. Mario; Huang, Chuan-Hsiang; Mandelker, Diana; Lengauer, Christoph; Gabelli, Sandra B.; Vogelstein, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">665-669</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The recent detn. of the structure of the class I phosphoinositide 3-kinase PI3Kα has identified important structural differences between the class 1 PI3Ks.  How can this information be used to improve cancer therapy.  Class I phosphoinositide 3-kinases (PI3Ks) are lipid kinases that regulate cell growth.  One of these kinases, PI3Kα, is frequently mutated in diverse tumor types.  The recently detd. structure of PI3Kα reveals features that distinguish this enzyme from related lipid kinases.  In addn., wild-type PI3Kγ differs from PI3Kα by a substitution identical to a PI3Kα oncogenic mutant (His1047Arg) that might explain the differences in the enzymic activities of the normal and mutant PI3Kα.  Comparison of the PI3K structures also identified structural features that could potentially be exploited for the design of isoform-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-V2mKhromdrVg90H21EOLACvtfcHk0liBQZf-LzRToA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWksLfJ&md5=2f6c4b1db6f8c9eb6ab712f5a83f4e70</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2443%26sid%3Dliteratum%253Aachs%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26aulast%3DHuang%26aufirst%3DC.-H.%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DStructural%2520Comparisons%2520of%2520Class%2520I%2520Phosphoinositide-3-Kinases%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D665%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_contrib-group">Sabbah, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, H.</span><span> </span><span class="NLM_article-title">Docking Studies on Isoform-Specific Inhibition of Phosphoinositide-3-Kinases</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1887</span><span class="NLM_x">–</span> <span class="NLM_lpage">1898</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci1002679" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtF2lurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1887-1898&author=D.+A.+Sabbahauthor=J.+L.+Vennerstromauthor=H.+Zhong&title=Docking+Studies+on+Isoform-Specific+Inhibition+of+Phosphoinositide-3-Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Studies on Isoform-Specific Inhibition of Phosphoinositide-3-Kinases</span></div><div class="casAuthors">Sabbah, Dima A.; Vennerstrom, Jonathan L.; Zhong, Haizhen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1887-1898</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol 3-kinase α (PI3Kα) is a promising target for anticancer drug design.  Oncogenic mutation H1047R in the catalytic domain is obsd. in many tumors and may enhance PI3Kα kinase activity by affecting loop confirmations as well as membrane binding.  We applied docking methods to 33 PI3K inhibitors against the wild type (wt) PI3Kα, the H1047R mutant of PI3Kα and the γ isoform of PI3K (PI3Kγ).  We also investigated the effect of protein flexibility on ligand binding by docking the same set of ligands to conformations of the wt and mutant PI3Kα generated by mol. dynamics simulations.  Our data suggests that conformational differences in Gln859, Ser854, Tyr836, and Ser774 between the PI3Kα wt and H1047R mutant may be used to design ligands that are active against both the wt and H1047R mutant isoforms.  Gln859, Ser854 and Ser774 may play crit. roles in ligand binding to the α isoform H1047R mutant while formation of H-bonds with Ser806 of PI3Kγ may enhance γ-isoform-specific inhibition.  In addn. to H-bond interactions, structural and size differences in the activation and hydrophobic domains of PI3Kα, PI3Kγ, and the PI3Kα H1047R mutant could be exploited to direct the design of isoform- and/or mutant-specific PI3K inhibitors.  Our data provide a reasonable explanation for the activity and selectivity of small mol. PI3K inhibitors and are in good agreement with available exptl. and computational data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdoBkSYgv-9LVg90H21EOLACvtfcHk0liqEc19SzxkXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtF2lurrN&md5=39e30173b4a35afba96ce678dad3cdc1</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fci1002679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci1002679%26sid%3Dliteratum%253Aachs%26aulast%3DSabbah%26aufirst%3DD.%2BA.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DZhong%26aufirst%3DH.%26atitle%3DDocking%2520Studies%2520on%2520Isoform-Specific%2520Inhibition%2520of%2520Phosphoinositide-3-Kinases%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1887%26epage%3D1898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">To predict binding poses by docking, a PI3Kα H1042R mutant structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HIZ">3HIZ</a>) was chosen over the only currently available wildtype structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD0">2RD0</a>). This is because the latter is considered to suffer more significantly from artifacts of crystal packing. Docking was performed using GLIDE (Schrödinger, LLC), and the conformations of three mobile side chains (R770, K802, D933) were allowed to move. The docked pose of GDC-941 was consistent with the reported structure of this inhibitor with mouse PI3Kδ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WXP">2WXP</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">The sequences of the kinase domains of the four PI3K isoforms from multiple species were aligned using PSI-BLAST (NCBI). A mouse PI3Kδ structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WXP">2WXP</a>) was chosen as the template because among all available structures, it shares with human PI3Kβ the highest level of sequence homology both overall and around the active site. In addition, residues 1–114 at the amino terminus, which is expected to be far removed from the active site according to the known structures, were omitted in modeling. Finally, sequence alignment was manually refined (sequence identity of 52%; see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) before a model of human PI3Kβ in complex with GDC-941 (from the template) was built using PRIME (Schrödinger, LLC) with standard parameters.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">A comparison of our homology model of PI3Kβ with the recently reported 3.3 Å cocrystal structure of PI3Kβ and <b>1</b> (ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a>) shows that the homology model correctly predicted the confirmation of the P-loop (Lys771-Ser775, numbering from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Y3A">2Y3A</a>), validating the choice of PI3Kδ as the homology template for the binding pocket.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">The aminopyrimidine group also adds mTOR inhibition and in many cases improved in vivo Cl. For details see refs <a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">8b</a> and <a onclick="showRef(event, 'cit8c'); return false;" href="javascript:void(0);" class="ref cit8c">8c</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">Electrostatic potential maps were computed using a Poisson–Boltzmann (PB) equation solver APBS Tools2 plugin for PyMOL (14a-c). Calculation was performed in nonlinear PB mode with these standard parameters: protein dielectric set as 2 and solvent dielectric as 78; atomic charges and radii assigned according to the AMBER force field; 0.150 M concentration for the +1 and −1 ion species; solvent radius of 1.4 Å; system temperature of 310 K. The molecule surface was computed using the option “similar to cubic spline, but with 7th order polynomial”, colored by the “potential on solvent accessible surface”, and visualized in PyMOL, version 1.2r3pre (Schrödinger, LLC). </p></div><div class="NLM_citation" id="cit19a"><span><span class="NLM_contrib-group">Baker, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sept, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span> </span><span class="NLM_article-title">Electrostatics of Nanosystems: Application to Microtubules and the Ribosome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">10037</span><span class="NLM_x">–</span> <span class="NLM_lpage">10041</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1073%2Fpnas.181342398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=11517324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=10037-10041&author=N.+A.+Bakerauthor=D+Septauthor=S+Josephauthor=M.+J.+Holstauthor=J.+A.+McCammon&title=Electrostatics+of+Nanosystems%3A+Application+to+Microtubules+and+the+Ribosome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Electrostatics of nanosystems: application to microtubules and the ribosome</span></div><div class="casAuthors">Baker, Nathan A.; Sept, David; Joseph, Simpson; Holst, Michael J.; McCammon, J. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">10037-10041</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Evaluation of the electrostatic properties of biomols. has become a std. practice in mol. biophysics.  Foremost among the models used to elucidate the electrostatic potential is the Poisson-Boltzmann equation; however, existing methods for solving this equation have limited the scope of accurate electrostatic calcns. to relatively small biomol. systems.  Here we present the application of numerical methods to enable the trivially parallel soln. of the Poisson-Boltzmann equation for supramol. structures that are orders of magnitude larger in size.  As a demonstration of this methodol., electrostatic potentials have been calcd. for large microtubule and ribosome structures.  The results point to the likely role of electrostatics in a variety of activities of these structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA_CAlhE0uX7Vg90H21EOLACvtfcHk0lg8huLDH-1nMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D&md5=1b861999ef12c6972e82e8ada0f387cb</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.181342398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.181342398%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DN.%2BA.%26aulast%3DSept%26aufirst%3DD%26aulast%3DJoseph%26aufirst%3DS%26aulast%3DHolst%26aufirst%3DM.%2BJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DElectrostatics%2520of%2520Nanosystems%253A%2520Application%2520to%2520Microtubules%2520and%2520the%2520Ribosome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D10037%26epage%3D10041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_contrib-group">Dolinsky, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, N. A.</span><span> </span><span class="NLM_article-title">PDB2PQR: An automated Pipeline for the Setup, Execution,and Analysis of Poisson–Boltzmann Electrostatics Calculations</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">W665</span><span class="NLM_x">–</span> <span class="NLM_lpage">W667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=W665-W667&author=T.+J.+Dolinskyauthor=J.+E.+Nielsenauthor=J.+A.+McCammonauthor=N.+A.+Baker&title=PDB2PQR%3A+An+automated+Pipeline+for+the+Setup%2C+Execution%2Cand+Analysis+of+Poisson%E2%80%93Boltzmann+Electrostatics+Calculations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDolinsky%26aufirst%3DT.%2BJ.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DPDB2PQR%253A%2520An%2520automated%2520Pipeline%2520for%2520the%2520Setup%252C%2520Execution%252Cand%2520Analysis%2520of%2520Poisson%25E2%2580%2593Boltzmann%2520Electrostatics%2520Calculations%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3DW665%26epage%3DW667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_contrib-group">Lerner, M. G.; Carlson, H. A.</span> <span class="citation_source-book">APBS Plugin for PyMOL</span>; <span class="NLM_publisher-name">University of Michigan</span>: <span class="NLM_publisher-loc">Ann Arbor, MI</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+G.+Lerner&author=H.+A.+Carlson&title=APBS+Plugin+for+PyMOL"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DM.%2BG.%26btitle%3DAPBS%2520Plugin%2520for%2520PyMOL%26pub%3DUniversity%2520of%2520Michigan%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Edgar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvin, M.</span><span> </span><span class="NLM_article-title">Isoform-Specific Phosphoinositide 3-Kinase Inhibitors Exert Distinct Effects in Solid Tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1164</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1164-1172&author=K.+A.+Edgarauthor=J.+J.+Wallinauthor=M.+Berryauthor=L.+B.+Leeauthor=W.+W.+Priorauthor=D.+Sampathauthor=L.+S.+Friedmanauthor=M.+Belvin&title=Isoform-Specific+Phosphoinositide+3-Kinase+Inhibitors+Exert+Distinct+Effects+in+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdgar%26aufirst%3DK.%2BA.%26aulast%3DWallin%26aufirst%3DJ.%2BJ.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DBelvin%26aufirst%3DM.%26atitle%3DIsoform-Specific%2520Phosphoinositide%25203-Kinase%2520Inhibitors%2520Exert%2520Distinct%2520Effects%2520in%2520Solid%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1164%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Folkes, A.; Shuttleworth, S.; Chuckowree, I.; Oxenford, S.; Wan, N. C.; Castanedo, G.; Gunzner, J.; Heffron, T.; Mathieu, S.; Olivero, A.; Sutherlin, D. P.; Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Preparation of Thienopyrimidines and Furopyrimidines as Lipid Kinase Inhibitors for Treating Cancer and Other Diseases</span>. WO2007/127175 A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Folkes&author=S.+Shuttleworth&author=I.+Chuckowree&author=S.+Oxenford&author=N.+C.+Wan&author=G.+Castanedo&author=J.+Gunzner&author=T.+Heffron&author=S.+Mathieu&author=A.+Olivero&author=D.+P.+Sutherlin&author=B.-Y.+Zhu&title=Preparation+of+Thienopyrimidines+and+Furopyrimidines+as+Lipid+Kinase+Inhibitors+for+Treating+Cancer+and+Other+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520Thienopyrimidines%2520and%2520Furopyrimidines%2520as%2520Lipid%2520Kinase%2520Inhibitors%2520for%2520Treating%2520Cancer%2520and%2520Other%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">The synthetic details of the remaining compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> are found in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> and the following: </p></div><div class="NLM_citation" id="cit22a"><span><span class="NLM_contrib-group">Folkes, A.; Shuttleworth, S.; Chuckowree, I.; Oxenford, S.; Wan, N. C.; Castanedo, G.; Gunzner, J.; Heffron, T.; Mathieu, S.; Olivero, A.; Sutherlin, D. P.; Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Preparation of Thienopyrimidines and Furopyrimidines as Lipid Kinase Inhibitors for Treating Cancer and Other Diseases</span>. WO2007/127175 A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Folkes&author=S.+Shuttleworth&author=I.+Chuckowree&author=S.+Oxenford&author=N.+C.+Wan&author=G.+Castanedo&author=J.+Gunzner&author=T.+Heffron&author=S.+Mathieu&author=A.+Olivero&author=D.+P.+Sutherlin&author=B.-Y.+Zhu&title=Preparation+of+Thienopyrimidines+and+Furopyrimidines+as+Lipid+Kinase+Inhibitors+for+Treating+Cancer+and+Other+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520Thienopyrimidines%2520and%2520Furopyrimidines%2520as%2520Lipid%2520Kinase%2520Inhibitors%2520for%2520Treating%2520Cancer%2520and%2520Other%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_contrib-group">Castanedo, G.; Dotson, J.; Goldsmith, R.; Gunzner, J.; Heffron, T.; Mathieu, S.; Olivero, A.; Staben, S.; Sutherlin, D. P.; Tsui, V.; Wang, S.; Zhu, B.-Y.; Bayliss, T.; Chuckowree, I.; Folkes, A.; Wan, N. C.</span><span> </span><span class="NLM_article-title">Thienopyrimidine and Furopyrimidine Derivatives as Phosphoinositide 3-Kinase Inhibitor and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Cancer</span>. WO2008/073785 A2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+Castanedo&author=J.+Dotson&author=R.+Goldsmith&author=J.+Gunzner&author=T.+Heffron&author=S.+Mathieu&author=A.+Olivero&author=S.+Staben&author=D.+P.+Sutherlin&author=V.+Tsui&author=S.+Wang&author=B.-Y.+Zhu&author=T.+Bayliss&author=I.+Chuckowree&author=A.+Folkes&author=N.+C.+Wan&title=Thienopyrimidine+and+Furopyrimidine+Derivatives+as+Phosphoinositide+3-Kinase+Inhibitor+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%26atitle%3DThienopyrimidine%2520and%2520Furopyrimidine%2520Derivatives%2520as%2520Phosphoinositide%25203-Kinase%2520Inhibitor%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Cancer%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_contrib-group">Bayliss, T.; Chuckowree, I.; Folkes, A.; Oxenford, S.; Wan, N. C.; Castanedo, G.; Goldsmith, R.; Gunzner, J.; Heffron, T.; Olivero, A.; Staben, S.; Sutherlin, D.; Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use</span>. WO2008/070740 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+Bayliss&author=I.+Chuckowree&author=A.+Folkes&author=S.+Oxenford&author=N.+C.+Wan&author=G.+Castanedo&author=R.+Goldsmith&author=J.+Gunzner&author=T.+Heffron&author=A.+Olivero&author=S.+Staben&author=D.+Sutherlin&author=B.-Y.+Zhu&title=Phosphoinositide+3-Kinase+Inhibitor+Compounds+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBayliss%26aufirst%3DT.%26atitle%3DPhosphoinositide%25203-Kinase%2520Inhibitor%2520Compounds%2520and%2520Methods%2520of%2520Use%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22d"><span><span class="NLM_contrib-group">Babu, S.; Cheng, Z.; Reynolds, M. E.; Savage, S. J.; Tian, Q.; Yajima, H.</span><span> </span><span class="NLM_article-title">Process for the Preparation of Thienopyrimidines as PI3K Inhibitors</span>. WO2009/055730 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Babu&author=Z.+Cheng&author=M.+E.+Reynolds&author=S.+J.+Savage&author=Q.+Tian&author=H.+Yajima&title=Process+for+the+Preparation+of+Thienopyrimidines+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBabu%26aufirst%3DS.%26atitle%3DProcess%2520for%2520the%2520Preparation%2520of%2520Thienopyrimidines%2520as%2520PI3K%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">The synthetic details of the remaining compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> are found in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> and the following: </p></div><span class="NLM_contrib-group">Do, S.; Goldsmith, R.; Heffron, T.; Kolesnikov, A.; Staben, S.; Olivero, A. G.; Siu, M.; Sutherlin, D. P.; Zhu, B.-Y.; Goldsmith, P.; Bayliss, T.; Folkes, A.; Pegg, N.</span><span> </span><span class="NLM_article-title">Preparation of Benzopyran and Benzoxepin as PI3K Inhibitors</span>. US2009/0247567 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Do&author=R.+Goldsmith&author=T.+Heffron&author=A.+Kolesnikov&author=S.+Staben&author=A.+G.+Olivero&author=M.+Siu&author=D.+P.+Sutherlin&author=B.-Y.+Zhu&author=P.+Goldsmith&author=T.+Bayliss&author=A.+Folkes&author=N.+Pegg&title=Preparation+of+Benzopyran+and+Benzoxepin+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDo%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Benzopyran%2520and%2520Benzoxepin%2520as%2520PI3K%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e','cit4f','cit4g','cit4h','cit4i'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f','cit6g'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':[],'ref16':[],'ref17':[],'ref18':[],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b','cit22c','cit22d'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 47 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hengmiao Cheng, Suvi T. M. Orr, Simon Bailey, Alexei Brooun, Ping Chen, Judith G. Deal, Yali L. Deng, Martin P. Edwards, Gary M. Gallego, Neil Grodsky, Buwen Huang, Mehran Jalaie, Stephen Kaiser, Robert S. Kania, Susan E. Kephart, Jennifer Lafontaine, Martha A. Ornelas, Mason Pairish, Simon Planken, Hong Shen, Scott Sutton, Luke Zehnder, Chau D. Almaden, Shubha Bagrodia, Matthew D. Falk, Hovhannes J. Gukasyan, Caroline Ho, Xiaolin Kang, Rachel E. Kosa, Ling Liu, Mary E. Spilker, Sergei Timofeevski, Ravi Visswanathan, Zhenxiong Wang, Fanxiu Meng, Shijian Ren, Li Shao, Feng Xu, <span class="NLM_string-name hlFld-ContribAuthor">John C. Kath</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 644-661. <a href="https://doi.org/10.1021/acs.jmedchem.0c01652" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01652%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDrug%252BDesign%252Band%252BSynthesis%252Bof%252BPI3K%2525CE%2525B1-Selective%252BInhibitor%252B%252528PF-06843195%252529%26aulast%3DCheng%26aufirst%3DHengmiao%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D21092020%26date%3D24122020%26volume%3D64%26issue%3D1%26spage%3D644%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiaqiang Dong, Jingjie Huang, Ji Zhou, Ye Tan, Jing Jin, Xi Tan, Bei Wang, Tao Yu, Chengde Wu, Shuhui Chen, <span class="NLM_string-name hlFld-ContribAuthor">Tie-Lin Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Quinazolin-4(3H)-on-3-yl-2,N-dimethylpropanamides as Orally Active and Selective PI3Kα Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (7)
                                     , 1463-1469. <a href="https://doi.org/10.1021/acsmedchemlett.0c00239" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00239%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3-Quinazolin-4%2525283H%252529-on-3-yl-2%25252CN-dimethylpropanamides%252Bas%252BOrally%252BActive%252Band%252BSelective%252BPI3K%2525CE%2525B1%252BInhibitors%26aulast%3DDong%26aufirst%3DJiaqiang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05052020%26date%3D10062020%26date%3D15062020%26date%3D10062020%26volume%3D11%26issue%3D7%26spage%3D1463%26epage%3D1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Rémy    Angelaud    </span><span class="hlFld-ContribAuthor "> Steve    Staben </span><span class="hlFld-ContribAuthor "> Timothy    Heffron </span><span class="hlFld-ContribAuthor "> Andreas    Schuster </span><span class="hlFld-ContribAuthor "> Frédéric    St-Jean </span>. </span><span class="cited-content_cbyCitation_article-title">From Discovery to Market Readiness: The Research and Development of the β-Sparing Phosphatidylinositol 3-Kinase Inhibitor Taselisib. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 61-83. <a href="https://doi.org/10.1021/bk-2019-1332.ch003" title="DOI URL">https://doi.org/10.1021/bk-2019-1332.ch003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2019-1332.ch003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2019-1332.ch003%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BDiscovery%252Bto%252BMarket%252BReadiness%25253A%252BThe%252BResearch%252Band%252BDevelopment%252Bof%252Bthe%252B%2525CE%2525B2-Sparing%252BPhosphatidylinositol%252B3-Kinase%252BInhibitor%252BTaselisib%26aulast%3DAngelaud%26aufirst%3DR%25C3%25A9my%26date%3D2019%26date%3D2019%26spage%3D61%26epage%3D83%26atitle%3DComplete%252BAccounts%252Bof%252BIntegrated%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BExamples%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%252BVolume%252B2%26aulast%3DPesti%26aufirst%3DJaan%2BA.%26date%3D2019%26date%3D2019%26volume%3D1332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephane  Perreault</span>, <span class="hlFld-ContribAuthor ">Jayaraman  Chandrasekhar</span>, <span class="hlFld-ContribAuthor ">Zhi-Hua  Cui</span>, <span class="hlFld-ContribAuthor ">Jerry  Evarts</span>, <span class="hlFld-ContribAuthor ">Jia  Hao</span>, <span class="hlFld-ContribAuthor ">Joshua A.  Kaplan</span>, <span class="hlFld-ContribAuthor ">Adam  Kashishian</span>, <span class="hlFld-ContribAuthor ">Kathleen S.  Keegan</span>, <span class="hlFld-ContribAuthor ">Thomas  Kenney</span>, <span class="hlFld-ContribAuthor ">David  Koditek</span>, <span class="hlFld-ContribAuthor ">Latesh  Lad</span>, <span class="hlFld-ContribAuthor ">Eve-Irene  Lepist</span>, <span class="hlFld-ContribAuthor ">Mary E.  McGrath</span>, <span class="hlFld-ContribAuthor ">Leena  Patel</span>, <span class="hlFld-ContribAuthor ">Bart  Phillips</span>, <span class="hlFld-ContribAuthor ">Joseph  Therrien</span>, <span class="hlFld-ContribAuthor ">Jennifer  Treiberg</span>, <span class="hlFld-ContribAuthor ">Anella  Yahiaoui</span>, and <span class="hlFld-ContribAuthor ">Gary  Phillips</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (4)
                                     , 1555-1567. <a href="https://doi.org/10.1021/acs.jmedchem.6b01821" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01821%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPhosphoinositide%252B3-Kinase%252B%252528PI3K%252529%252B%2525CE%2525B2%25252F%2525CE%2525B4%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BPhosphatase%252Band%252BTensin%252BHomolog%252B%252528PTEN%252529%252BDeficient%252BTumors%25253A%252BBuilding%252BPI3K%2525CE%2525B2%252BPotency%252Bin%252Ba%252BPI3K%2525CE%2525B4-Selective%252BTemplate%252Bby%252BTargeting%252BNonconserved%252BAsp856%26aulast%3DPerreault%26aufirst%3DStephane%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D14122016%26date%3D07022017%26date%3D23022017%26date%3D20012017%26volume%3D60%26issue%3D4%26spage%3D1555%26epage%3D1567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Robert A.  Heald</span>, <span class="hlFld-ContribAuthor ">Chudi  Ndubaku</span>, <span class="hlFld-ContribAuthor ">BinQing  Wei</span>, <span class="hlFld-ContribAuthor ">Martin  Augistin</span>, <span class="hlFld-ContribAuthor ">Steven  Do</span>, <span class="hlFld-ContribAuthor ">Kyle  Edgar</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Lori  Friedman</span>, <span class="hlFld-ContribAuthor ">Emanuela  Gancia</span>, <span class="hlFld-ContribAuthor ">Philip S.  Jackson</span>, <span class="hlFld-ContribAuthor ">Graham  Jones</span>, <span class="hlFld-ContribAuthor ">Aleksander  Kolesnikov</span>, <span class="hlFld-ContribAuthor ">Leslie B.  Lee</span>, <span class="hlFld-ContribAuthor ">John D.  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Neville  McLean</span>, <span class="hlFld-ContribAuthor ">Mario  Mörtl</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Steve  Price</span>, <span class="hlFld-ContribAuthor ">Wei Wei  Prior</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">Stefan  Steinbacher</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Wallin</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, and <span class="hlFld-ContribAuthor ">Alan G.  Olivero</span>  . </span><span class="cited-content_cbyCitation_article-title">The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 985-1002. <a href="https://doi.org/10.1021/acs.jmedchem.5b01483" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01483%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BRational%252BDesign%252Bof%252BSelective%252BBenzoxazepin%252BInhibitors%252Bof%252Bthe%252B%2525CE%2525B1-Isoform%252Bof%252BPhosphoinositide%252B3-Kinase%252BCulminating%252Bin%252Bthe%252BIdentification%252Bof%252B%252528S%252529-2-%252528%2525282-%2525281-Isopropyl-1H-1%25252C2%25252C4-triazol-5-yl%252529-5%25252C6-dihydrobenzo%25255Bf%25255Dimidazo%25255B1%25252C2-d%25255D%25255B1%25252C4%25255Doxazepin-9-yl%252529oxy%252529propanamide%252B%252528GDC-0326%252529%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D23092015%26date%3D20012016%26date%3D11022016%26date%3D07012016%26volume%3D59%26issue%3D3%26spage%3D985%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Timothy P.    Heffron </span><span class="hlFld-ContribAuthor "> Andrew    McClory </span><span class="hlFld-ContribAuthor "> Andreas    Stumpf </span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery and Process Chemistry Development of GDC-0084, a Brain Penetrating Inhibitor of PI3K and mTOR. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 147-173. <a href="https://doi.org/10.1021/bk-2016-1239.ch006" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch006%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Band%252BProcess%252BChemistry%252BDevelopment%252Bof%252BGDC-0084%25252C%252Ba%252BBrain%252BPenetrating%252BInhibitor%252Bof%252BPI3K%252Band%252BmTOR%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26spage%3D147%26epage%3D173%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nazariy T.  Pokhodylo</span>, <span class="hlFld-ContribAuthor ">Olga Ya.  Shyyka</span>, <span class="hlFld-ContribAuthor ">Vasyl S.  Matiychuk</span>, and <span class="hlFld-ContribAuthor ">Mykola D.  Obushak</span>  . </span><span class="cited-content_cbyCitation_article-title">New Convenient Strategy for Annulation of Pyrimidines to Thiophenes or Furans via the One-pot Multistep Cascade Reaction of 1H-Tetrazoles with Aliphatic Amines. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2015,</strong> <em>17 </em>
                                    (7)
                                     , 399-403. <a href="https://doi.org/10.1021/co5001376" title="DOI URL">https://doi.org/10.1021/co5001376</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/co5001376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fco5001376%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DNew%252BConvenient%252BStrategy%252Bfor%252BAnnulation%252Bof%252BPyrimidines%252Bto%252BThiophenes%252Bor%252BFurans%252Bvia%252Bthe%252BOne-pot%252BMultistep%252BCascade%252BReaction%252Bof%252B1H-Tetrazoles%252Bwith%252BAliphatic%252BAmines%26aulast%3DPokhodylo%26aufirst%3DNazariy%2BT.%26date%3D2015%26date%3D2015%26date%3D2013%26date%3D26062013%26date%3D29062015%26date%3D13072015%26date%3D19062015%26volume%3D17%26issue%3D7%26spage%3D399%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huimin  Cheng</span>, <span class="hlFld-ContribAuthor ">Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Lianwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Qingwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Jibu  Lu</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Ren</span>, and <span class="hlFld-ContribAuthor ">Ke  Ding</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification and Optimization of New Dual Inhibitors of B-Raf and Epidermal Growth Factor Receptor Kinases for Overcoming Resistance against Vemurafenib. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (6)
                                     , 2692-2703. <a href="https://doi.org/10.1021/jm500007h" title="DOI URL">https://doi.org/10.1021/jm500007h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500007h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500007h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BOptimization%252Bof%252BNew%252BDual%252BInhibitors%252Bof%252BB-Raf%252Band%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BKinases%252Bfor%252BOvercoming%252BResistance%252Bagainst%252BVemurafenib%26aulast%3DCheng%26aufirst%3DHuimin%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D03012014%26date%3D18032014%26date%3D27032014%26date%3D03032014%26volume%3D57%26issue%3D6%26spage%3D2692%26epage%3D2703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun Yuen  Leung</span>, <span class="hlFld-ContribAuthor ">Jaeok  Park</span>, <span class="hlFld-ContribAuthor ">Joris W.  De Schutter</span>, <span class="hlFld-ContribAuthor ">Michael  Sebag</span>, <span class="hlFld-ContribAuthor ">Albert M.  Berghuis</span>, and <span class="hlFld-ContribAuthor ">Youla S.  Tsantrizos</span>  . </span><span class="cited-content_cbyCitation_article-title">Thienopyrimidine Bisphosphonate (ThPBP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase: Optimization and Characterization of the Mode of Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 7939-7950. <a href="https://doi.org/10.1021/jm400946f" title="DOI URL">https://doi.org/10.1021/jm400946f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400946f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400946f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThienopyrimidine%252BBisphosphonate%252B%252528ThPBP%252529%252BInhibitors%252Bof%252Bthe%252BHuman%252BFarnesyl%252BPyrophosphate%252BSynthase%25253A%252BOptimization%252Band%252BCharacterization%252Bof%252Bthe%252BMode%252Bof%252BInhibition%26aulast%3DLeung%26aufirst%3DChun%2BYuen%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D25062013%26date%3D03102013%26date%3D24102013%26date%3D02092013%26volume%3D56%26issue%3D20%26spage%3D7939%26epage%3D7950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chudi O.  Ndubaku</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">Matthew  Baumgardner</span>, <span class="hlFld-ContribAuthor ">Nicole  Blaquiere</span>, <span class="hlFld-ContribAuthor ">Erin  Bradley</span>, <span class="hlFld-ContribAuthor ">Richard  Bull</span>, <span class="hlFld-ContribAuthor ">Steven  Do</span>, <span class="hlFld-ContribAuthor ">Jennafer  Dotson</span>, <span class="hlFld-ContribAuthor ">Danette  Dudley</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Edgar</span>, <span class="hlFld-ContribAuthor ">Lori S.  Friedman</span>, <span class="hlFld-ContribAuthor ">Richard  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Robert A.  Heald</span>, <span class="hlFld-ContribAuthor ">Aleksandr  Kolesnikov</span>, <span class="hlFld-ContribAuthor ">Leslie  Lee</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Michelle  Nannini</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Steve  Price</span>, <span class="hlFld-ContribAuthor ">Wei Wei  Prior</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Jeffery J.  Wallin</span>, <span class="hlFld-ContribAuthor ">Lan  Wang</span>, <span class="hlFld-ContribAuthor ">BinQing  Wei</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, and <span class="hlFld-ContribAuthor ">Alan G.  Olivero</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-{3-[2-(1-Isopropyl-3-methyl-1H-1,2–4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide (GDC-0032): A β-Sparing Phosphoinositide 3-Kinase Inhibitor with High Unbound Exposure and Robust in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 4597-4610. <a href="https://doi.org/10.1021/jm4003632" title="DOI URL">https://doi.org/10.1021/jm4003632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4003632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4003632%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-%25257B3-%25255B2-%2525281-Isopropyl-3-methyl-1H-1%25252C2%2525E2%252580%2525934-triazol-5-yl%252529-5%25252C6-dihydrobenzo%25255Bf%25255Dimidazo%25255B1%25252C2-d%25255D%25255B1%25252C4%25255Doxazepin-9-yl%25255D-1H-pyrazol-1-yl%25257D-2-methylpropanamide%252B%252528GDC-0032%252529%25253A%252BA%252B%2525CE%2525B2-Sparing%252BPhosphoinositide%252B3-Kinase%252BInhibitor%252Bwith%252BHigh%252BUnbound%252BExposure%252Band%252BRobust%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DNdubaku%26aufirst%3DChudi%2BO.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D11032013%26date%3D03062013%26date%3D13062013%26date%3D10052013%26volume%3D56%26issue%3D11%26spage%3D4597%26epage%3D4610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linda  Pudnika</span>, <span class="hlFld-ContribAuthor ">Ilona  Domraceva</span>, <span class="hlFld-ContribAuthor ">Thomas  Werner</span>, <span class="hlFld-ContribAuthor ">Raivis  Zalubovskis</span>, <span class="hlFld-ContribAuthor ">Aiga  Grandane</span>. </span><span class="cited-content_cbyCitation_article-title">Base-Free Catalytic Wittig-/Cross-Coupling Reaction Sequence as Short Synthetic Strategy for the Preparation of Highly Functionalized Arylbenzoxepinones. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2021,</strong> <em>54 </em><a href="https://doi.org/10.1055/a-1509-6078" title="DOI URL">https://doi.org/10.1055/a-1509-6078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/a-1509-6078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fa-1509-6078%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3DBase-Free%252BCatalytic%252BWittig-%25252FCross-Coupling%2525C2%2525A0Reaction%252BSequence%252Bas%252BShort%252BSynthetic%252BStrategy%252Bfor%252Bthe%2525C2%2525A0Preparation%2525C2%2525A0of%252BHighly%252BFunctionalized%252BArylbenzoxepinones%26aulast%3DPudnika%26aufirst%3DLinda%26date%3D2021%26date%3D2021%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed F.  Saber</span>, <span class="hlFld-ContribAuthor ">Mostafa  Sayed</span>, <span class="hlFld-ContribAuthor ">Mahmoud S.  Tolba</span>, <span class="hlFld-ContribAuthor ">Adel M.  Kamal El-Dean</span>, <span class="hlFld-ContribAuthor ">Reda  Hassanien</span>, <span class="hlFld-ContribAuthor ">Mostafa  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">A facile method for preparation and evaluation of the antimicrobial efficiency of various heterocycles containing thieno[2,3-
              d
              ]pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em>51 </em>
                                    (3)
                                     , 398-409. <a href="https://doi.org/10.1080/00397911.2020.1829645" title="DOI URL">https://doi.org/10.1080/00397911.2020.1829645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2020.1829645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2020.1829645%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DA%252Bfacile%252Bmethod%252Bfor%252Bpreparation%252Band%252Bevaluation%252Bof%252Bthe%252Bantimicrobial%252Befficiency%252Bof%252Bvarious%252Bheterocycles%252Bcontaining%252Bthieno%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%26aulast%3DSaber%26aufirst%3DAhmed%2BF.%26date%3D2021%26date%3D2020%26volume%3D51%26issue%3D3%26spage%3D398%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dilpreet Kaur  Dhiman</span>, <span class="hlFld-ContribAuthor ">Sankar Nath  Sanyal</span>, <span class="hlFld-ContribAuthor ">Vivek  Vaish</span>. </span><span class="cited-content_cbyCitation_article-title">Imatinib exhibit synergistic pleiotropy in the prevention of colorectal cancer by suppressing proinflammatory, cell survival and angiogenic signaling. </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2020,</strong> <em>76 </em>, 109803. <a href="https://doi.org/10.1016/j.cellsig.2020.109803" title="DOI URL">https://doi.org/10.1016/j.cellsig.2020.109803</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2020.109803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2020.109803%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DImatinib%252Bexhibit%252Bsynergistic%252Bpleiotropy%252Bin%252Bthe%252Bprevention%252Bof%252Bcolorectal%252Bcancer%252Bby%252Bsuppressing%252Bproinflammatory%25252C%252Bcell%252Bsurvival%252Band%252Bangiogenic%252Bsignaling%26aulast%3DDhiman%26aufirst%3DDilpreet%2BKaur%26date%3D2020%26volume%3D76%26spage%3D109803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingzhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Hyunbum  Jang</span>, <span class="hlFld-ContribAuthor ">Ruth  Nussinov</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K inhibitors: review and new strategies. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (23)
                                     , 5855-5865. <a href="https://doi.org/10.1039/D0SC01676D" title="DOI URL">https://doi.org/10.1039/D0SC01676D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC01676D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC01676D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DPI3K%252Binhibitors%25253A%252Breview%252Band%252Bnew%252Bstrategies%26aulast%3DZhang%26aufirst%3DMingzhen%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D23%26spage%3D5855%26epage%3D5865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Jenninfer  LeCouter</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Jacob  Chen</span>, <span class="hlFld-ContribAuthor ">Jay  Cheng</span>, <span class="hlFld-ContribAuthor ">Tom  Lee</span>, <span class="hlFld-ContribAuthor ">Joe  Lubach</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Sheerin  Shahidi-Latham</span>, <span class="hlFld-ContribAuthor ">Cristine  Quiason</span>, <span class="hlFld-ContribAuthor ">Eric  Solon</span>, <span class="hlFld-ContribAuthor ">Matthew  Wright</span>, <span class="hlFld-ContribAuthor ">Cornelis E.C.A.  Hop</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of Antineovascularization Activity and Ocular Pharmacokinetics of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GNE-947. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2020,</strong> <em>48 </em>
                                    (5)
                                     , 408-419. <a href="https://doi.org/10.1124/dmd.119.089763" title="DOI URL">https://doi.org/10.1124/dmd.119.089763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.119.089763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.119.089763%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DCharacterization%252Bof%252BAntineovascularization%252BActivity%252Band%252BOcular%252BPharmacokinetics%252Bof%252BPhosphoinositide%252B3-Kinase%25252FMammalian%252BTarget%252Bof%252BRapamycin%252BInhibitor%252BGNE-947%26aulast%3DLiu%26aufirst%3DXingrong%26date%3D2020%26date%3D2020%26volume%3D48%26issue%3D5%26spage%3D408%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiuyun  Sun</span>, <span class="hlFld-ContribAuthor ">Hongying  Gao</span>, <span class="hlFld-ContribAuthor ">Yiqing  Yang</span>, <span class="hlFld-ContribAuthor ">Ming  He</span>, <span class="hlFld-ContribAuthor ">Yue  Wu</span>, <span class="hlFld-ContribAuthor ">Yugang  Song</span>, <span class="hlFld-ContribAuthor ">Yan  Tong</span>, <span class="hlFld-ContribAuthor ">Yu  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">PROTACs: great opportunities for academia and industry. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2019,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-019-0101-6" title="DOI URL">https://doi.org/10.1038/s41392-019-0101-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-019-0101-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-019-0101-6%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DPROTACs%25253A%252Bgreat%252Bopportunities%252Bfor%252Bacademia%252Band%252Bindustry%26aulast%3DSun%26aufirst%3DXiuyun%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasa Rao  Dasari</span>, <span class="hlFld-ContribAuthor ">Subbaiah  Tondepu</span>, <span class="hlFld-ContribAuthor ">Lakshmana Rao  Vadali</span>, <span class="hlFld-ContribAuthor ">Nareshvarma  Seelam</span>. </span><span class="cited-content_cbyCitation_article-title">Retracted
              : Design, Synthesis and Molecular Modeling of Nonsteroidal Anti‐inflammatory Drugs Tagged Substituted 1,2,3‐Triazole Derivatives and Evaluation of Their Biological Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2019,</strong> <em>56 </em>
                                    (4)
                                     , 1318-1329. <a href="https://doi.org/10.1002/jhet.3503" title="DOI URL">https://doi.org/10.1002/jhet.3503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3503%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DRetracted%252B%25253A%252BDesign%25252C%252BSynthesis%252Band%252BMolecular%252BModeling%252Bof%252BNonsteroidal%252BAnti%2525E2%252580%252590inflammatory%252BDrugs%252BTagged%252BSubstituted%252B1%25252C2%25252C3%2525E2%252580%252590Triazole%252BDerivatives%252Band%252BEvaluation%252Bof%252BTheir%252BBiological%252BActivities%26aulast%3DDasari%26aufirst%3DSrinivasa%2BRao%26date%3D2019%26date%3D2019%26volume%3D56%26issue%3D4%26spage%3D1318%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle  Miller</span>, <span class="hlFld-ContribAuthor ">Philip  Thompson</span>, <span class="hlFld-ContribAuthor ">Sandra  Gabelli</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Determinants of Isoform Selectivity in PI3K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (3)
                                     , 82. <a href="https://doi.org/10.3390/biom9030082" title="DOI URL">https://doi.org/10.3390/biom9030082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9030082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9030082%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DStructural%252BDeterminants%252Bof%252BIsoform%252BSelectivity%252Bin%252BPI3K%252BInhibitors%26aulast%3DMiller%26aufirst%3DMichelle%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D3%26spage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Triloknadh  Settypalli</span>, <span class="hlFld-ContribAuthor ">Venkata Rao  Chunduri</span>, <span class="hlFld-ContribAuthor ">Nagaraju  Kerru</span>, <span class="hlFld-ContribAuthor ">Hari Krishna  Nallapaneni</span>, <span class="hlFld-ContribAuthor ">Venkata Ramaiah  Chintha</span>, <span class="hlFld-ContribAuthor ">Trinath  Daggupati</span>, <span class="hlFld-ContribAuthor ">Suneetha  Yeguvapalli</span>, <span class="hlFld-ContribAuthor ">Rajendra  Wudayagiri</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Neuroprotective and Antibacterial Activities of 1,2,4‐Triazolo[3,4‐b]1,3,4‐thiadiazole Linked Thieno[2,3‐d]pyrimidine Derivatives and In Silico Docking Studies. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (5)
                                     , 1627-1634. <a href="https://doi.org/10.1002/slct.201803917" title="DOI URL">https://doi.org/10.1002/slct.201803917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201803917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201803917%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BNeuroprotective%252Band%252BAntibacterial%252BActivities%252Bof%252B1%25252C2%25252C4%2525E2%252580%252590Triazolo%25255B3%25252C4%2525E2%252580%252590b%25255D1%25252C3%25252C4%2525E2%252580%252590thiadiazole%252BLinked%252BThieno%25255B2%25252C3%2525E2%252580%252590d%25255Dpyrimidine%252BDerivatives%252Band%252BIn%252BSilico%252BDocking%252BStudies%26aulast%3DSettypalli%26aufirst%3DTriloknadh%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D5%26spage%3D1627%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun  Li</span>, <span class="hlFld-ContribAuthor ">Xunhua  Lu</span>, <span class="hlFld-ContribAuthor ">Yuanyong  Yang</span>, <span class="hlFld-ContribAuthor ">Shenggang  Yang</span>, <span class="hlFld-ContribAuthor ">Lin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Ionic liquid promoted synthesis of heterocycle-fused pyrimidine-2,4(1H,3H)-diones utilising CO2. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (25)
                                     , 2463-2466. <a href="https://doi.org/10.1016/j.tetlet.2018.05.043" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.05.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.05.043%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DIonic%252Bliquid%252Bpromoted%252Bsynthesis%252Bof%252Bheterocycle-fused%252Bpyrimidine-2%25252C4%2525281H%25252C3H%252529-diones%252Butilising%252BCO2%26aulast%3DLi%26aufirst%3DChun%26date%3D2018%26volume%3D59%26issue%3D25%26spage%3D2463%26epage%3D2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlu  Li</span>, <span class="hlFld-ContribAuthor ">Chunmei  Gao</span>, <span class="hlFld-ContribAuthor ">Lei  Zhao</span>, <span class="hlFld-ContribAuthor ">Zigao  Yuan</span>, <span class="hlFld-ContribAuthor ">Yuzong  Chen</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Phthalimide conjugations for the degradation of oncogenic PI3K. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 237-247. <a href="https://doi.org/10.1016/j.ejmech.2018.03.066" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.066%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhthalimide%252Bconjugations%252Bfor%252Bthe%252Bdegradation%252Bof%252Boncogenic%252BPI3K%26aulast%3DLi%26aufirst%3DWenlu%26date%3D2018%26volume%3D151%26spage%3D237%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiuyan  Yang</span>, <span class="hlFld-ContribAuthor ">Xi  Zhang</span>, <span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Kun  Song</span>, <span class="hlFld-ContribAuthor ">Xuefen  Li</span>, <span class="hlFld-ContribAuthor ">Meilang  Huang</span>, <span class="hlFld-ContribAuthor ">Linghua  Meng</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights into PI3K Inhibitor Design using X-ray Structures of PI3Kα Complexed with a Potent Lead Compound. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-15260-5" title="DOI URL">https://doi.org/10.1038/s41598-017-15260-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-15260-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-15260-5%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DNew%252BInsights%252Binto%252BPI3K%252BInhibitor%252BDesign%252Busing%252BX-ray%252BStructures%252Bof%252BPI3K%2525CE%2525B1%252BComplexed%252Bwith%252Ba%252BPotent%252BLead%252BCompound%26aulast%3DYang%26aufirst%3DXiuyan%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amna  Ghith</span>, <span class="hlFld-ContribAuthor ">Nasser S.M.  Ismail</span>, <span class="hlFld-ContribAuthor ">Khairia  Youssef</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2017,</strong> <em>350 </em>
                                    (11)
                                     , 1700242. <a href="https://doi.org/10.1002/ardp.201700242" title="DOI URL">https://doi.org/10.1002/ardp.201700242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201700242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201700242%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DMedicinal%252BAttributes%252Bof%252BThienopyrimidine%252BBased%252BScaffold%252BTargeting%252BTyrosine%252BKinases%252Band%252BTheir%252BPotential%252BAnticancer%252BActivities%26aulast%3DGhith%26aufirst%3DAmna%26date%3D2017%26date%3D2017%26volume%3D350%26issue%3D11%26spage%3D1700242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinqin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Li</span>, <span class="hlFld-ContribAuthor ">Chengyu  Sun</span>, <span class="hlFld-ContribAuthor ">Binliang  Zhang</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (11)
                                     , 1870. <a href="https://doi.org/10.3390/molecules22111870" title="DOI URL">https://doi.org/10.3390/molecules22111870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22111870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22111870%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252B4-Morpholino-7%25252C8-Dihydro-5H-Thiopyrano%25255B4%25252C3-d%25255Dpyrimidine%252BDerivatives%252BBearing%252BPyrazoline%252BScaffold%26aulast%3DWang%26aufirst%3DQinqin%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D11%26spage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B.  Wilding</span>, <span class="hlFld-ContribAuthor ">N.  Klempier</span>. </span><span class="cited-content_cbyCitation_article-title">Newest Developments in the Preparation of Thieno[2,3-
              d
              ]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Preparations and Procedures International</span><span> <strong>2017,</strong> <em>49 </em>
                                    (3)
                                     , 183-215. <a href="https://doi.org/10.1080/00304948.2017.1320513" title="DOI URL">https://doi.org/10.1080/00304948.2017.1320513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00304948.2017.1320513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00304948.2017.1320513%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Preparations%2520and%2520Procedures%2520International%26atitle%3DNewest%252BDevelopments%252Bin%252Bthe%252BPreparation%252Bof%252BThieno%25255B2%25252C3-%252Bd%252B%25255Dpyrimidines%26aulast%3DWilding%26aufirst%3DB.%26date%3D2017%26date%3D2017%26volume%3D49%26issue%3D3%26spage%3D183%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-zhu  Wan</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Guan-lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xin-guang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 7181-7200. <a href="https://doi.org/10.18632/oncotarget.12742" title="DOI URL">https://doi.org/10.18632/oncotarget.12742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12742%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRecent%252Bdevelopment%252Bof%252BATP-competitive%252Bsmall%252Bmolecule%252Bphosphatidylinostitol-3-kinase%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DLiu%26aufirst%3DYu%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D7181%26epage%3D7200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven T.  Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Isoform Selective PI3K Inhibitors for Treating Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 333-333. <a href="https://doi.org/10.1007/7355_2016_27" title="DOI URL">https://doi.org/10.1007/7355_2016_27</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2016_27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2016_27%26sid%3Dliteratum%253Aachs%26atitle%3DIsoform%252BSelective%252BPI3K%252BInhibitors%252Bfor%252BTreating%252BCancer%26aulast%3DStaben%26aufirst%3DSteven%2BT.%26date%3D2017%26spage%3D333%26epage%3D333%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCancer%252BII%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2018%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamal  Sweidan</span>, <span class="hlFld-ContribAuthor ">Dima A.  Sabbah</span>, <span class="hlFld-ContribAuthor ">Sanaa  Bardaweel</span>, <span class="hlFld-ContribAuthor ">Khadeja Abu  Dush</span>, <span class="hlFld-ContribAuthor ">Ghassan Abu  Sheikha</span>, <span class="hlFld-ContribAuthor ">Mohammad S.  Mubarak</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-aided design, synthesis, and biological evaluation of new indole-2-carboxamide derivatives as PI3Kα/EGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (11)
                                     , 2685-2690. <a href="https://doi.org/10.1016/j.bmcl.2016.04.011" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DComputer-aided%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252Bindole-2-carboxamide%252Bderivatives%252Bas%252BPI3K%2525CE%2525B1%25252FEGFR%252Binhibitors%26aulast%3DSweidan%26aufirst%3DKamal%26date%3D2016%26volume%3D26%26issue%3D11%26spage%3D2685%26epage%3D2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia-Lin  Guo</span>, <span class="hlFld-ContribAuthor ">Yun-Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Ya-Zhong  Pei</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 3-(piperidin-4-yl)isoxazolo[4,5-d]pyrimidine derivatives as novel PI3Kδ inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2015,</strong> <em>26 </em>
                                    (10)
                                     , 1283-1288. <a href="https://doi.org/10.1016/j.cclet.2015.05.041" title="DOI URL">https://doi.org/10.1016/j.cclet.2015.05.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2015.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2015.05.041%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3-%252528piperidin-4-yl%252529isoxazolo%25255B4%25252C5-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bnovel%252BPI3K%2525CE%2525B4%252Binhibitors%26aulast%3DGuo%26aufirst%3DJia-Lin%26date%3D2015%26volume%3D26%26issue%3D10%26spage%3D1283%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khurshed  Bozorov</span>, <span class="hlFld-ContribAuthor ">Jiang-Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Burkhon  Elmuradov</span>, <span class="hlFld-ContribAuthor ">Apar  Pataer</span>, <span class="hlFld-ContribAuthor ">Haji A.  Aisa</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 552-573. <a href="https://doi.org/10.1016/j.ejmech.2015.08.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Bregarding%252Bthe%252Buse%252Bof%252Bthieno%25255B2%25252C3-d%25255Dpyrimidin-4-one%252Bderivatives%252Bin%252Bmedicinal%252Bchemistry%25252C%252Bwith%252Ba%252Bfocus%252Bon%252Btheir%252Bsynthesis%252Band%252Banticancer%252Bproperties%26aulast%3DBozorov%26aufirst%3DKhurshed%26date%3D2015%26volume%3D102%26spage%3D552%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dima A.  Sabbah</span>, <span class="hlFld-ContribAuthor ">Musaab  Saada</span>, <span class="hlFld-ContribAuthor ">Reema Abu  Khalaf</span>, <span class="hlFld-ContribAuthor ">Sanaa  Bardaweel</span>, <span class="hlFld-ContribAuthor ">Kamal  Sweidan</span>, <span class="hlFld-ContribAuthor ">Tariq  Al-Qirim</span>, <span class="hlFld-ContribAuthor ">Amani  Al-Zughier</span>, <span class="hlFld-ContribAuthor ">Heba Abdel  Halim</span>, <span class="hlFld-ContribAuthor ">Ghassan Abu  Sheikha</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling based approach, synthesis, and cytotoxic activity of novel benzoin derivatives targeting phosphoinostide 3-kinase (PI3Kα). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (16)
                                     , 3120-3124. <a href="https://doi.org/10.1016/j.bmcl.2015.06.011" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMolecular%252Bmodeling%252Bbased%252Bapproach%25252C%252Bsynthesis%25252C%252Band%252Bcytotoxic%252Bactivity%252Bof%252Bnovel%252Bbenzoin%252Bderivatives%252Btargeting%252Bphosphoinostide%252B3-kinase%252B%252528PI3K%2525CE%2525B1%252529%26aulast%3DSabbah%26aufirst%3DDima%2BA.%26date%3D2015%26volume%3D25%26issue%3D16%26spage%3D3120%26epage%3D3124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Yin</span>, <span class="hlFld-ContribAuthor ">Yan-Qing  Zhang</span>, <span class="hlFld-ContribAuthor ">Biao  Jin</span>, <span class="hlFld-ContribAuthor ">Shao  Sha</span>, <span class="hlFld-ContribAuthor ">Xun  Wu</span>, <span class="hlFld-ContribAuthor ">Chetan B.  Sangani</span>, <span class="hlFld-ContribAuthor ">She-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Fang  Qiao</span>, <span class="hlFld-ContribAuthor ">Ai-Min  Lu</span>, <span class="hlFld-ContribAuthor ">Peng-Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">6,7-Dihydrobenzo[f]benzo[4,5]imidazo[1,2-d][1,4]oxazepine derivatives as selective inhibitors of PI3Kα. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (6)
                                     , 1231-1240. <a href="https://doi.org/10.1016/j.bmc.2015.01.052" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.01.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.01.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.01.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D6%25252C7-Dihydrobenzo%25255Bf%25255Dbenzo%25255B4%25252C5%25255Dimidazo%25255B1%25252C2-d%25255D%25255B1%25252C4%25255Doxazepine%252Bderivatives%252Bas%252Bselective%252Binhibitors%252Bof%252BPI3K%2525CE%2525B1%26aulast%3DYin%26aufirst%3DYong%26date%3D2015%26volume%3D23%26issue%3D6%26spage%3D1231%26epage%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nitipol  Srimongkolpithak</span>, <span class="hlFld-ContribAuthor ">Sandeep  Sundriyal</span>, <span class="hlFld-ContribAuthor ">Fengling  Li</span>, <span class="hlFld-ContribAuthor ">Masoud  Vedadi</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Fuchter</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2014,</strong> <em>5 </em>
                                    (12)
                                     , 1821-1828. <a href="https://doi.org/10.1039/C4MD00274A" title="DOI URL">https://doi.org/10.1039/C4MD00274A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00274A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00274A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIdentification%252Bof%252B2%25252C4-diamino-6%25252C7-dimethoxyquinoline%252Bderivatives%252Bas%252BG9a%252Binhibitors%26aulast%3DSrimongkolpithak%26aufirst%3DNitipol%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D12%26spage%3D1821%26epage%3D1828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Bugge</span>, <span class="hlFld-ContribAuthor ">E. M.  Skjønsfjell</span>, <span class="hlFld-ContribAuthor ">F. B.  Willumsen</span>, <span class="hlFld-ContribAuthor ">E.  Sundby</span>, <span class="hlFld-ContribAuthor ">B. H.  Hoff</span>. </span><span class="cited-content_cbyCitation_article-title">Improved and Scalable Preparation of 6-Bromo-4-Chlorothieno[2,3-d]Pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2014,</strong> <em>50 </em>
                                    (8)
                                     , 1177-1187. <a href="https://doi.org/10.1007/s10593-014-1579-z" title="DOI URL">https://doi.org/10.1007/s10593-014-1579-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-014-1579-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-014-1579-z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DImproved%252Band%252BScalable%252BPreparation%252Bof%252B6-Bromo-4-Chlorothieno%25255B2%25252C3-d%25255DPyrimidine%26aulast%3DBugge%26aufirst%3DS.%26date%3D2014%26date%3D2014%26volume%3D50%26issue%3D8%26spage%3D1177%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng Jun  Wang</span>, <span class="hlFld-ContribAuthor ">De Yun  Zeng</span>, <span class="hlFld-ContribAuthor ">Shan Shan  Gong</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">An Unexpected Synthesis of 2H-Benzimidazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2014,</strong> <em>1023 </em>, 43-46. <a href="https://doi.org/10.4028/www.scientific.net/AMR.1023.43" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.1023.43</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.1023.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.1023.43%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DAn%252BUnexpected%252BSynthesis%252Bof%252B2H-Benzimidazole%252BDerivatives%26aulast%3DWang%26aufirst%3DCheng%2BJun%26date%3D2014%26date%3D2014%26volume%3D1023%26spage%3D43%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujeong  Jeong</span>, <span class="hlFld-ContribAuthor ">Daeil  Kwon</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Selective and potent small-molecule inhibitors of PI3Ks. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (7)
                                     , 737-756. <a href="https://doi.org/10.4155/fmc.14.28" title="DOI URL">https://doi.org/10.4155/fmc.14.28</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.28%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252Band%252Bpotent%252Bsmall-molecule%252Binhibitors%252Bof%252BPI3Ks%26aulast%3DJeong%26aufirst%3DYujeong%26date%3D2014%26volume%3D6%26issue%3D7%26spage%3D737%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nazariy T.  Pokhodylo</span>, <span class="hlFld-ContribAuthor ">Olga Y.  Shyyka</span>, <span class="hlFld-ContribAuthor ">Mykola D.  Obushak</span>. </span><span class="cited-content_cbyCitation_article-title">Facile and Efficient One-Pot Procedure for Thieno[2,3-
              e
              ][1,2,3]triazolo[1,5-
              a
              ]pyrimidines Preparation. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2014,</strong> <em>44 </em>
                                    (7)
                                     , 1002-1006. <a href="https://doi.org/10.1080/00397911.2013.840729" title="DOI URL">https://doi.org/10.1080/00397911.2013.840729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2013.840729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2013.840729%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DFacile%252Band%252BEfficient%252BOne-Pot%252BProcedure%252Bfor%252BThieno%25255B2%25252C3-%252Be%252B%25255D%25255B1%25252C2%25252C3%25255Dtriazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrimidines%252BPreparation%26aulast%3DPokhodylo%26aufirst%3DNazariy%2BT.%26date%3D2014%26date%3D2014%26volume%3D44%26issue%3D7%26spage%3D1002%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Rewcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the Phosphatidylinositol 3-Kinase Pathway. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 449-478. <a href="https://doi.org/10.1016/B978-0-12-396521-9.00015-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-396521-9.00015-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396521-9.00015-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396521-9.00015-2%26sid%3Dliteratum%253Aachs%26atitle%3DInhibitors%252Bof%252Bthe%252BPhosphatidylinositol%252B3-Kinase%252BPathway%26aulast%3DDenny%26aufirst%3DWilliam%2BA.%26date%3D2014%26spage%3D449%26epage%3D478%26pub%3DElsevier%26atitle%3DCancer%252BDrug%252BDesign%252Band%252BDiscovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  Welker</span>, <span class="hlFld-ContribAuthor ">George  Kulik</span>. </span><span class="cited-content_cbyCitation_article-title">Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (14)
                                     , 4063-4091. <a href="https://doi.org/10.1016/j.bmc.2013.04.083" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.04.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.04.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.04.083%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bsyntheses%252Bof%252BPI3K%25252FAkt%25252FmTOR%252Bsignaling%252Bpathway%252Binhibitors%26aulast%3DWelker%26aufirst%3DMark%2BE.%26date%3D2013%26volume%3D21%26issue%3D14%26spage%3D4063%26epage%3D4091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">Chudi  Ndubaku</span>, <span class="hlFld-ContribAuthor ">Nicole  Blaquiere</span>, <span class="hlFld-ContribAuthor ">Marcia  Belvin</span>, <span class="hlFld-ContribAuthor ">Richard J.  Bull</span>, <span class="hlFld-ContribAuthor ">Danette  Dudley</span>, <span class="hlFld-ContribAuthor ">Kyle  Edgar</span>, <span class="hlFld-ContribAuthor ">Daniel  Gray</span>, <span class="hlFld-ContribAuthor ">Robert  Heald</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Graham E.  Jones</span>, <span class="hlFld-ContribAuthor ">Mark  Jones</span>, <span class="hlFld-ContribAuthor ">Aleks  Kolesnikov</span>, <span class="hlFld-ContribAuthor ">Leslie  Lee</span>, <span class="hlFld-ContribAuthor ">John  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Neville J.  McLean</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Alan G.  Olivero</span>, <span class="hlFld-ContribAuthor ">Rachel  Ord</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Stephen  Price</span>, <span class="hlFld-ContribAuthor ">Wei Wei  Prior</span>, <span class="hlFld-ContribAuthor ">Lionel  Rouge</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Jeff  Wallin</span>, <span class="hlFld-ContribAuthor ">Lan  Wang</span>, <span class="hlFld-ContribAuthor ">BinQing  Wei</span>, <span class="hlFld-ContribAuthor ">Christian  Weismann</span>, <span class="hlFld-ContribAuthor ">Ping  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase β isoform. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (9)
                                     , 2606-2613. <a href="https://doi.org/10.1016/j.bmcl.2013.02.102" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.02.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.02.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.02.102%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bthiazolobenzoxepin%252BPI3-kinase%252Binhibitors%252Bthat%252Bspare%252Bthe%252BPI3-kinase%252B%2525CE%2525B2%252Bisoform%26aulast%3DStaben%26aufirst%3DSteven%2BT.%26date%3D2013%26volume%3D23%26issue%3D9%26spage%3D2606%26epage%3D2613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun-Yuen  Leung</span>, <span class="hlFld-ContribAuthor ">Adrienne M.  Langille</span>, <span class="hlFld-ContribAuthor ">John  Mancuso</span>, <span class="hlFld-ContribAuthor ">Youla S.  Tsantrizos</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of thienopyrimidine-based inhibitors of the human farnesyl pyrophosphate synthase—Parallel synthesis of analogs via a trimethylsilyl ylidene intermediate. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (8)
                                     , 2229-2240. <a href="https://doi.org/10.1016/j.bmc.2013.02.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.02.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.02.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthienopyrimidine-based%252Binhibitors%252Bof%252Bthe%252Bhuman%252Bfarnesyl%252Bpyrophosphate%252Bsynthase%2525E2%252580%252594Parallel%252Bsynthesis%252Bof%252Banalogs%252Bvia%252Ba%252Btrimethylsilyl%252Bylidene%252Bintermediate%26aulast%3DLeung%26aufirst%3DChun-Yuen%26date%3D2013%26volume%3D21%26issue%3D8%26spage%3D2229%26epage%3D2240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Isoform Selective PI3K-beta Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2013,</strong> <em>31 </em>
                                    (3)
                                     , 299-303. <a href="https://doi.org/10.1002/cjoc.201300030" title="DOI URL">https://doi.org/10.1002/cjoc.201300030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201300030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201300030%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DIsoform%252BSelective%252BPI3K-beta%252BInhibitors%26aulast%3DLin%26aufirst%3DHong%26date%3D2013%26date%3D2013%26volume%3D31%26issue%3D3%26spage%3D299%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">Nicole  Blaquiere</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Aleksandr  Kolesnikov</span>, <span class="hlFld-ContribAuthor ">Steven  Do</span>, <span class="hlFld-ContribAuthor ">Erin K.  Bradley</span>, <span class="hlFld-ContribAuthor ">Jenna  Dotson</span>, <span class="hlFld-ContribAuthor ">Richard  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">John  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Alan G.  Olivero</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Lionel  Rouge</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">BinQing  Wei</span>, <span class="hlFld-ContribAuthor ">Christian  Wiesmann</span>, <span class="hlFld-ContribAuthor ">Ping  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (3)
                                     , 897-901. <a href="https://doi.org/10.1016/j.bmcl.2012.10.121" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.10.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.10.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.10.121%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCis-Amide%252Bisosteric%252Breplacement%252Bin%252Bthienobenzoxepin%252Binhibitors%252Bof%252BPI3-kinase%26aulast%3DStaben%26aufirst%3DSteven%2BT.%26date%3D2013%26volume%3D23%26issue%3D3%26spage%3D897%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dima A.  Sabbah</span>, <span class="hlFld-ContribAuthor ">Neka A.  Simms</span>, <span class="hlFld-ContribAuthor ">Wang  Wang</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Dong</span>, <span class="hlFld-ContribAuthor ">Edward L.  Ezell</span>, <span class="hlFld-ContribAuthor ">Michael G.  Brattain</span>, <span class="hlFld-ContribAuthor ">Jonathan L.  Vennerstrom</span>, <span class="hlFld-ContribAuthor ">Haizhen A.  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (24)
                                     , 7175-7183. <a href="https://doi.org/10.1016/j.bmc.2012.09.059" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.09.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.09.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.09.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DN-Phenyl-4-hydroxy-2-quinolone-3-carboxamides%252Bas%252Bselective%252Binhibitors%252Bof%252Bmutant%252BH1047R%252Bphosphoinositide-3-kinase%252B%252528PI3K%2525CE%2525B1%252529%26aulast%3DSabbah%26aufirst%3DDima%2BA.%26date%3D2012%26volume%3D20%26issue%3D24%26spage%3D7175%26epage%3D7183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Kevin  Yang</span>, <span class="hlFld-ContribAuthor ">Nobuko  Nishimura</span>, <span class="hlFld-ContribAuthor ">Yunxin  Bo</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Sean  Caenepeel</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Freeman</span>, <span class="hlFld-ContribAuthor ">John D.  McCarter</span>, <span class="hlFld-ContribAuthor ">Erin L.  Mullady</span>, <span class="hlFld-ContribAuthor ">Tisha San  Miguel</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhang</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Jian  Jiang</span>, <span class="hlFld-ContribAuthor ">Raju  Subramanian</span>, <span class="hlFld-ContribAuthor ">Paul E.  Hughes</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (17)
                                     , 5714-5720. <a href="https://doi.org/10.1016/j.bmcl.2012.06.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.06.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.06.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.06.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bdual%252BPI3K%25252FmTOR%252Binhibitors%252Bbased%252Bon%252Ba%252B4-amino-6-methyl-1%25252C3%25252C5-triazine%252Bsulfonamide%252Bscaffold%26aulast%3DWurz%26aufirst%3DRyan%2BP.%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5714%26epage%3D5720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaohua  Zheng</span>, <span class="hlFld-ContribAuthor ">Syazwani I.  Amran</span>, <span class="hlFld-ContribAuthor ">Jiuxiang  Zhu</span>, <span class="hlFld-ContribAuthor ">Oleg  Schmidt-Kittler</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Kinzler</span>, <span class="hlFld-ContribAuthor ">Bert  Vogelstein</span>, <span class="hlFld-ContribAuthor ">Peter R.  Shepherd</span>, <span class="hlFld-ContribAuthor ">Philip E.  Thompson</span>, <span class="hlFld-ContribAuthor ">Ian G.  Jennings</span>. </span><span class="cited-content_cbyCitation_article-title">Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysis. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2012,</strong> <em>444 </em>
                                    (3)
                                     , 529-535. <a href="https://doi.org/10.1042/BJ20120499" title="DOI URL">https://doi.org/10.1042/BJ20120499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BJ20120499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBJ20120499%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DDefinition%252Bof%252Bthe%252Bbinding%252Bmode%252Bof%252Ba%252Bnew%252Bclass%252Bof%252Bphosphoinositide%252B3-kinase%252B%2525CE%2525B1-selective%252Binhibitors%252Busing%252Bin%252Bvitro%252Bmutagenesis%252Bof%252Bnon-conserved%252Bamino%252Bacids%252Band%252Bkinetic%252Banalysis%26aulast%3DZheng%26aufirst%3DZhaohua%26date%3D2012%26date%3D2012%26volume%3D444%26issue%3D3%26spage%3D529%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard A.  Norman</span>, <span class="hlFld-ContribAuthor ">Dorin  Toader</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Ferguson</span>. </span><span class="cited-content_cbyCitation_article-title">Structural approaches to obtain kinase selectivity. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2012,</strong> <em>33 </em>
                                    (5)
                                     , 273-278. <a href="https://doi.org/10.1016/j.tips.2012.03.005" title="DOI URL">https://doi.org/10.1016/j.tips.2012.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2012.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2012.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DStructural%252Bapproaches%252Bto%252Bobtain%252Bkinase%252Bselectivity%26aulast%3DNorman%26aufirst%3DRichard%2BA.%26date%3D2012%26volume%3D33%26issue%3D5%26spage%3D273%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0017.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cocrystal structure of <b>1</b> in PI3Kγ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS">3DBS</a>). Residues nearest the active site that are different between PI3Kα and at least one other isoform are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Model of <b>1</b> in PI3Kα. Hydrogen bonds with Ser773 backbone NH and Arg770 are illustrated. (b) Model of <b>1</b> in PI3Kβ, illustrating hydrogen bond with Asp780 backbone NH but suboptimal distance to Lys777. (c) Model of <b>6</b> in PI3Kα. Hydrogen bonds with Ser773 backbone NH and Arg770 are illustrated. (d) Model of <b>6</b> in PI3Kβ, illustrating suboptimal hydrogen bonding distances to Asp780 backbone NH and Lys777. (e) Overlay of <b>1</b> (green), <b>6</b> (magenta), and <b>7</b> (lavender), with morpholine and indazole rigidly superimposed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Cocrystal structure of benzoxepin <b>21</b> in PI3Kγ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R7R">3R7R</a>). (b) Overlay of <b>1</b> in the cocrystal structure of <b>21</b> in PI3Kγ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Correlation of the position of substitution on the benzoxepin core and level of PI3Kβ/PI3Kα selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Poisson–Boltzmann electrostatic potentials plotted on the solvent accessible surfaces of PI3Kα crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HIZ">3HIZ</a>) (a) and PI3Kβ homology model (b). Compound <b>21</b> is depicted for reference.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0015.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. A cocrystal structure of PI3Kγ and <b>33</b> (PDB code <a href="https://3T8M" class="ext-link">3T8M</a>) shows a hydrogen bond between the piperazineamide carbonyl and Ser806.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DPPA, Et<sub>3</sub>N, <i>t</i>-BuOH; (b) <i>n</i>-BuLi, TMEDA, CO(OMe)<sub>2</sub>; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (d) ClO<sub>2</sub>SNCO, CH<sub>2</sub>Cl<sub>2</sub>; (e) 1.5 M NaOH in MeOH; (f) POCl<sub>3</sub>, <i>i</i>-Pr<sub>2</sub>NEtN; (g) morpholine, MeOH; (h) <i>n</i>-BuLi, THF, −78 °C, DMF; (i) piperazinemethanesulfonamide HCl, CH(OMe)<sub>3</sub>, DCE; (j) NaBH(OAc)<sub>3</sub>; (k) indazole-4-boronic acid pinacol ester, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, toluene/EtOH/water (4:2:1).</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClSO<sub>2</sub>NC, CH<sub>2</sub>Cl<sub>2</sub>, aq NaOH, aq HCl; (b) POCl<sub>3</sub>, CH<sub>3</sub>CN, reflux, 24 h; (c) morpholine, MeOH, 1 h; (d) <i>n</i>-BuLi, THF, −78 °C, DMF; (e) NaBH<sub>4</sub>, MeOH; (f) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (g) HNRR′, <i>i</i>-Pr<sub>2</sub>NEt, THF; (h) 2-aminopyrimidine-5-boronic acid pinacol ester, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M aq KOAc, CH<sub>3</sub>CN, microwave, 150 °C, 15 min; (i) HCl, MeOH; (j) MeSO<sub>2</sub>Cl, Et<sub>3</sub>N, THF; (k) <i>n</i>-BuLi, THF, −78 °C, I<sub>2</sub>; (l) 3-SO<sub>2</sub>Me phenylboronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1 M aq Na<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, microwave, 100 °C, 10 min.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/medium/jm-2011-007084_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm2007084/production/images/large/jm-2011-007084_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007084&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl 4-bromobutanoate, K<sub>2</sub>CO<sub>3</sub>, cat. NaI, acetone; (b) LiOH, H<sub>2</sub>O, THF; (c) PPA, toluene; (d) POCl<sub>3</sub>, DMF; (e) K<sub>2</sub>CO<sub>3</sub>, methyl thioglycolate, DMF; (f) LiOH, H<sub>2</sub>O, THF; (g) SOCl<sub>2</sub>; (h) <i>N</i>-methyl-2-chloroaniline, NEt<sub>3</sub>, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (i) aryl boronate, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1 M aq Na<sub>2</sub>CO<sub>3</sub>, DMF; (j) CuCN, DMF; (k) NH<sub>2</sub>COCH<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub>, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, dioxane; (l) Mo(CO)<sub>6</sub>, MeOH, THF, amine, Herrmann’s catalyst, DBU.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i100">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="note"><p class="first last">Recent reviews that discuss the isoform selectivity of PI3K inhibitors include the following: </p></div><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_contrib-group">Marone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cmiljanovic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span> </span><span class="NLM_article-title">Targeting Phosphoinositide 3-Kinase: Moving towards Therapy</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1784</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1784&publication_year=2008&pages=159-185&author=R.+Maroneauthor=V.+Cmiljanovicauthor=B.+Gieseauthor=M.+P.+Wymann&title=Targeting+Phosphoinositide+3-Kinase%3A+Moving+towards+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DCmiljanovic%26aufirst%3DV.%26aulast%3DGiese%26aufirst%3DB.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DTargeting%2520Phosphoinositide%25203-Kinase%253A%2520Moving%2520towards%2520Therapy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1784%26spage%3D159%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Chemically Targetting the PI3K Family</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1042%2FBST0350245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=17371250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=245-249&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Chemically+Targetting+the+PI3K+Family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically targeting the PI3K family</span></div><div class="casAuthors">Knight, Z. A.; Shokat, K. M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-249</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  PI3K (phosphoinositide 3-kinase) is a key regulator of cell growth, metab., and survival.  The frequent activation of the PI3K pathway in cancer has stimulated widespread interest in identifying potent and selective inhibitors of PI3K isoforms.  The present paper highlights recent progress in identifying such mols. and the challenges that remain for efforts to pharmacol. target the PI3K family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtmivxnuTfQ7Vg90H21EOLACvtfcHk0ljZvgkpsmxIOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrsb4%253D&md5=b7243ad076ba15f65214acc8a3b09d65</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1042%2FBST0350245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0350245%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DChemically%2520Targetting%2520the%2520PI3K%2520Family%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26spage%3D245%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_contrib-group">Ward, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span> </span><span class="NLM_article-title">Isoform-Specific Phosphoinositide 3-Kinase Inhibitors as Therapeutic Agents</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2FS1471-4892%2803%2900078-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=12901953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFGju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=426-434&author=S.+G.+Wardauthor=P.+Finan&title=Isoform-Specific+Phosphoinositide+3-Kinase+Inhibitors+as+Therapeutic+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents</span></div><div class="casAuthors">Ward, Stephen G.; Finan, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">426-434</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) family of enzymes consists of several closely related isoforms that are thought to have distinct biol. roles.  Until now, researchers have been frustrated by poor selectivity of the available pharmacol. inhibitors, which are unable to distinguish adequately the activities of different PI3K isoforms.  Recently published patent specifications describe new PI3K inhibitors, including several that are selective for the PI3Kδ isoform.  There is now cautious optimism that isoform-selective PI3K inhibitors will provide new avenues for therapeutic applications in a range of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoooGyT_yJeLLVg90H21EOLACvtfcHk0lht_kVPuQUh3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFGju7c%253D&md5=301655ddf3635b506ddb01a95d608f1d</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2803%2900078-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252803%252900078-X%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BG.%26aulast%3DFinan%26aufirst%3DP.%26atitle%3DIsoform-Specific%2520Phosphoinositide%25203-Kinase%2520Inhibitors%2520as%2520Therapeutic%2520Agents%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D426%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_contrib-group">Sundstrom, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D. L.</span><span> </span><span class="NLM_article-title">Inhibitors of Phosphoinositide-3-Kinase: A Structure-Based Approach to Understanding Potency and Selectivity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">840</span><span class="NLM_x">–</span> <span class="NLM_lpage">850</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1039%2Fb819067b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=19225663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFGru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=840-850&author=T.+J.+Sundstromauthor=A.+C.+Andersonauthor=D.+L.+Wright&title=Inhibitors+of+Phosphoinositide-3-Kinase%3A+A+Structure-Based+Approach+to+Understanding+Potency+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of phosphoinositide-3-kinase: a structure-based approach to understanding potency and selectivity</span></div><div class="casAuthors">Sundstrom, Teather J.; Anderson, Amy C.; Wright, Dennis L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">840-850</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide-3-kinase is a pivotal protein involved in a wide variety of signaling cascades and there has been a great deal of interest in the development of potent and selective inhibitors of this enzyme.  In this review, the potency and selectivity of the known inhibitors is presented along with key structural information that helps rationalize the obsd. trends.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1X1C0qBQxy7Vg90H21EOLACvtfcHk0ljG6dKCsLR_-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFGru70%253D&md5=77356f92a07e4314aa2bd90e2382c7c0</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1039%2Fb819067b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb819067b%26sid%3Dliteratum%253Aachs%26aulast%3DSundstrom%26aufirst%3DT.%2BJ.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26aulast%3DWright%26aufirst%3DD.%2BL.%26atitle%3DInhibitors%2520of%2520Phosphoinositide-3-Kinase%253A%2520A%2520Structure-Based%2520Approach%2520to%2520Understanding%2520Potency%2520and%2520Selectivity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D840%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenwaelder, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goncalves, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesbitt, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dopheide, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgeon, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabaharan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniele, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saylik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, H. H.</span><span> </span><span class="NLM_article-title">PI 3-Kinase p110β: A New Target for Antithrombotic Therapy</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnm1232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=15834429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=507-514&author=S.+P.+Jacksonauthor=S.+M.+Schoenwaelderauthor=I.+Goncalvesauthor=W.+S.+Nesbittauthor=C.+L.+Yapauthor=C.+E.+Wrightauthor=V.+Kencheauthor=K.+E.+Andersonauthor=S.+M.+Dopheideauthor=Y.+Yuanauthor=S.+A.+Sturgeonauthor=H.+Prabaharanauthor=P.+E.+Thompsonauthor=G.+D.+Smithauthor=P.+R.+Shepherdauthor=N.+Danieleauthor=S.+Kulkarniauthor=B.+Abbottauthor=D.+Saylikauthor=C.+Jonesauthor=L.+Luauthor=S.+Giulianoauthor=S.+C.+Hughanauthor=J.+A.+Angusauthor=A.+D.+Robertsonauthor=H.+H.+Salem&title=PI+3-Kinase+p110%CE%B2%3A+A+New+Target+for+Antithrombotic+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PI 3-kinase p110β: a new target for antithrombotic therapy</span></div><div class="casAuthors">Jackson, Shaun P.; Schoenwaelder, Simone M.; Goncalves, Isaac; Nesbitt, Warwick S.; Yap, Cindy L.; Wright, Christine E.; Kenche, Vijaya; Anderson, Karen E.; Dopheide, Sacha M.; Yuan, Yuping; Sturgeon, Sharelle A.; Prabaharan, Hishani; Thompson, Philip E.; Smith, Gregg D.; Shepherd, Peter R.; Daniele, Nathalie; Kulkarni, Suhasini; Abbott, Belinda; Saylik, Dilek; Jones, Catherine; Lu, Lucy; Giuliano, Simon; Hughan, Sascha C.; Angus, James A.; Robertson, Alan D.; Salem, Hatem H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-514</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelet activation at sites of vascular injury is essential for the arrest of bleeding; however, excessive platelet accumulation at regions of atherosclerotic plaque rupture can result in the development of arterial thrombi, pptg. diseases such as acute myocardial infarction and ischemic stroke.  Rheol. disturbances (high shear stress) have an important role in promoting arterial thrombosis by enhancing the adhesive and signaling function of platelet integrin αIIbβ3 (GPIIb-IIIa).  In this study we have defined a key role for the Type Ia phosphoinositide 3-kinase (PI3K) p110β isoform in regulating the formation and stability of integrin αIIbβ3 adhesion bonds, necessary for shear activation of platelets.  Isoform-selective PI3K p110β inhibitors have been developed which prevent formation of stable integrin αIIbβ3 adhesion contacts, leading to defective platelet thrombus formation.  In vivo, these inhibitors eliminate occlusive thrombus formation but do not prolong bleeding time.  These studies define PI3K p110β as an important new target for antithrombotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYYnYolzsDrrVg90H21EOLACvtfcHk0ljG6dKCsLR_-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOlsrk%253D&md5=c8dc7ba1955e86104ae913d39f22674b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnm1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1232%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DSchoenwaelder%26aufirst%3DS.%2BM.%26aulast%3DGoncalves%26aufirst%3DI.%26aulast%3DNesbitt%26aufirst%3DW.%2BS.%26aulast%3DYap%26aufirst%3DC.%2BL.%26aulast%3DWright%26aufirst%3DC.%2BE.%26aulast%3DKenche%26aufirst%3DV.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DDopheide%26aufirst%3DS.%2BM.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DSturgeon%26aufirst%3DS.%2BA.%26aulast%3DPrabaharan%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DSmith%26aufirst%3DG.%2BD.%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26aulast%3DDaniele%26aufirst%3DN.%26aulast%3DKulkarni%26aufirst%3DS.%26aulast%3DAbbott%26aufirst%3DB.%26aulast%3DSaylik%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DGiuliano%26aufirst%3DS.%26aulast%3DHughan%26aufirst%3DS.%2BC.%26aulast%3DAngus%26aufirst%3DJ.%2BA.%26aulast%3DRobertson%26aufirst%3DA.%2BD.%26aulast%3DSalem%26aufirst%3DH.%2BH.%26atitle%3DPI%25203-Kinase%2520p110%25CE%25B2%253A%2520A%2520New%2520Target%2520for%2520Antithrombotic%2520Therapy%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D507%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><div class="note"><p class="first last">For a report of PI3Kβ/PI3Kδ dual inhibitors see the following: </p></div><span class="NLM_contrib-group">Kinght, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alaimo, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenski, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Isoform-Specific Phosphoinositide 3-Kinase Inhibitors from an Arylmorpholine Scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4749</span><span class="NLM_x">–</span> <span class="NLM_lpage">4759</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=4749-4759&author=Z.+A.+Kinghtauthor=G.+G.+Chiangauthor=P.+J.+Alaimoauthor=D.+M.+Kenskiauthor=C.+B.+Hoauthor=K.+Coanauthor=R.+T.+Abrahamauthor=K.+M.+Shokat&title=Isoform-Specific+Phosphoinositide+3-Kinase+Inhibitors+from+an+Arylmorpholine+Scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKinght%26aufirst%3DZ.%2BA.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAlaimo%26aufirst%3DP.%2BJ.%26aulast%3DKenski%26aufirst%3DD.%2BM.%26aulast%3DHo%26aufirst%3DC.%2BB.%26aulast%3DCoan%26aufirst%3DK.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DIsoform-Specific%2520Phosphoinositide%25203-Kinase%2520Inhibitors%2520from%2520an%2520Arylmorpholine%2520Scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D4749%26epage%3D4759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_contrib-group">Sadhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tino, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staunton, D. E.</span><span> </span><span class="NLM_article-title">Selective Role of PI3Kδ in Neutrophil Inflammatory Responses</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2003&pages=764-769&author=C.+Sadhuauthor=K.+Dickauthor=W.+T.+Tinoauthor=D.+E.+Staunton&title=Selective+Role+of+PI3K%CE%B4+in+Neutrophil+Inflammatory+Responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSadhu%26aufirst%3DC.%26aulast%3DDick%26aufirst%3DK.%26aulast%3DTino%26aufirst%3DW.%2BT.%26aulast%3DStaunton%26aufirst%3DD.%2BE.%26atitle%3DSelective%2520Role%2520of%2520PI3K%25CE%25B4%2520in%2520Neutrophil%2520Inflammatory%2520Responses%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D308%26spage%3D764%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_contrib-group">Fruman, D. A.</span><span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase and Its Targets in B-Cell and T-Cell Signaling</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2Fj.coi.2004.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=15134780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVamtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=314-320&author=D.+A.+Fruman&title=Phosphoinositide+3-Kinase+and+Its+Targets+in+B-Cell+and+T-Cell+Signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling</span></div><div class="casAuthors">Fruman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-320</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide 3-kinase (PI3K) activation is essential for lymphocyte proliferation driven by receptors for antigen, costimulatory ligands and cytokines.  The lipid products of PI3K contribute to the assembly of membrane-assocd. signaling complexes by promoting recruitment of selected proteins from the cytoplasm.  Many proteins possess domains that are able to bind selectively to PI3K products.  Different 'PI3K effector' proteins are coupled to distinct biol. responses, depending on cell type and on the receptor that is engaged.  In B cells and T cells, Tec-family tyrosine kinases and Akt serine/threonine kinases are emerging as crucial mediators of proliferation and survival signals downstream of PI3K.  Of particular interest is recent evidence that PI3K signaling controls increases in lymphocyte size and metabolic activity that accompany cell cycle progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnOMRHTLdWzbVg90H21EOLACvtfcHk0liY3T8xFxtsSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVamtr4%253D&md5=18b4b46533f2d49312f123a4c72915b8</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2004.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2004.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DFruman%26aufirst%3DD.%2BA.%26atitle%3DPhosphoinositide%25203-Kinase%2520and%2520Its%2520Targets%2520in%2520B-Cell%2520and%2520T-Cell%2520Signaling%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2004%26volume%3D16%26spage%3D314%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesbroeck, B.</span><span> </span><span class="NLM_article-title">PI3K in Lymphocyte Development, Differentiation, and Activation</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnri1056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=12669022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFWku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=317-330&author=K.+Okkenhaugauthor=B.+Vanhaesbroeck&title=PI3K+in+Lymphocyte+Development%2C+Differentiation%2C+and+Activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K in lymphocyte development, differentiation and activation</span></div><div class="casAuthors">Okkenhaug, Klaus; Vanhaesebroeck, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide 3-kinases (PI3K) regulate numerous biol. processes, including cell growth, differentiation, survival, proliferation, migration, and metab.  In the immune system, impaired PI3K signaling leads to immunodeficiency, whereas unrestrained PI3K signaling contributes to autoimmunity and leukemia.  New insights into the role of PI3K in lymphocyte biol. have been derived from gene-targeting studies, which have identified the PI3K subunits that are involved in B-cell and T-cell signaling.  In particular, the catalytic subunit p110δ seems to be adapted to transmit antigen receptor signaling in B and T cells.  Addnl. recent work has provided new insights into the mol. interactions that lead to PI3K activation and the signaling pathways that are regulated by PI3K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqMNzLr_tCL7Vg90H21EOLACvtfcHk0liY3T8xFxtsSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFWku70%253D&md5=97161849a1a965ce48f2641ec19c7941</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1038%2Fnri1056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1056%26sid%3Dliteratum%253Aachs%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DVanhaesbroeck%26aufirst%3DB.%26atitle%3DPI3K%2520in%2520Lymphocyte%2520Development%252C%2520Differentiation%252C%2520and%2520Activation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D3%26spage%3D317%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span> </span><span class="NLM_article-title">PI3Kδ and PI3Kγ: Partners in Crime in Inflammation in Rheumatoid Arthritis and Beyond?</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnri2036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=17290298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVGrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=191-201&author=C.+Rommelauthor=M.+Campsauthor=H.+Ji&title=PI3K%CE%B4+and+PI3K%CE%B3%3A+Partners+in+Crime+in+Inflammation+in+Rheumatoid+Arthritis+and+Beyond%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?</span></div><div class="casAuthors">Rommel, Christian; Camps, Montserrat; Ji, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">191-201</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dysregulated signal transduction in innate and adaptive immune cells is known to be assocd. with the development of various autoimmune and inflammatory diseases.  Consequently, targeting intracellular signaling of the pro-inflammatory cytokine network heralds hope for the next generation of anti-inflammatory drugs.  Phosphoinositide 3-kinases (PI3Ks) generate lipid-based second messengers that control an array of intracellular signaling pathways that are known to have important roles in leukocytes.  In light of the recent progress in the development of selective PI3K inhibitors, and the beneficial effects of these inhibitors in models of acute and chronic inflammatory disorders, the authors discuss the therapeutic potential of blocking PI3K isoforms for the treatment of rheumatoid arthritis and other immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKSAduhwUrPrVg90H21EOLACvtfcHk0li5_jeZH9HvgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVGrtbk%253D&md5=2fdb3507d06ddf7d5485185f4573790f</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1038%2Fnri2036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2036%26sid%3Dliteratum%253Aachs%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DPI3K%25CE%25B4%2520and%2520PI3K%25CE%25B3%253A%2520Partners%2520in%2520Crime%2520in%2520Inflammation%2520in%2520Rheumatoid%2520Arthritis%2520and%2520Beyond%253F%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D7%26spage%3D191%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span> </span><span class="NLM_article-title">PI3Kγ Inhibition: Towards an Aspirin for the 21st Century?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=903-918&author=T.+Ruckleauthor=M.+K.+Schwarzauthor=C.+Rommel&title=PI3K%CE%B3+Inhibition%3A+Towards+an+Aspirin+for+the+21st+Century%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DRommel%26aufirst%3DC.%26atitle%3DPI3K%25CE%25B3%2520Inhibition%253A%2520Towards%2520an%2520Aspirin%2520for%2520the%252021st%2520Century%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D903%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4f"><span><span class="NLM_contrib-group">Barbier, D. F</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barolome, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redondo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Arias, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balomenos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, A. C.</span><span> </span><span class="NLM_article-title">PI3Kγ Inhibition Blocks Glomerulonephritis and Extends Lifespan in a Mouse Model of Systemic Lupus</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=16127435" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=933-935&author=D.+F+Barbierauthor=A.+Barolomeauthor=C.+Hernandezauthor=J.+M.+Floresauthor=C.+Redondoauthor=C.+Fernandez-Ariasauthor=M.+Campsauthor=T.+Ruckleauthor=M.+K.+Schwarzauthor=S.+Rodriguezauthor=C.+Martinezauthor=D.+Balomenosauthor=C.+Rommelauthor=A.+C.+Carrera&title=PI3K%CE%B3+Inhibition+Blocks+Glomerulonephritis+and+Extends+Lifespan+in+a+Mouse+Model+of+Systemic+Lupus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarbier%26aufirst%3DD.%2BF%26aulast%3DBarolome%26aufirst%3DA.%26aulast%3DHernandez%26aufirst%3DC.%26aulast%3DFlores%26aufirst%3DJ.%2BM.%26aulast%3DRedondo%26aufirst%3DC.%26aulast%3DFernandez-Arias%26aufirst%3DC.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DRodriguez%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DC.%26aulast%3DBalomenos%26aufirst%3DD.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DCarrera%26aufirst%3DA.%2BC.%26atitle%3DPI3K%25CE%25B3%2520Inhibition%2520Blocks%2520Glomerulonephritis%2520and%2520Extends%2520Lifespan%2520in%2520a%2520Mouse%2520Model%2520of%2520Systemic%2520Lupus%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D933%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4g"><span><span class="NLM_contrib-group">Wymann, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklof, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trifilieff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altruda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laffargue, M.</span><span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase γ: A Key Modulator in Inflammation and Allergy</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4g&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1042%2FBST0310275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4g&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=12546701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4g&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=275-280&author=M.+P.+Wymannauthor=K.+Bjorklofauthor=R.+Calvezauthor=P.+Finanauthor=M.+Thomasauthor=A.+Trifilieffauthor=M.+Barbierauthor=F.+Altrudaauthor=E.+Hirschauthor=M.+Laffargue&title=Phosphoinositide+3-Kinase+%CE%B3%3A+A+Key+Modulator+in+Inflammation+and+Allergy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4gR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoinositide 3-kinase γ: a key modulator in inflammation and allergy</span></div><div class="casAuthors">Wymann, M. P.; Bjoerkloef, K.; Calvez, R.; Finan, P.; Thomast, M.; Trifilieff, A.; Barbier, M.; Altruda, F.; Hirsch, E.; Laffargue, M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">275-280</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic inflammation and allergy involve the activation of tissue-resident cells and, later on, the invasion of effector cells.  We have previously shown that the loss of phosphoinositide 3-kinase (PI3K) γ impairs chemokine-dependent migration of neutrophils and macrophages both in vitro and in vivo .  On the other hand, PI3Kγ is not required either during phagocytic processes or in the activation of bactericidal activities like granule secretion and particle-mediated respiratory burst in neutrophils.  Tissue mast cells are key regulators in allergy and inflammation and release histamine upon clustering of their IgE receptors.  We have demonstrated that murine mast cell responses are exacerbated in vitro and in vivo by autocrine signals, and require functional PI3Kγ.  Adenosine, acting through the A3 adenosine receptor, as well as other agonists of Gαi-coupled receptors, transiently increased PtdIns(3,4,5) P 3 exclusively via PI3Kγ.  PI3Kγ-derived PtdIns(3,4,5) P 3 was instrumental for initiation of a sustained influx of external Ca2+ and degranulation.  Mice that lacked PI3Kγ did not form edema when challenged by passive systemic anaphylaxis.  PI3Kγ thus relays inflammatory signals through various GPCRs, and is thus central to mast cell function.  Taken together, this suggests that pharmaceutical targeting of PI3Kγ might alleviate inflammation at both early and late stages of the allergic response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSxvbIu0vVf7Vg90H21EOLACvtfcHk0lju2wRmrDLHJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptF2qtw%253D%253D&md5=5163ba45e24d7304db751f5beb16556f</span></div><a href="/servlet/linkout?suffix=cit4g&amp;dbid=16384&amp;doi=10.1042%2FBST0310275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0310275%26sid%3Dliteratum%253Aachs%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DBjorklof%26aufirst%3DK.%26aulast%3DCalvez%26aufirst%3DR.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DTrifilieff%26aufirst%3DA.%26aulast%3DBarbier%26aufirst%3DM.%26aulast%3DAltruda%26aufirst%3DF.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DLaffargue%26aufirst%3DM.%26atitle%3DPhosphoinositide%25203-Kinase%2520%25CE%25B3%253A%2520A%2520Key%2520Modulator%2520in%2520Inflammation%2520and%2520Allergy%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D275%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4h"><span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katanaev, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garlanda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzolino, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silengo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sozzani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantovani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altruda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span> </span><span class="NLM_article-title">Central Role for G Protein-Coupled Phosphoinositide 3-Kinase γ in Inflammation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=1049-1053&author=E.+Hirschauthor=V.+L.+Katanaevauthor=C.+Garlandaauthor=O.+Azzolinoauthor=L.+Pirolaauthor=L.+Silengoauthor=S.+Sozzaniauthor=A.+Mantovaniauthor=F.+Altrudaauthor=M.+P.+Wymann&title=Central+Role+for+G+Protein-Coupled+Phosphoinositide+3-Kinase+%CE%B3+in+Inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DKatanaev%26aufirst%3DV.%2BL.%26aulast%3DGarlanda%26aufirst%3DC.%26aulast%3DAzzolino%26aufirst%3DO.%26aulast%3DPirola%26aufirst%3DL.%26aulast%3DSilengo%26aufirst%3DL.%26aulast%3DSozzani%26aufirst%3DS.%26aulast%3DMantovani%26aufirst%3DA.%26aulast%3DAltruda%26aufirst%3DF.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DCentral%2520Role%2520for%2520G%2520Protein-Coupled%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%2520in%2520Inflammation%26jtitle%3DScience%26date%3D2000%26volume%3D287%26spage%3D1049%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4i"><span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rückle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardissone, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rintelen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillieron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitte, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span> </span><span class="NLM_article-title">Blockade of PI3Kγ Suppresses Joint Inflammation and Damage in Mouse Models of Rheumatoid Arthritis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4i&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnm1284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4i&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=16127437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4i&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslelur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=936-943&author=M.+Campsauthor=T.+R%C3%BCckleauthor=H.+Jiauthor=V.+Ardissoneauthor=F.+Rintelenauthor=J.+Shawauthor=C.+Ferrandiauthor=C.+Chabertauthor=C.+Gillieronauthor=B.+Franconauthor=T.+Martinauthor=D.+Gretenerauthor=D.+Perrinauthor=D.+Leroyauthor=P.-A.+Vitteauthor=E.+Hirschauthor=M.+P.+Wymannauthor=R.+Cirilloauthor=M.+K.+Schwarzauthor=C.+Rommel&title=Blockade+of+PI3K%CE%B3+Suppresses+Joint+Inflammation+and+Damage+in+Mouse+Models+of+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4iR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis</span></div><div class="casAuthors">Camps, Montserrat; Rueckle, Thomas; Ji, Hong; Ardissone, Vittoria; Rintelen, Felix; Shaw, Jeffrey; Ferrandi, Chiara; Chabert, Christian; Gillieron, Corine; Francon, Bernard; Martin, Thierry; Gretener, Denise; Perrin, Dominique; Leroy, Didier; Vitte, Pierre-Alain; Hirsch, Emilio; Wymann, Matthias P.; Cirillo, Rocco; Schwarz, Matthias K.; Rommel, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">936-943</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3K) have long been considered promising drug targets for the treatment of inflammatory and autoimmune disorders as well as cancer and cardiovascular diseases.  But the lack of specificity, isoform selectivity and poor biopharmaceutical profile of PI3K inhibitors have so far hampered rigorous disease-relevant target validation.  Here we describe the identification and development of specific, selective and orally active small-mol. inhibitors of PI3Kγ (encoded by Pik3cg).  We show that Pik3cg-/- mice are largely protected in mouse models of rheumatoid arthritis; this protection correlates with defective neutrophil migration, further validating PI3Kγ as a therapeutic target.  We also describe that oral treatment with a PI3Kγ inhibitor suppresses the progression of joint inflammation and damage in two distinct mouse models of rheumatoid arthritis, reproducing the protective effects shown by Pik3cg-/- mice.  Our results identify selective PI3Kγ inhibitors as potential therapeutic mols. for the treatment of chronic inflammatory disorders such as rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEyzzdnR3FXLVg90H21EOLACvtfcHk0ljhOqAWJpoQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslelur8%253D&md5=1fed7126427b519a4a457a8bf31ade7d</span></div><a href="/servlet/linkout?suffix=cit4i&amp;dbid=16384&amp;doi=10.1038%2Fnm1284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1284%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DArdissone%26aufirst%3DV.%26aulast%3DRintelen%26aufirst%3DF.%26aulast%3DShaw%26aufirst%3DJ.%26aulast%3DFerrandi%26aufirst%3DC.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DGillieron%26aufirst%3DC.%26aulast%3DFrancon%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DT.%26aulast%3DGretener%26aufirst%3DD.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DVitte%26aufirst%3DP.-A.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DCirillo%26aufirst%3DR.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DRommel%26aufirst%3DC.%26atitle%3DBlockade%2520of%2520PI3K%25CE%25B3%2520Suppresses%2520Joint%2520Inflammation%2520and%2520Damage%2520in%2520Mouse%2520Models%2520of%2520Rheumatoid%2520Arthritis%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D936%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, J. D.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) δ and γ</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.2174%2F156802609789044434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=19689378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=738-753&author=M.+K.+Ameriksauthor=J.+D.+Venable&title=Small+Molecule+Inhibitors+of+Phosphoinositide+3-Kinase+%28PI3K%29+%CE%B4+and+%CE%B3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of phosphoinositide 3-kinase (PI3K) δ and γ</span></div><div class="casAuthors">Ameriks, Michael K.; Venable, Jennifer D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">738-753</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, pharmaceutical companies have increasingly focused on phosphoinositide 3-kinases delta (PI3Kδ) and gamma (PI3Kγ) as therapeutic targets for the treatment of inflammatory and autoimmune diseases.  All class 1 PI3-kinases (α/β/γ/δ) generate phospholipid second messengers that help govern cellular processes such as migration, proliferation, and apoptosis.  PI3K δ/γ lipid kinases are mainly restricted to the hematopoetic system whereas PI3Kα/β are ubiquitously expressed, thus raising potential toxicity concerns for chronic indications such as asthma and rheumatoid arthritis.  Therefore, the challenge in developing a small mol. inhibitor of PI3K is to define and attain the appropriate isoform selectivity profile.  Significant advances in the design of such compds. have been achieved by utilizing x-ray crystal structures of various inhibitors bound to PI3Kγ in conjunction with pharmacophore modeling and high-throughput screening.  Herein, we review the history and challenges involved with the discovery of small mol. isoform-specific PI3K inhibitors.  Recent progress in the design of selective PI3Kδ, PI3Kγ, and PI3Kδ/γ dual inhibitors will be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeoiBWisF3T7Vg90H21EOLACvtfcHk0lhBJRlq8NcLKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLnP&md5=1cae29b32c03158fe8b933fabe8b7a2b</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.2174%2F156802609789044434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789044434%26sid%3Dliteratum%253Aachs%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DVenable%26aufirst%3DJ.%2BD.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%2528PI3K%2529%2520%25CE%25B4%2520and%2520%25CE%25B3%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D738%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_contrib-group">Sadhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masinovsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowell, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staunton, D. E.</span><span> </span><span class="NLM_article-title">Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=2647-2654&author=C.+Sadhuauthor=B.+Masinovskyauthor=K.+Dickauthor=C.+G.+Sowellauthor=D.+E.+Staunton&title=Essential+Role+of+Phosphoinositide+3-Kinase+%CE%B4+in+Neutrophil+Directional+Movement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSadhu%26aufirst%3DC.%26aulast%3DMasinovsky%26aufirst%3DB.%26aulast%3DDick%26aufirst%3DK.%26aulast%3DSowell%26aufirst%3DC.%2BG.%26aulast%3DStaunton%26aufirst%3DD.%2BE.%26atitle%3DEssential%2520Role%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%2520in%2520Neutrophil%2520Directional%2520Movement%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_contrib-group">Pomel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgat-Charvillon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valognes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillieron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rückle, T.</span><span> </span><span class="NLM_article-title">Furan-2-ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase γ</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3857</span><span class="NLM_x">–</span> <span class="NLM_lpage">3871</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0601598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3857-3871&author=V.+Pomelauthor=J.+Klicicauthor=D.+Coviniauthor=D.+D.+Churchauthor=J.+P.+Shawauthor=K.+Roulinauthor=F.+Burgat-Charvillonauthor=D.+Valognesauthor=M.+Campsauthor=C.+Chabertauthor=C.+Gillieronauthor=B.+Franconauthor=D.+Perrinauthor=D.+Leroyauthor=D.+Gretenerauthor=A.+Nicholsauthor=P.+A.+Vitteauthor=S.+Carboniauthor=C.+Rommelauthor=M.+K.+Schwarzauthor=T.+R%C3%BCckle&title=Furan-2-ylmethylene+Thiazolidinediones+as+Novel%2C+Potent%2C+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Fjm0601598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601598%26sid%3Dliteratum%253Aachs%26aulast%3DPomel%26aufirst%3DV.%26aulast%3DKlicic%26aufirst%3DJ.%26aulast%3DCovini%26aufirst%3DD.%26aulast%3DChurch%26aufirst%3DD.%2BD.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DRoulin%26aufirst%3DK.%26aulast%3DBurgat-Charvillon%26aufirst%3DF.%26aulast%3DValognes%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DChabert%26aufirst%3DC.%26aulast%3DGillieron%26aufirst%3DC.%26aulast%3DFrancon%26aufirst%3DB.%26aulast%3DPerrin%26aufirst%3DD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DGretener%26aufirst%3DD.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DVitte%26aufirst%3DP.%2BA.%26aulast%3DCarboni%26aufirst%3DS.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26atitle%3DFuran-2-ylmethylene%2520Thiazolidinediones%2520as%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3857%26epage%3D3871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_contrib-group">Pereira, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strangman, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, R. J.</span><span> </span><span class="NLM_article-title">Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8523</span><span class="NLM_x">–</span> <span class="NLM_lpage">8533</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100531u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFShtb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8523-8533&author=A.+R.+Pereiraauthor=W.+K.+Strangmanauthor=F.+Marionauthor=L.+Feldbergauthor=D.+Rollauthor=R.+Mallonauthor=I.+Hollanderauthor=R.+J.+Andersen&title=Synthesis+of+Phosphatidylinositol+3-Kinase+%28PI3K%29+Inhibitory+Analogues+of+the+Sponge+Meroterpenoid+Liphagal"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal</span></div><div class="casAuthors">Pereira, Alban R.; Strangman, Wendy K.; Marion, Frederic; Feldberg, Larry; Roll, Deborah; Mallon, Robert; Hollander, Irwin; Andersen, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8523-8533</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sponge meroterpenoid liphagal (+)-I and racemic and nonracemic analogs such as (±)-II were prepd. and their inhibition of phosphatidylinositol-3-kinases α and γ (PI3Kα and PI3Kγ, resp.) was detd.  II inhibited PI3Kα and PI3Kγ with IC50 values of 66 nM and 1840 nM, resp., showing a 27-fold preference for PI3Kα; in addn., II exhibited enhanced chem. stability and modestly enhanced potency and selectivity compared with those of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dJ0WNMQ0nrVg90H21EOLACvtfcHk0lgA6VBegB_16Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFShtb7F&md5=fe31011bbe5e502c62daf12167cea734</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1021%2Fjm100531u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100531u%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DA.%2BR.%26aulast%3DStrangman%26aufirst%3DW.%2BK.%26aulast%3DMarion%26aufirst%3DF.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DRoll%26aufirst%3DD.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAndersen%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520of%2520Phosphatidylinositol%25203-Kinase%2520%2528PI3K%2529%2520Inhibitory%2520Analogues%2520of%2520the%2520Sponge%2520Meroterpenoid%2520Liphagal%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8523%26epage%3D8533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">The Phosphatidylinositol 3-Kinase-AKT Pathway in Human Cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnrc839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=12094235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=489-501&author=I.+Vivancoauthor=C.+L.+Sawyers&title=The+Phosphatidylinositol+3-Kinase-AKT+Pathway+in+Human+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-Kinase-AKT pathway in human cancer</span></div><div class="casAuthors">Vivanco, Igor; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One signal that is overactivated in a wide range of tumor types is the prodn. of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K).  This lipid and the protein kinase that is activated by it, AKT, trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumor progression.  Small-mol. therapeutics that block PI3K signaling might deal a severe blow to cancer cells by blocking many aspects of the tumor-cell phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAQ-0qeD7pLVg90H21EOLACvtfcHk0lhX86Mehba_Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D&md5=c6762d32f9f1281632f4ccdbcd29268c</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnrc839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc839%26sid%3Dliteratum%253Aachs%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DThe%2520Phosphatidylinositol%25203-Kinase-AKT%2520Pathway%2520in%2520Human%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The Phosphoinositide 3-Kinase Pathway</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1126%2Fscience.296.5573.1655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=12040186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1655-1657&author=L.+C.+Cantley&title=The+Phosphoinositide+3-Kinase+Pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphoinositide 3-kinase pathway</span></div><div class="casAuthors">Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1655-1657</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 8 refs.  Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components.  The role of phosphoinositide 3-kinase (PI3K), which catalyzes the prodn. of phosphatidylinositol 3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metab.; and cytoskeletal rearrangements are highlighted.  The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9pxSplxmS1rVg90H21EOLACvtfcHk0lhX86Mehba_Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D&md5=110c8a351448aed6ab938b9ccf90a655</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1126%2Fscience.296.5573.1655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.296.5573.1655%26sid%3Dliteratum%253Aachs%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520Phosphoinositide%25203-Kinase%2520Pathway%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D1655%26epage%3D1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the Role of mTOR in Cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+Role+of+mTOR+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520Role%2520of%2520mTOR%2520in%2520Cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_contrib-group">Fasolo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessa, C.</span><span> </span><span class="NLM_article-title">mTOR Inhibitors in the Treatment of Cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1717-1734&author=A.+Fasoloauthor=C.+Sessa&title=mTOR+Inhibitors+in+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFasolo%26aufirst%3DA.%26aulast%3DSessa%26aufirst%3DC.%26atitle%3DmTOR%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1717%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_contrib-group">Bellacosa, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cristofano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span> </span><span class="NLM_article-title">Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2FS0065-230X%2805%2994002-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=16095999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=29-86&author=A+Bellacosaauthor=C.+C.+Kumarauthor=A.+Di+Cristofanoauthor=J.+R.+Testa&title=Activation+of+AKT+Kinases+in+Cancer%3A+Implications+for+Therapeutic+Targeting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of AKT kinases in cancer: implications for therapeutic targeting</span></div><div class="casAuthors">Bellacosa, Alfonso; Kumar, C. Chandra; Di Cristofano, Antonio; Testa, Joseph Robert</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-86</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The AKT1, AKT2, and AKT3 kinases have emerged as crit. mediators of signal transduction pathways downstream of activated tyrosine kinases and phosphatidylinositol 3-kinase.  An ever-increasing list of AKT substrates has precisely defined the multiple functions of this kinase family in normal physiol. and disease states.  Cellular processes regulated by AKT include cell proliferation and survival, cell size and response to nutrient availability, intermediary metab., angiogenesis, and tissue invasion.  All these processes represent hallmarks of cancer, and a burgeoning literature has defined the importance of AKT alterations in human cancer and exptl. models of tumorigenesis, continuing the legacy represented by the original identification of v-Akt as the transforming oncogene of a murine retrovirus.  Many oncoproteins and tumor suppressors intersect in the AKT pathway, finely regulating cellular functions at the interface of signal transduction and classical metabolic regulation.  This careful balance is altered in human cancer by a variety of activating and inactivating mechanisms that target both AKT and interrelated proteins.  Reprogramming of this altered circuitry by pharmacol. modulation of the AKT pathway represents a powerful strategy for rational cancer therapy.  In this review, we summarize a large body of data, from many types of cancer, indicating that AKT activation is one of the most common mol. alterations in human malignancy.  We also review mechanisms of activation of AKT kinases, examples of therapeutic modulation of the AKT pathway in animal models, and the current status of efforts to target mol. components of the AKT pathway for cancer therapy and, possibly, cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtUdzglK927Vg90H21EOLACvtfcHk0lgI-CV_j05NZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D&md5=556e3c5787e0179786db3cb2e2f1dcf6</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2805%2994002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252805%252994002-5%26sid%3Dliteratum%253Aachs%26aulast%3DBellacosa%26aufirst%3DA%26aulast%3DKumar%26aufirst%3DC.%2BC.%26aulast%3DDi%2BCristofano%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26atitle%3DActivation%2520of%2520AKT%2520Kinases%2520in%2520Cancer%253A%2520Implications%2520for%2520Therapeutic%2520Targeting%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2005%26volume%3D94%26spage%3D29%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_contrib-group">Ihle, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">Take Your PIK: Phosphatidylinositol 3-Kinase Inhibitors Race through the Clinic toward Cancer Therapy</span> <span class="citation_source-journal">Mol. Cancer. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1158%2F1535-7163.MCT-08-0801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=19139107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1-9&author=N.+T.+Ihleauthor=G.+Powis&title=Take+Your+PIK%3A+Phosphatidylinositol+3-Kinase+Inhibitors+Race+through+the+Clinic+toward+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6fR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy</span></div><div class="casAuthors">Ihle, Nathan T.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is currently one of the most exciting drug targets in oncol.  However, only a short time ago, the paradigm existed that drugs targeted to the four PI3K class I isoforms would be too toxic for use in cancer therapy due to effects on physiol. signaling.  Since that time, studies have delineated the roles of these four isoforms in nonpathol. signaling as well as their roles in cancer.  An extensive effort has gone into developing agents that inhibit one or more PI3K isoforms, as well as closely related proteins implicated in cancer.  These agents have proved to be tolerable and therapeutically beneficial in animal studies, and a no. are in clin. testing.  The agents, their properties, and their mol. targets are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtwozBC-h437Vg90H21EOLACvtfcHk0lgaVMwZJ4IzZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D&md5=4bc339da7fdd1dc74e13eadf76ae53ce</span></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0801%26sid%3Dliteratum%253Aachs%26aulast%3DIhle%26aufirst%3DN.%2BT.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DTake%2520Your%2520PIK%253A%2520Phosphatidylinositol%25203-Kinase%2520Inhibitors%2520Race%2520through%2520the%2520Clinic%2520toward%2520Cancer%2520Therapy%26jtitle%3DMol.%2520Cancer.%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6g"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J. J.</span><span> </span><span class="NLM_article-title">Targeting the Phosphoinositide 3-Kinase Pathway in Cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhou&title=Targeting+the+Phosphoinositide+3-Kinase+Pathway+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6gR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0lh_E4lyYUZ4Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhou%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520Phosphoinositide%25203-Kinase%2520Pathway%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Imidazo[1,2-<i>a</i>]pyridine Derivatives as Novel PI3 Kinase p110α Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=403-412&author=M.+Hayakawaauthor=H.+Kaizawaauthor=K.+Kawaguchiauthor=N.+Ishikawaauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Yamanoauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamotoauthor=F.+I.+Raynaudauthor=M.+D.+Waterfieldauthor=P.+Parkerauthor=P.+Workman&title=Synthesis+and+Biological+Evaluation+of+Imidazo%5B1%2C2-a%5Dpyridine+Derivatives+as+Novel+PI3+Kinase+p110%CE%B1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DK.%26aulast%3DIshikawa%26aufirst%3DN.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DYamano%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Imidazo%255B1%252C2-a%255Dpyridine%2520Derivatives%2520as%2520Novel%2520PI3%2520Kinase%2520p110%25CE%25B1%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D403%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_contrib-group">Pereira, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strangman, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, R.</span><span> </span><span class="NLM_article-title">Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8523</span><span class="NLM_x">–</span> <span class="NLM_lpage">8533</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100531u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFShtb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8523-8533&author=A.+R.+Pereiraauthor=W.+K.+Strangmanauthor=F.+Marionauthor=L.+Feldbergauthor=D.+Rollauthor=R.+Mallonauthor=I.+Hollanderauthor=R.+Andersen&title=Synthesis+of+Phosphatidylinositol+3-Kinase+%28PI3K%29+Inhibitory+Analogues+of+the+Sponge+Meroterpenoid+Liphagal"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal</span></div><div class="casAuthors">Pereira, Alban R.; Strangman, Wendy K.; Marion, Frederic; Feldberg, Larry; Roll, Deborah; Mallon, Robert; Hollander, Irwin; Andersen, Raymond J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8523-8533</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sponge meroterpenoid liphagal (+)-I and racemic and nonracemic analogs such as (±)-II were prepd. and their inhibition of phosphatidylinositol-3-kinases α and γ (PI3Kα and PI3Kγ, resp.) was detd.  II inhibited PI3Kα and PI3Kγ with IC50 values of 66 nM and 1840 nM, resp., showing a 27-fold preference for PI3Kα; in addn., II exhibited enhanced chem. stability and modestly enhanced potency and selectivity compared with those of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-dJ0WNMQ0nrVg90H21EOLACvtfcHk0ljfktJF0yE9VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFShtb7F&md5=fe31011bbe5e502c62daf12167cea734</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fjm100531u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100531u%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DA.%2BR.%26aulast%3DStrangman%26aufirst%3DW.%2BK.%26aulast%3DMarion%26aufirst%3DF.%26aulast%3DFeldberg%26aufirst%3DL.%26aulast%3DRoll%26aufirst%3DD.%26aulast%3DMallon%26aufirst%3DR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DAndersen%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520Phosphatidylinositol%25203-Kinase%2520%2528PI3K%2529%2520Inhibitory%2520Analogues%2520of%2520the%2520Sponge%2520Meroterpenoid%2520Liphagal%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8523%26epage%3D8533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehnhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldberg, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, R.</span><span> </span><span class="NLM_article-title">Novel Purine and Pyrazolo[3,4-<i>d</i>]pyrimidine Inhibitors of PI3 Kinase-α: Hit to Lead Studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=636-639&author=A.+M.+Gilbertauthor=P.+Nowakauthor=N.+Brooijmansauthor=M.+G.+Bursavichauthor=C.+Dehnhardtauthor=E.+Delos+Santosauthor=L.+R.+Feldbergauthor=I.+Hollanderauthor=S.+Kimauthor=S.+Lombardiauthor=K.+Parkauthor=A.+M.+Venkatesanauthor=R.+Mallon&title=Novel+Purine+and+Pyrazolo%5B3%2C4-d%5Dpyrimidine+Inhibitors+of+PI3+Kinase-%CE%B1%3A+Hit+to+Lead+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DFeldberg%26aufirst%3DL.%2BR.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DLombardi%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DVenkatesan%26aufirst%3DA.%2BM.%26aulast%3DMallon%26aufirst%3DR.%26atitle%3DNovel%2520Purine%2520and%2520Pyrazolo%255B3%252C4-d%255Dpyrimidine%2520Inhibitors%2520of%2520PI3%2520Kinase-%25CE%25B1%253A%2520Hit%2520to%2520Lead%2520Studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D636%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_contrib-group">Kendall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baguley, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaussade, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, P. R.</span><span> </span><span class="NLM_article-title">Synthesis, Biological Evaluation and Molecular Modeling of Sulfonohydrazides as Selective PI3K p110α Inhibitors</span> <span class="citation_source-journal">Biol. Org. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7677</span><span class="NLM_x">–</span> <span class="NLM_lpage">7687</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2Fj.bmc.2007.08.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=17869522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2msLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7677-7687&author=J.+D.+Kendallauthor=G.+W.+Rewcastleauthor=R.+Frederickauthor=C.+Mawsonauthor=W.+A.+Dennyauthor=E.+S.+Marshallauthor=B.+C.+Baguleyauthor=C.+Chaussadeauthor=S.+P.+Jacksonauthor=P.+R.+Shepherd&title=Synthesis%2C+Biological+Evaluation+and+Molecular+Modeling+of+Sulfonohydrazides+as+Selective+PI3K+p110%CE%B1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110α inhibitors</span></div><div class="casAuthors">Kendall, Jackie D.; Rewcastle, Gordon W.; Frederick, Raphael; Mawson, Claire; Denny, William A.; Marshall, Elaine S.; Baguley, Bruce C.; Chaussade, Claire; Jackson, Shaun P.; Shepherd, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7677-7687</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 2-methyl-5-nitrobenzenesulfonohydrazides were prepd. and evaluated as inhibitors of PI3K.  An isoquinoline deriv. shows good selectivity for the p110α isoform over p110β and p110δ, and also demonstrates good in vitro activity in a cell proliferation assay.  Mol. modeling provides a rationalisation for the obsd. SAR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry8V-UY9ZUwrVg90H21EOLACvtfcHk0lj88KwNYzD_BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2msLzI&md5=c797f6d91f0a9c0ac29b66a790becade</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.08.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.08.062%26sid%3Dliteratum%253Aachs%26aulast%3DKendall%26aufirst%3DJ.%2BD.%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DMawson%26aufirst%3DC.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DMarshall%26aufirst%3DE.%2BS.%26aulast%3DBaguley%26aufirst%3DB.%2BC.%26aulast%3DChaussade%26aufirst%3DC.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26atitle%3DSynthesis%252C%2520Biological%2520Evaluation%2520and%2520Molecular%2520Modeling%2520of%2520Sulfonohydrazides%2520as%2520Selective%2520PI3K%2520p110%25CE%25B1%2520Inhibitors%26jtitle%3DBiol.%2520Org.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7677%26epage%3D7687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_contrib-group">Jamieson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolekar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baguley, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, P. R.</span><span> </span><span class="NLM_article-title">A Drug Targeting Only p110α Can Block Phosphoinositide 3-Kinase Signaling and Tumour Growth in Certain Cell Types</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2011&pages=53-62&author=S.+Jamiesonauthor=J.+U.+Flanaganauthor=S.+Kolekarauthor=S.+Buchananauthor=J.+D.+Kendallauthor=W.-J.+Leeauthor=G.+W.+Rewcastleauthor=W.+A.+Dennyauthor=R.+Singhauthor=J.+Dicksonauthor=B.+C.+Baguleyauthor=P.+R.+Shepherd&title=A+Drug+Targeting+Only+p110%CE%B1+Can+Block+Phosphoinositide+3-Kinase+Signaling+and+Tumour+Growth+in+Certain+Cell+Types"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DS.%26aulast%3DFlanagan%26aufirst%3DJ.%2BU.%26aulast%3DKolekar%26aufirst%3DS.%26aulast%3DBuchanan%26aufirst%3DS.%26aulast%3DKendall%26aufirst%3DJ.%2BD.%26aulast%3DLee%26aufirst%3DW.-J.%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DDickson%26aufirst%3DJ.%26aulast%3DBaguley%26aufirst%3DB.%2BC.%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26atitle%3DA%2520Drug%2520Targeting%2520Only%2520p110%25CE%25B1%2520Can%2520Block%2520Phosphoinositide%25203-Kinase%2520Signaling%2520and%2520Tumour%2520Growth%2520in%2520Certain%2520Cell%2520Types%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D438%26spage%3D53%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2Fj.cell.2006.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=16647110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+Pharmacological+Map+of+the+PI3-K+Family+Defines+a+Role+for+p110%CE%B1+in+Insulin+Signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span></div><div class="casAuthors">Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">733-747</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined.  We describe here an approach to pharmacol. interrogate the PI3-K family.  A chem. diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochem. enumerated, revealing cryptic homologies across targets and chemotypes.  Crystal structures of three inhibitors bound to p110γ identify a conformationally mobile region that is uniquely exploited by selective compds.  This chem. array was then used to define the PI3-K isoforms required for insulin signaling.  We find that p110α is the primary insulin-responsive PI3-K in cultured cells, whereas p110β is dispensable but sets a phenotypic threshold for p110α activity.  Compds. targeting p110α block the acute effects of insulin treatment in vivo, whereas a p110β inhibitor has no effect.  These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozjvOeMXP3bVg90H21EOLACvtfcHk0lhx1hsgoI4cXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D&md5=b95a8cb433927ff9a75b33fc4ac2c8a0</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520Pharmacological%2520Map%2520of%2520the%2520PI3-K%2520Family%2520Defines%2520a%2520Role%2520for%2520p110%25CE%25B1%2520in%2520Insulin%2520Signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26spage%3D733%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The Identification of 2-(1<i>H</i>-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=P.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+Identification+of+2-%281H-Indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+Potent%2C+Selective%2C+Orally+Bioavailable+Inhibitor+of+Class+I+PI3+Kinase+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0ljvjnMpVUyrIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DP.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520Identification%2520of%25202-%25281H-Indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520Potent%252C%2520Selective%252C%2520Orally%2520Bioavailable%2520Inhibitor%2520of%2520Class%2520I%2520PI3%2520Kinase%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901284w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1086-1097&author=D.+P.+Sutherlinauthor=D.+Sampathauthor=M.+Berryauthor=G.+Castanedoauthor=Z.+Changauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=L.+Friedmanauthor=R.+Goldsmithauthor=T.+Heffronauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=Q.+Tianauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=C.+Wiesmannauthor=S.+Wongauthor=B.-Y.+Zhu&title=Discovery+of+%28Thienopyrimidin-2-yl%29aminopyrimidines+as+Potent%2C+Selective%2C+and+Orally+Available+Pan-PI3-Kinase+and+Dual+Pan-PI3-Kinase%2FmTOR+Inhibitors+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DHeffron%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.-Y.%26atitle%3DDiscovery%2520of%2520%2528Thienopyrimidin-2-yl%2529aminopyrimidines%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520Pan-PI3-Kinase%2520and%2520Dual%2520Pan-PI3-Kinase%252FmTOR%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B. Y.</span><span> </span><span class="NLM_article-title">Identification of GNE-477, a Potent and Efficacious Dual PI3K/mTOR Inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2408</span><span class="NLM_x">–</span> <span class="NLM_lpage">2411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2408-2411&author=T.+P.+Heffronauthor=M.+Berryauthor=G.+Castanedoauthor=C.+Changauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=J.+Gunznerauthor=J.+D.+Lesnickauthor=C.+Lewisauthor=S.+Mathieuauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=J.+Pangauthor=D.+Petersonauthor=L.+Salphatiauthor=D.+Sampathauthor=S.+Siderisauthor=D.+P.+Sutherlinauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=S.+Wongauthor=B.+Y.+Zhu&title=Identification+of+GNE-477%2C+a+Potent+and+Efficacious+Dual+PI3K%2FmTOR+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DCastanedo%26aufirst%3DG.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DGunzner%26aufirst%3DJ.%26aulast%3DLesnick%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DD.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DB.%2BY.%26atitle%3DIdentification%2520of%2520GNE-477%252C%2520a%2520Potent%2520and%2520Efficacious%2520Dual%2520PI3K%252FmTOR%2520Inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2408%26epage%3D2411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_contrib-group">Staben, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanedo, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plise, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weismann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B. Z.</span><span> </span><span class="NLM_article-title">Structure-Based Optimization of Pyrazolo–Pyrimidine and –Pyridine Inhibitors of PI3 Kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6048</span><span class="NLM_x">–</span> <span class="NLM_lpage">6051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6048-6051&author=S.+T.+Stabenauthor=T.+P.+Heffronauthor=D.+P.+Sutherlinauthor=S.+R.+Bhatauthor=G.+M.+Castanedoauthor=I.+Chuckowreeauthor=J.+Dotsonauthor=A.+Folkesauthor=L.+Friedmanauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=J.+Nonomiyaauthor=A.+Oliveroauthor=E.+Pliseauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=L.+Rougeauthor=D.+Sampathauthor=V.+Tsuiauthor=N.+C.+Wanauthor=S.+Wangauthor=C.+Weismannauthor=P.+Wuauthor=B.+Z.+Zhu&title=Structure-Based+Optimization+of+Pyrazolo%E2%80%93Pyrimidine+and+%E2%80%93Pyridine+Inhibitors+of+PI3+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DBhat%26aufirst%3DS.%2BR.%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DChuckowree%26aufirst%3DI.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DFolkes%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DOlivero%26aufirst%3DA.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DRouge%26aufirst%3DL.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWeismann%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DB.%2BZ.%26atitle%3DStructure-Based%2520Optimization%2520of%2520Pyrazolo%25E2%2580%2593Pyrimidine%2520and%2520%25E2%2580%2593Pyridine%2520Inhibitors%2520of%2520PI3%2520Kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6048%26epage%3D6051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_contrib-group">Staben, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouge, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Thienobenzoxepin Inhibitors of PI3-Kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4054</span><span class="NLM_x">–</span> <span class="NLM_lpage">4058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2Fj.bmcl.2011.04.124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=21636270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVCisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4054-4058&author=S.+T.+Stabenauthor=M.+Siuauthor=R.+Goldsmithauthor=A.+G.+Oliveroauthor=S.+Doauthor=D.+Burdickauthor=T.+P.+Heffronauthor=D.+P.+Sutherlinauthor=B.-Y.+Zhuauthor=V.+Tsuiauthor=H.+Leauthor=L.+Leeauthor=J.+Lesnickauthor=C.+Lewisauthor=J.+M.+Murrayauthor=J.+Nonomiyaauthor=J.+Pangauthor=W.+W.+Priorauthor=L.+Salphatiauthor=L.+Rougeauthor=D.+Sampathauthor=C.+Wiesmannauthor=P.+Wu&title=Structure-Based+Design+of+Thienobenzoxepin+Inhibitors+of+PI3-Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of thienobenzoxepin inhibitors of PI3-kinase</span></div><div class="casAuthors">Staben, Steven T.; Siu, Michael; Goldsmith, Richard; Olivero, Alan G.; Do, Steven; Burdick, Daniel J.; Heffron, Timothy P.; Dotson, Jenna; Sutherlin, Daniel P.; Zhu, Bing-Yan; Tsui, Vickie; Le, Hoa; Lee, Leslie; Lesnick, John; Lewis, Cristina; Murray, Jeremy M.; Nonomiya, Jim; Pang, Jodie; Prior, Wei Wei; Salphati, Laurent; Rouge, Lionel; Sampath, Deepak; Sideris, Steve; Wiesmann, Christian; Wu, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4054-4058</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Starting from thienobenzopyran HTS hit 1 (I), co-crystn., mol. modeling and metabolic anal. were used to design potent and metabolically stable inhibitors of PI3-kinase.  Compd. 15 demonstrated PI3K pathway suppression in a mouse MCF7 xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK5PrbzVKCkbVg90H21EOLACvtfcHk0liE1RCXxOIimA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVCisLs%253D&md5=9b807be1ac4093a6f139c0304757037a</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.124%26sid%3Dliteratum%253Aachs%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DBurdick%26aufirst%3DD.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DZhu%26aufirst%3DB.-Y.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLesnick%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DRouge%26aufirst%3DL.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DP.%26atitle%3DStructure-Based%2520Design%2520of%2520Thienobenzoxepin%2520Inhibitors%2520of%2520PI3-Kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4054%26epage%3D4058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><div class="note"><p class="first last">There have been reports suggesting that inhibition of PI3Kβ might contribute to insulin resistance, while other reports indicate a minor role of PI3Kβ in insulin signaling. For a recent review including discussion of the role of PI3Kβ in metabolism see the following: </p></div><span class="NLM_contrib-group">Costa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span> </span><span class="NLM_article-title">More Than Just Kinases: The Scaffolding Function of PI3K</span> <span class="citation_source-journal">Curr. Top. Microbiol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2011&pages=171-182&author=C.+Costaauthor=E.+Hirsch&title=More+Than+Just+Kinases%3A+The+Scaffolding+Function+of+PI3K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DC.%26aulast%3DHirsch%26aufirst%3DE.%26atitle%3DMore%2520Than%2520Just%2520Kinases%253A%2520The%2520Scaffolding%2520Function%2520of%2520PI3K%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D2011%26volume%3D346%26spage%3D171%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><div class="note"><p class="first last">The first crystal structure of PI3Kβ was reported after the completion of our studies: </p></div><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vadas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perisic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=567-578&author=X.+Zhangauthor=O.+Vadasauthor=O.+Perisicauthor=K.+E.+Andersonauthor=J.+Clarkauthor=P.+T.+Hawkinsauthor=L.+R.+Stephensauthor=R.+L.+Williams&title=Structure+of+Lipid+Kinase+p110%CE%B2%2Fp85%CE%B2+Elucidates+an+Unusual+SH2-Domain-Mediated+Inhibitory+Mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DVadas%26aufirst%3DO.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DStructure%2520of%2520Lipid%2520Kinase%2520p110%25CE%25B2%252Fp85%25CE%25B2%2520Elucidates%2520an%2520Unusual%2520SH2-Domain-Mediated%2520Inhibitory%2520Mechanism%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D41%26spage%3D567%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Walker, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perisic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1016%2FS1097-2765%2805%2900089-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=11090628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=909-919&author=E.+H.+Walkerauthor=M.+E.+Pacoldauthor=O.+Perisicauthor=L.+Stephensauthor=P.+T.+Hawkinsauthor=M.+P.+Wymannauthor=R.+L.+Williams&title=Structural+Determinants+of+Phosphoinositide+3-Kinase+Inhibition+by+Wortmannin%2C+LY294002%2C+Quercetin%2C+Myricetin%2C+and+Staurosporine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine</span></div><div class="casAuthors">Walker, Edward H.; Pacold, Michael E.; Perisic, Olga; Stephens, Len; Hawkins, Philip T.; Wymann, Matthias P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">909-919</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The specific phosphoinositide 3-kinase (P13K) inhibitors wortmannin and LY294002 have been invaluable tools for elucidating the roles of these enzymes in signal transduction pathways.  The X-ray crystallog. structures of P13K bound to these lipid kinase inhibitors and to the broad-spectrum protein kinase inhibitors quercetin, myricetin, and staurosporine reveal how these compds. fit into the ATP binding pocket.  With a nanomolar IC50, wortmannin most closely fits and fills the active site and induces a conformational change in the catalytic domain.  Surprisingly, LY294002 and the lead compd. on which it was designed, quercetin, as well as the closely related flavonoid myricetin bind P13K in remarkably different orientations that are related to each other by 1800 rotations.  Staurosporine/P13K interactions are reminiscent of low-affinity protein kinase/staurosporine complexes.  These results provide a rich basis for development of isoform-specific P13K inhibitors with therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgIbTky2xQmbVg90H21EOLACvtfcHk0lg19Flt8FjP_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D&md5=5dd92f9b48c437e43c0023fdff10c1ac</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2805%2900089-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252805%252900089-4%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DE.%2BH.%26aulast%3DPacold%26aufirst%3DM.%2BE.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DStephens%26aufirst%3DL.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DStructural%2520Determinants%2520of%2520Phosphoinositide%25203-Kinase%2520Inhibition%2520by%2520Wortmannin%252C%2520LY294002%252C%2520Quercetin%252C%2520Myricetin%252C%2520and%2520Staurosporine%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D909%26epage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Berndt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hon, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rückle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">The p110δ Structure: Mechanisms for Selectivity and Potency of New PI(3)K Inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.-C.+Honauthor=P.+Renauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+R%C3%BCckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williams&title=The+p110%CE%B4+Structure%3A+Mechanisms+for+Selectivity+and+Potency+of+New+PI%283%29K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110δ.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110δ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110δ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0lg19Flt8FjP_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.-C.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DThe%2520p110%25CE%25B4%2520Structure%253A%2520Mechanisms%2520for%2520Selectivity%2520and%2520Potency%2520of%2520New%2520PI%25283%2529K%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D117%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, L.</span><span> </span><span class="NLM_article-title">The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1744</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1744-1748&author=C.+H.+Huangauthor=D.+Mandelkerauthor=O.+Schmidt-Kittlerauthor=J.+Zhuauthor=C.+Huangauthor=K.+Kinslerauthor=B.+Vogelsteinauthor=L.+Amzel&title=The+Structure+of+a+Human+p110%CE%B1%2Fp85%CE%B1+Complex+Elucidates+the+Effects+of+Oncogenic+PI3K%CE%B1+Mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DKinsler%26aufirst%3DK.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DAmzel%26aufirst%3DL.%26atitle%3DThe%2520Structure%2520of%2520a%2520Human%2520p110%25CE%25B1%252Fp85%25CE%25B1%2520Complex%2520Elucidates%2520the%2520Effects%2520of%2520Oncogenic%2520PI3K%25CE%25B1%2520Mutations%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1744%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">For a comparative analysis of the binding sites of the four class I PI3Ks see the following: </p></div><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_contrib-group">Amzel, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabelli, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span> </span><span class="NLM_article-title">Structural Comparisons of Class I Phosphoinositide-3-Kinases</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1038%2Fnrc2443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=18633356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWksLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=665-669&author=L.+M.+Amzelauthor=C.-H.+Huangauthor=D.+Mandelkerauthor=C.+Lengauerauthor=S.+B.+Gabelliauthor=B.+Vogelstein&title=Structural+Comparisons+of+Class+I+Phosphoinositide-3-Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural comparisons of class I phosphoinositide 3-kinases</span></div><div class="casAuthors">Amzel, L. Mario; Huang, Chuan-Hsiang; Mandelker, Diana; Lengauer, Christoph; Gabelli, Sandra B.; Vogelstein, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">665-669</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The recent detn. of the structure of the class I phosphoinositide 3-kinase PI3Kα has identified important structural differences between the class 1 PI3Ks.  How can this information be used to improve cancer therapy.  Class I phosphoinositide 3-kinases (PI3Ks) are lipid kinases that regulate cell growth.  One of these kinases, PI3Kα, is frequently mutated in diverse tumor types.  The recently detd. structure of PI3Kα reveals features that distinguish this enzyme from related lipid kinases.  In addn., wild-type PI3Kγ differs from PI3Kα by a substitution identical to a PI3Kα oncogenic mutant (His1047Arg) that might explain the differences in the enzymic activities of the normal and mutant PI3Kα.  Comparison of the PI3K structures also identified structural features that could potentially be exploited for the design of isoform-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-V2mKhromdrVg90H21EOLACvtfcHk0lhr9MnUUH8CbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWksLfJ&md5=2f6c4b1db6f8c9eb6ab712f5a83f4e70</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2443%26sid%3Dliteratum%253Aachs%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26aulast%3DHuang%26aufirst%3DC.-H.%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DStructural%2520Comparisons%2520of%2520Class%2520I%2520Phosphoinositide-3-Kinases%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D665%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_contrib-group">Sabbah, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, H.</span><span> </span><span class="NLM_article-title">Docking Studies on Isoform-Specific Inhibition of Phosphoinositide-3-Kinases</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1887</span><span class="NLM_x">–</span> <span class="NLM_lpage">1898</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci1002679" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtF2lurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1887-1898&author=D.+A.+Sabbahauthor=J.+L.+Vennerstromauthor=H.+Zhong&title=Docking+Studies+on+Isoform-Specific+Inhibition+of+Phosphoinositide-3-Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Studies on Isoform-Specific Inhibition of Phosphoinositide-3-Kinases</span></div><div class="casAuthors">Sabbah, Dima A.; Vennerstrom, Jonathan L.; Zhong, Haizhen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1887-1898</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol 3-kinase α (PI3Kα) is a promising target for anticancer drug design.  Oncogenic mutation H1047R in the catalytic domain is obsd. in many tumors and may enhance PI3Kα kinase activity by affecting loop confirmations as well as membrane binding.  We applied docking methods to 33 PI3K inhibitors against the wild type (wt) PI3Kα, the H1047R mutant of PI3Kα and the γ isoform of PI3K (PI3Kγ).  We also investigated the effect of protein flexibility on ligand binding by docking the same set of ligands to conformations of the wt and mutant PI3Kα generated by mol. dynamics simulations.  Our data suggests that conformational differences in Gln859, Ser854, Tyr836, and Ser774 between the PI3Kα wt and H1047R mutant may be used to design ligands that are active against both the wt and H1047R mutant isoforms.  Gln859, Ser854 and Ser774 may play crit. roles in ligand binding to the α isoform H1047R mutant while formation of H-bonds with Ser806 of PI3Kγ may enhance γ-isoform-specific inhibition.  In addn. to H-bond interactions, structural and size differences in the activation and hydrophobic domains of PI3Kα, PI3Kγ, and the PI3Kα H1047R mutant could be exploited to direct the design of isoform- and/or mutant-specific PI3K inhibitors.  Our data provide a reasonable explanation for the activity and selectivity of small mol. PI3K inhibitors and are in good agreement with available exptl. and computational data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdoBkSYgv-9LVg90H21EOLACvtfcHk0ljkNk_5UkDiFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtF2lurrN&md5=39e30173b4a35afba96ce678dad3cdc1</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fci1002679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci1002679%26sid%3Dliteratum%253Aachs%26aulast%3DSabbah%26aufirst%3DD.%2BA.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26aulast%3DZhong%26aufirst%3DH.%26atitle%3DDocking%2520Studies%2520on%2520Isoform-Specific%2520Inhibition%2520of%2520Phosphoinositide-3-Kinases%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1887%26epage%3D1898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">To predict binding poses by docking, a PI3Kα H1042R mutant structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HIZ">3HIZ</a>) was chosen over the only currently available wildtype structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD0">2RD0</a>). This is because the latter is considered to suffer more significantly from artifacts of crystal packing. Docking was performed using GLIDE (Schrödinger, LLC), and the conformations of three mobile side chains (R770, K802, D933) were allowed to move. The docked pose of GDC-941 was consistent with the reported structure of this inhibitor with mouse PI3Kδ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WXP">2WXP</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">The sequences of the kinase domains of the four PI3K isoforms from multiple species were aligned using PSI-BLAST (NCBI). A mouse PI3Kδ structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WXP">2WXP</a>) was chosen as the template because among all available structures, it shares with human PI3Kβ the highest level of sequence homology both overall and around the active site. In addition, residues 1–114 at the amino terminus, which is expected to be far removed from the active site according to the known structures, were omitted in modeling. Finally, sequence alignment was manually refined (sequence identity of 52%; see <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) before a model of human PI3Kβ in complex with GDC-941 (from the template) was built using PRIME (Schrödinger, LLC) with standard parameters.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">A comparison of our homology model of PI3Kβ with the recently reported 3.3 Å cocrystal structure of PI3Kβ and <b>1</b> (ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a>) shows that the homology model correctly predicted the confirmation of the P-loop (Lys771-Ser775, numbering from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Y3A">2Y3A</a>), validating the choice of PI3Kδ as the homology template for the binding pocket.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">The aminopyrimidine group also adds mTOR inhibition and in many cases improved in vivo Cl. For details see refs <a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">8b</a> and <a onclick="showRef(event, 'cit8c'); return false;" href="javascript:void(0);" class="ref cit8c">8c</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">Electrostatic potential maps were computed using a Poisson–Boltzmann (PB) equation solver APBS Tools2 plugin for PyMOL (14a-c). Calculation was performed in nonlinear PB mode with these standard parameters: protein dielectric set as 2 and solvent dielectric as 78; atomic charges and radii assigned according to the AMBER force field; 0.150 M concentration for the +1 and −1 ion species; solvent radius of 1.4 Å; system temperature of 310 K. The molecule surface was computed using the option “similar to cubic spline, but with 7th order polynomial”, colored by the “potential on solvent accessible surface”, and visualized in PyMOL, version 1.2r3pre (Schrödinger, LLC). </p></div><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_contrib-group">Baker, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sept, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span> </span><span class="NLM_article-title">Electrostatics of Nanosystems: Application to Microtubules and the Ribosome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">10037</span><span class="NLM_x">–</span> <span class="NLM_lpage">10041</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm2007084&amp;key=10.1073%2Fpnas.181342398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm2007084&amp;key=11517324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm2007084&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=10037-10041&author=N.+A.+Bakerauthor=D+Septauthor=S+Josephauthor=M.+J.+Holstauthor=J.+A.+McCammon&title=Electrostatics+of+Nanosystems%3A+Application+to+Microtubules+and+the+Ribosome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Electrostatics of nanosystems: application to microtubules and the ribosome</span></div><div class="casAuthors">Baker, Nathan A.; Sept, David; Joseph, Simpson; Holst, Michael J.; McCammon, J. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">10037-10041</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Evaluation of the electrostatic properties of biomols. has become a std. practice in mol. biophysics.  Foremost among the models used to elucidate the electrostatic potential is the Poisson-Boltzmann equation; however, existing methods for solving this equation have limited the scope of accurate electrostatic calcns. to relatively small biomol. systems.  Here we present the application of numerical methods to enable the trivially parallel soln. of the Poisson-Boltzmann equation for supramol. structures that are orders of magnitude larger in size.  As a demonstration of this methodol., electrostatic potentials have been calcd. for large microtubule and ribosome structures.  The results point to the likely role of electrostatics in a variety of activities of these structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA_CAlhE0uX7Vg90H21EOLACvtfcHk0ljkNk_5UkDiFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D&md5=1b861999ef12c6972e82e8ada0f387cb</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.181342398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.181342398%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DN.%2BA.%26aulast%3DSept%26aufirst%3DD%26aulast%3DJoseph%26aufirst%3DS%26aulast%3DHolst%26aufirst%3DM.%2BJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DElectrostatics%2520of%2520Nanosystems%253A%2520Application%2520to%2520Microtubules%2520and%2520the%2520Ribosome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D10037%26epage%3D10041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_contrib-group">Dolinsky, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, N. A.</span><span> </span><span class="NLM_article-title">PDB2PQR: An automated Pipeline for the Setup, Execution,and Analysis of Poisson–Boltzmann Electrostatics Calculations</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">W665</span><span class="NLM_x">–</span> <span class="NLM_lpage">W667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=W665-W667&author=T.+J.+Dolinskyauthor=J.+E.+Nielsenauthor=J.+A.+McCammonauthor=N.+A.+Baker&title=PDB2PQR%3A+An+automated+Pipeline+for+the+Setup%2C+Execution%2Cand+Analysis+of+Poisson%E2%80%93Boltzmann+Electrostatics+Calculations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDolinsky%26aufirst%3DT.%2BJ.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DPDB2PQR%253A%2520An%2520automated%2520Pipeline%2520for%2520the%2520Setup%252C%2520Execution%252Cand%2520Analysis%2520of%2520Poisson%25E2%2580%2593Boltzmann%2520Electrostatics%2520Calculations%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3DW665%26epage%3DW667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_contrib-group">Lerner, M. G.; Carlson, H. A.</span> <span class="citation_source-book">APBS Plugin for PyMOL</span>; <span class="NLM_publisher-name">University of Michigan</span>: <span class="NLM_publisher-loc">Ann Arbor, MI</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+G.+Lerner&author=H.+A.+Carlson&title=APBS+Plugin+for+PyMOL"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DM.%2BG.%26btitle%3DAPBS%2520Plugin%2520for%2520PyMOL%26pub%3DUniversity%2520of%2520Michigan%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Edgar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvin, M.</span><span> </span><span class="NLM_article-title">Isoform-Specific Phosphoinositide 3-Kinase Inhibitors Exert Distinct Effects in Solid Tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1164</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1164-1172&author=K.+A.+Edgarauthor=J.+J.+Wallinauthor=M.+Berryauthor=L.+B.+Leeauthor=W.+W.+Priorauthor=D.+Sampathauthor=L.+S.+Friedmanauthor=M.+Belvin&title=Isoform-Specific+Phosphoinositide+3-Kinase+Inhibitors+Exert+Distinct+Effects+in+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdgar%26aufirst%3DK.%2BA.%26aulast%3DWallin%26aufirst%3DJ.%2BJ.%26aulast%3DBerry%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DBelvin%26aufirst%3DM.%26atitle%3DIsoform-Specific%2520Phosphoinositide%25203-Kinase%2520Inhibitors%2520Exert%2520Distinct%2520Effects%2520in%2520Solid%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1164%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Folkes, A.; Shuttleworth, S.; Chuckowree, I.; Oxenford, S.; Wan, N. C.; Castanedo, G.; Gunzner, J.; Heffron, T.; Mathieu, S.; Olivero, A.; Sutherlin, D. P.; Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Preparation of Thienopyrimidines and Furopyrimidines as Lipid Kinase Inhibitors for Treating Cancer and Other Diseases</span>. WO2007/127175 A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Folkes&author=S.+Shuttleworth&author=I.+Chuckowree&author=S.+Oxenford&author=N.+C.+Wan&author=G.+Castanedo&author=J.+Gunzner&author=T.+Heffron&author=S.+Mathieu&author=A.+Olivero&author=D.+P.+Sutherlin&author=B.-Y.+Zhu&title=Preparation+of+Thienopyrimidines+and+Furopyrimidines+as+Lipid+Kinase+Inhibitors+for+Treating+Cancer+and+Other+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520Thienopyrimidines%2520and%2520Furopyrimidines%2520as%2520Lipid%2520Kinase%2520Inhibitors%2520for%2520Treating%2520Cancer%2520and%2520Other%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">The synthetic details of the remaining compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> are found in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> and the following: </p></div><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_contrib-group">Folkes, A.; Shuttleworth, S.; Chuckowree, I.; Oxenford, S.; Wan, N. C.; Castanedo, G.; Gunzner, J.; Heffron, T.; Mathieu, S.; Olivero, A.; Sutherlin, D. P.; Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Preparation of Thienopyrimidines and Furopyrimidines as Lipid Kinase Inhibitors for Treating Cancer and Other Diseases</span>. WO2007/127175 A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Folkes&author=S.+Shuttleworth&author=I.+Chuckowree&author=S.+Oxenford&author=N.+C.+Wan&author=G.+Castanedo&author=J.+Gunzner&author=T.+Heffron&author=S.+Mathieu&author=A.+Olivero&author=D.+P.+Sutherlin&author=B.-Y.+Zhu&title=Preparation+of+Thienopyrimidines+and+Furopyrimidines+as+Lipid+Kinase+Inhibitors+for+Treating+Cancer+and+Other+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520Thienopyrimidines%2520and%2520Furopyrimidines%2520as%2520Lipid%2520Kinase%2520Inhibitors%2520for%2520Treating%2520Cancer%2520and%2520Other%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_contrib-group">Castanedo, G.; Dotson, J.; Goldsmith, R.; Gunzner, J.; Heffron, T.; Mathieu, S.; Olivero, A.; Staben, S.; Sutherlin, D. P.; Tsui, V.; Wang, S.; Zhu, B.-Y.; Bayliss, T.; Chuckowree, I.; Folkes, A.; Wan, N. C.</span><span> </span><span class="NLM_article-title">Thienopyrimidine and Furopyrimidine Derivatives as Phosphoinositide 3-Kinase Inhibitor and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Cancer</span>. WO2008/073785 A2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+Castanedo&author=J.+Dotson&author=R.+Goldsmith&author=J.+Gunzner&author=T.+Heffron&author=S.+Mathieu&author=A.+Olivero&author=S.+Staben&author=D.+P.+Sutherlin&author=V.+Tsui&author=S.+Wang&author=B.-Y.+Zhu&author=T.+Bayliss&author=I.+Chuckowree&author=A.+Folkes&author=N.+C.+Wan&title=Thienopyrimidine+and+Furopyrimidine+Derivatives+as+Phosphoinositide+3-Kinase+Inhibitor+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%26atitle%3DThienopyrimidine%2520and%2520Furopyrimidine%2520Derivatives%2520as%2520Phosphoinositide%25203-Kinase%2520Inhibitor%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Cancer%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_contrib-group">Bayliss, T.; Chuckowree, I.; Folkes, A.; Oxenford, S.; Wan, N. C.; Castanedo, G.; Goldsmith, R.; Gunzner, J.; Heffron, T.; Olivero, A.; Staben, S.; Sutherlin, D.; Zhu, B.-Y.</span><span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use</span>. WO2008/070740 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+Bayliss&author=I.+Chuckowree&author=A.+Folkes&author=S.+Oxenford&author=N.+C.+Wan&author=G.+Castanedo&author=R.+Goldsmith&author=J.+Gunzner&author=T.+Heffron&author=A.+Olivero&author=S.+Staben&author=D.+Sutherlin&author=B.-Y.+Zhu&title=Phosphoinositide+3-Kinase+Inhibitor+Compounds+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBayliss%26aufirst%3DT.%26atitle%3DPhosphoinositide%25203-Kinase%2520Inhibitor%2520Compounds%2520and%2520Methods%2520of%2520Use%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22d"><span><span class="NLM_contrib-group">Babu, S.; Cheng, Z.; Reynolds, M. E.; Savage, S. J.; Tian, Q.; Yajima, H.</span><span> </span><span class="NLM_article-title">Process for the Preparation of Thienopyrimidines as PI3K Inhibitors</span>. WO2009/055730 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Babu&author=Z.+Cheng&author=M.+E.+Reynolds&author=S.+J.+Savage&author=Q.+Tian&author=H.+Yajima&title=Process+for+the+Preparation+of+Thienopyrimidines+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBabu%26aufirst%3DS.%26atitle%3DProcess%2520for%2520the%2520Preparation%2520of%2520Thienopyrimidines%2520as%2520PI3K%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">The synthetic details of the remaining compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> are found in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a> and the following: </p></div><span class="NLM_contrib-group">Do, S.; Goldsmith, R.; Heffron, T.; Kolesnikov, A.; Staben, S.; Olivero, A. G.; Siu, M.; Sutherlin, D. P.; Zhu, B.-Y.; Goldsmith, P.; Bayliss, T.; Folkes, A.; Pegg, N.</span><span> </span><span class="NLM_article-title">Preparation of Benzopyran and Benzoxepin as PI3K Inhibitors</span>. US2009/0247567 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Do&author=R.+Goldsmith&author=T.+Heffron&author=A.+Kolesnikov&author=S.+Staben&author=A.+G.+Olivero&author=M.+Siu&author=D.+P.+Sutherlin&author=B.-Y.+Zhu&author=P.+Goldsmith&author=T.+Bayliss&author=A.+Folkes&author=N.+Pegg&title=Preparation+of+Benzopyran+and+Benzoxepin+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDo%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520Benzopyran%2520and%2520Benzoxepin%2520as%2520PI3K%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T8M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3T8M','PDB','3T8M'); return false;">PDB: 3T8M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DBS','PDB','3DBS'); return false;">PDB: 3DBS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R7R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R7R','PDB','3R7R'); return false;">PDB: 3R7R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HIZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HIZ','PDB','3HIZ'); return false;">PDB: 3HIZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD0','PDB','2RD0'); return false;">PDB: 2RD0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WXP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2WXP','PDB','2WXP'); return false;">PDB: 2WXP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Y3A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Y3A','PDB','2Y3A'); return false;">PDB: 2Y3A</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i96"><a href="/doi/suppl/10.1021/jm2007084">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34215"></div></div></div></div></div><hr /></hr><p class="last">A homology model of human PI3Kβ in PDB format and the sequence alignment of human PI3Kβ and mouse PI3Kδ that was used for model building. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2007084/suppl_file/jm2007084_si_001.pdb">jm2007084_si_001.pdb (1.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2007084/suppl_file/jm2007084_si_002.pdf">jm2007084_si_002.pdf (44.53 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm2007084&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm2007084%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm2007084" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679980542b213c70","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
